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ABSTRACT 
 
Jacqueline Pearl Kaplan: Impact of Free Chlorine on the Fate of Biochemically Active 
Compounds in Drinking Water  
(Under the direction of Dr. Howard S. Weinberg) 
 
As a result of the rapid development of the pharmaceutical and agricultural industries, 
the biochemically active compounds they produce to treat human ailments, maintain 
livestock health, and improve crop output are finding their way into the aquatic environment.  
Surface waters supplying drinking water treatment plants may be particularly vulnerable if 
the chemicals persist through upstream wastewater treatment or appear in run-off from land 
application.  During drinking water treatment physicochemical processes may remove some 
of these chemicals or transform them into products with unknown structures and biological 
activity.   
In order to better understand the impacts of biochemically active compounds on water 
supply and their fate during drinking water treatment source, settled, and finished waters 
from plants in North Carolina were analyzed using liquid chromatography tandem mass 
spectrometry. Both atrazine and the insecticide DEET were found to consistently survive 
conventional treatment. Additionally, bench-scale chlorination experiments designed to 
simulate disinfection were conducted to determine the extent of chlorine incorporation into 
the parent chemical thereby “hiding” products from detection which may still have 
biochemical activity.   
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1. INTRODUCTION 
 
Areas of rapid commercial and scientific development are the pharmaceutical, 
personal care product and agricultural chemical industries in which compounds are 
synthesized to treat human ailments, improve livestock health and quality of human life, and 
control agricultural crop output.  These compounds are synthesized to have a particular 
biochemical functionality that is specific to the application for which the product was 
designed.  If the biochemically active compound (BAC) migrates away from its target it may 
have unintended consequences for human and environmental health.  Major sources of 
introduction of BACs into the environment are from the release of treated wastewater 
effluent into receiving streams and surface water runoff with the consequence that some are 
found downstream in reservoirs that become drinking water sources.  This means that the 
parent compounds as well as their metabolites are constantly released at low concentrations 
into the environment and drinking water sources with unknown long-term consequences.  
Although studies have shown the attenuation of parent BACs during drinking water treatment 
(Stackelberg et al., 2007), other studies have shown that the parent BAC may have 
undergone transformation (Glassmeyer and Shoemaker, 2005).  It has been observed that the 
active ingredients in BACs are not limited to illicit a response in the target organism, and 
there are indications that aquatic organisms which are exposed to BAC residues in water may 
be negatively affected (Jobling et al., 1998).  Determining both the fate of parent BACs and 
the identity of the unknown transformation products formed during drinking water treatment 
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remains a challenging area of environmental research, but would provide essential 
information to help direct toxicology and sampling research, evaluate effective treatment 
technologies, and develop more environmentally responsible drug and agricultural products.   
 
 
1.1 Literature Review 
1.1.1 Uses of Biochemically Active Compounds 
Biochemically active compounds (BACs) are those manufactured to effect a 
biological response in a target cell, and include a broad range of compounds including human 
and animal use pharmaceuticals, personal care products (PCPs), endocrine disrupting 
compounds (EDCs), agricultural products, artificial sweeteners and stimulants.  
Pharmaceutical compounds are those that are available either with or without a prescription 
including antibiotics, lipid regulators, beta blockers, anti-epileptics, anti-cholesterols, 
analgesics and anti-anxiety compounds to name a few.  PCPs include compounds that are in 
soaps and lotions such as anti-microbial agents as well as insect repellants and flame 
retardants.  EDCs induce a change in the endocrine system and include steroid hormones and 
synthetic estrogens, among others.  Agricultural products are those that are used for land 
application and include herbicides and insecticides.  Other compounds that are biochemically 
active are stimulants such as caffeine, artificial sweeteners such as sucralose, and illegal 
drugs.   
In 2009, human-use pharmaceutical sales accounted for a $300.3 billion dollar 
industry in the United States (Gatyas and Savage, 2008), and this figure does not take into 
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account the illegal purchase of prescription or recreational drug use.  The top six most 
commonly prescribed pharmaceuticals in the U.S. were lipid regulators, analgesics, thyroid 
regulators, blood pressure regulators and antibiotics (rxlist.com).  Antibiotics and steroid 
hormones are the most commonly used veterinary pharmaceuticals and account for a 
significant portion of the pharmaceuticals used.  
In the U.S. PCPs and agricultural chemicals including flame retardants, 
antimicrobials, detergents, pesticides and herbicides are highly used.  For example, the 
average annual estimate of the use of the insect repellant N,N-diethyl-meta-toluamide 
(DEET) in 1990 was approximately 4 million pounds of the active ingredient (U.S. EPA, 
1998).  The herbicide, atrazine, is one of the two most highly used agricultural pesticides, 
and is used for the majority of the corn, sugarcane, and sorghum production (U.S.EPA, 
2006).  The estimated annual use of atrazine is 64 to 76 million pounds and prohibiting its 
use would result in a significant loss in crop yield and revenue for the industry (U.S.EPA, 
2006).  Although these figures are not up to date it may be assumed that the current use of 
human and veterinary pharmaceuticals, PCPs, and agricultural chemicals is at least as high as 
the reported values.   
 
 
1.1.2 Routes of BAC Exposure into the Environment 
Due to their variety of uses, there are many pathways of BACs into the environment 
(Figure 1.1).  Veterinary pharmaceuticals such as antibiotics and steroid hormones are 
incompletely metabolized and the pharmaceutical residues in animal waste can contaminate 
surface waters (Table 1.1).  Incomplete metabolism of human-use pharmaceuticals in the 
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body also results in their excretion and subsequent introduction into wastewater treatment 
plants (WWTPs).  Limited options for unused prescription drug disposal results in BACs 
being flushed down the toilet or thrown out in the trash allowing them to enter WWTPs or 
landfills, respectively.  PCPs such as sunscreens, bug sprays, lotions, etc. may wash off the 
user when either washing hands, showering, or swimming in lakes/rivers.   
 
 
 
Figure 1.1 Pathways of BACs into Drinking Water (Heberer, 2002) 
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Table 1.1  Percent Excretion of BACs from the Body Unchanged  
   
Compound Excretion as unchanged (%) Reference 
   
Atenolol 50 Kasprzyk-Hordern et al., 2009 
Bezafibrate 50 Kasprzyk-Hordern et al., 2009 
Carbamazepine 3 Kasprzyk-Hordern et al., 2009 
Diclofenac 5-10 Kasprzyk-Hordern et al., 2009 
Erythromycin-H2O >60 Hirsch et al., 1999 
Ibuprofen 1 Kasprzyk-Hordern et al., 2009 
Sulfamethoxazole 30 Kasprzyk-Hordern et al., 2009 
Tetracycline 80-90 Hirsch et al., 1999 
Trimethoprim 80 Kasprzyk-Hordern et al., 2009 
 
 
Wastewater treatment does not achieve effective removal for many BACs (Table 1.2), 
and this may be due to the high polarities of the compounds and their preference for the 
aqueous phase as well as their biological properties.  Treated wastewater effluent is released 
into receiving streams that may become downstream sources of drinking water.  In fact, 
compounds resistant to removal during wastewater treatment are used as indicator 
compounds to determine if surface or drinking waters have been impacted by wastewater 
treatment plant effluent (Ferreira et al., 2005).  These multiple routes of exposure into the 
environment including incomplete removal during wastewater treatment results in BACs 
being constantly introduced into surface waters and increases the potential for contaminating 
drinking water sources. 
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Table 1.2  Removal of BACs During Wastewater Treatment (Heberer, et al., 2002) 
     
Compound Cave influent(µg/L) Cave effluent(µg/L) Removal (%) 
    
Carbamazepine 1.78 1.63 8 
Clofibric acid 0.46 0.48 0 
Diclofenac 3.02 2.51 17 
Caffeine 230 0.18 <99.9 
 
 
 There are also many ways in which BACs may contaminate water resources as the 
result of land use.  The application of herbicides and insecticides to agricultural land is 
usually completed by spraying fields.  Due to this practice, herbicide aerosols may be directly 
introduced into the atmosphere or may sorb onto particulate matter in the air where it is then 
transported long distances via wind.  A study of air samples collected in 1995 showed that in 
agricultural areas during the application of the widely used herbicide atrazine, it was detected 
in 67% (n = 21) of particulate samples (Cmax= 0.42ng/m3) and in 42% (n = 21) of air samples 
(Cmax=2.6ng/m3) (Coupe et al., 2000).  The same study also showed that atrazine was 
detected in urban air in 29% (n = 24) (Cmax= 0.019ng/m3) on particulate and was not detected 
in the gas phase (Coupe et al., 2000).   
Atrazine that reaches land can be transported during rain events to surface water due 
to storm water runoff from agricultural fields (Thurman et al., 1992).  Additionally, atrazine 
may be transported to ground water by migrating through soil and has been detected in wells 
at concentrations up to 2.09µg/L (Burkart and Kolpin, 1993).  Atrazine that has been 
deposited onto fields may volatilize into the atmosphere, although the rate was found to be 
relatively low in comparison to other herbicides most likely due to its low vapor pressure 
(Glotfelty et al., 1989).   
7 
 
Whether atrazine is directly released into the atmosphere as an aerosol, bound to 
particulate matter in the air, or evaporates from soil, rain events may scrub the atmosphere, 
with particulate matter being more effectively removed (Goolsby et al., 1997).  A two year 
study showed that atrazine was always present in rainwater samples with the highest detected 
concentration of 2.19 µg/L during the early spring (May), which correlated to the spraying of 
the fields with the herbicide around that time (Wu, 1981).  Rainwater can incorporate 
aerosols and particulate matter and one study by the U.S. Geological Survey (USGS) 
revealed that atrazine was detected in 30.2% of all rainwater samples tested from the 
midwestern and northeastern U.S. (n=2,085) and was present in rainfall at concentrations up 
to 10.9 µg/L (Goolsby et al., 1997).  As the result of atrazine being transported via wind and 
scrubbed from the atmosphere by rain it is potentially deposited into surface water. 
The aforementioned discussion is just a brief overview of the complex nature of the 
fate of atrazine after its introduction to the environment.  As with many anthropogenic 
compounds, its fate is extremely complex and not well understood.  Therefore, extreme 
caution should be undertaken when highly persistent and ubiquitous chemicals are being 
constantly introduced into the environment.  A summary of some of the routes of exposure of 
BACs into the environment are shown in Figure 1.1.   
 
 
1.1.3 Fate of BACs in the Environment 
Physicochemical Properties 
Pharmaceuticals and their metabolites that persist through both the human body and 
wastewater treatment, enter receiving streams where they are subjected to dilution, 
photolysis, biodegradation, hydrolysis, and sorption onto soils and sediments (Lam et al., 
8 
 
2004; Lam and Mabury, 2005; Löffler et al., 2005).  PCPs are either introduced directly into 
surface waters as the result of recreational use or may be subjected to wastewater treatment 
and eventual release into the environment.  Agricultural chemicals and animal use 
pharmaceuticals are subjected to dilution, photolysis, and hydrolysis in surface water, 
mobility through soils, and transport via evaporation or sorption onto particulate matter in the 
atmosphere.  Important physicochemical properties that govern a compound’s behavior and 
ultimate fate in the environment are the octanol-water distribution coefficient (Kow) and the 
acidity constant(s) (pKa).   
The Kow describes a compounds affinity for either the organic or aqueous phase of a 
solution and is helpful in understanding if a compound will be more likely to remain in water 
or migrate into soils/sediments.  If a chemical has a high log Kow value which indicates 
hydrophobicity such as for the steroid hormones compounds (estrone and 17-α-ethinyl 
estradiol (EE2)), this means that the chemical is more likely to sorb onto soils and not be 
detected in the aqueous phase.  As a result BACs that migrate into soils may be subjected to 
biodegradation or uptake into plants.  BACs with low log Kow values are expected to be more 
polar and hydrophilic and are more likely to remain in the aqueous phase.  
The pKa, or acidity constant, indicates the speciation (protonated or deprotonated) of 
a compound based on the pH of the solution.  When the pKa of a compound is higher than the 
pH of water the BAC will exist in its protonated state.  As an example, acetaminophen with a 
pKa of 9.7 will exist as a neutral species in natural waters where the pH is typically in the 
range 6-9.  In summary, compounds with low values of log Kow and pKa are more likely to 
persist in the aquatic environment as opposed to the sediment system (Löffler et al., 2005). 
Table 1.3 shows log Kow and pKa values for a range of BACs and Figure 1.2 the pH 
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dependent dissociation in water for three BACs.  Table 1.3 also shows, in parenthesis, the pH 
dependent transitions of each BAC.   
 
 
Photolysis and Sorption onto Soils 
Organic compounds are able to undergo direct (i.e. light directly from the sun) or 
indirect (i.e. from photolysis radicals) photolysis, and the mechanism of action varies 
between BACs (Lam and Mabury, 2005).  A study on the persistence of eight 
pharmaceuticals in controlled outdoor field microcosms concluded that indirect photolysis 
reactions due to the presence of dissolved organic matter (DOM) in water are more likely to 
degrade pharmaceuticals in the natural environment than hydrolysis or biodegradation (Lam 
et al., 2004).  A compound in the tetracycline family of antibiotics was found to degrade 
rapidly under sunlight irradiation and photolysis was proposed to contribute more 
significantly to the attenuation than hydrolysis in shallow non-turbid water (Xuan et al., 
2010).  The chemical structure of BACs including heteroatoms, aromatic rings, phenol, and 
nitro groups explain their reactivity due to their ability to absorb solar radiation (Boreen et 
al., 2003).   
Interactions of BACs between the water/sediment systems can also impact their fate.  
Hydrophobic chemicals have a higher affinity towards sediment systems (Löffler et al., 
2005).  Of the BACs listed in Table 1.3 those with the highest log Kow values are 17-α-ethinyl 
estradiol, estrone, bezafibrate, and gemfibrozil.  The log Kow values of these compounds 
correlate to their intended biochemical endpoints in which all are lipids and hydrophobic.  
Compounds with the lowest log Kow values include acetaminophen, atenolol and caffeine, 
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and these polar and hydrophilic compounds have been found to remain in the aqueous phase 
and are not detected in sediments (Wu et al., 2009).  The persistence of BACs that are 
applied directly to land are of particular interest, and the adsorption of pesticides including 
atrazine is largely dependent on soil composition and pH (Gao et al., 1998). 
 
 
Hydrolysis 
The results of a microcosm study in water revealed that attenuation of the studied 
BACs (acetaminophen, caffeine, carbamazepine, sulfamethoxazole, and trimethoprim) was 
minimal and therefore hydrolysis was not considered to have a large impact on the 
degradation of the studied compounds (Lam et al., 2004).  Also, a compound in the 
tetracycline family of antibiotics was found to undergo hydrolysis fastest at neutral pH, but 
was not the primary method of attenuation as degradation was found to be minimal in the 
dark (Xuan et al., 2010). 
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Table 1.3  Physical Properties of BACs 
   
BAC Log Kow pKa 
   
17-α-ethynylestradiol 3.67b ~10.5b (0/-) 
Acetaminophen 0.46b 9.7b (0/-) 
Atenolol 0.16c 9.6e (0/-) 
Atrazine 2.61b <2b (+/0) 
Bezafibrate 4.25f 3.6e (0/-) 
Caffeine <0b 6.1b (+/0) 
Carbamazepine 2.45b <2b (+/0) 
Clofibric Acid 2.57f 3.2g (0/-) 
DEET= N,N-Diethyl-meta-toluamide 2.18b <2b (+/0) 
Diazepam 2.82b 2.4/1.5b (2+/+/0) 
Diclofenac 0.7b 4.15e (0/-) 
Estrone 3.13c 10.3b (0/-) 
Erythromycin-hydrate 3.06b 8.2h (0/-) 
Fenoprop 3.86m 3.2a (0/-) 
Gemfibrozil 4.77b 4.7b (0/-) 
Ibuprofen 3.97b 4.5b (0/-) 
Meprobamate 0.7b <2b(+/0) 
Sucralose  -0.5i Not Applicable 
Sulfamethoxazole 0.89b 1.7/5.6n (0/-/2-) 
TCEP= tris(2-carboxyethyl)phosphine 1.44d Not Found 
Tetracycline  -1.19j 3.30/7.68/9.69k (+/0/-/2-) 
Trimethoprim 0.91b 1.3o/7.5l (2+/+/0) 
 Legend 0 = neutral; - = negatively charged species; + = positively charged species 
(a)Garrison et al., 1994; (b)Westerhoff et al., 2005; (c) Hansch et al., 1995; (d) Trenholm et 
al., 2006; (e) SRC, 2011; (f) Kujawa-Roeleveld et al., 2008; (g) Bhandari et al., 2009; (h) 
Qiang and Adams, 2004; (i) Neset et al., 2010; (j) Wollenberger et al., 2000; (k) Stephens 
et al., 1956; (l) Cocco et al., 1983; (m) Isnard and Lambert, 1989; (n) Lucida et al., 2000; 
(o) Cao and Cross, 2000 
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Figure 1.2 pH Dependent Speciation of BACs: (a) Acetaminophen, (b) Trimethoprim, and (c) 
Tetracycline 
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1.1.4 Analytical Methods 
The development of sensitive methods amenable to the extraction and analysis of 
BACs is based on pairing knowledge of physicochemical properties of target BACs with 
available analytical instrumentation.  This is not an easy task as BACs have a wide range of 
polarities and exist as acidic, neutral, or basic species.  An effective goal is to have a 
comprehensive method that can process a variety of BACs with the minimal amount of 
sample preparation which usually includes sample collection, preservation, filtration, 
extraction, elution, concentration, and instrumental analysis.   
Due to their high sensitivity and selectivity, the analytical instruments of choice are 
mass spectrometers (MS).  While it is possible to scan for a broad range of masses (full scan 
analysis) this practice drastically reduces sensitivity.  Therefore, one limitation of mass 
spectrometry is that you can only detect compounds with a high level of sensitivity that are 
directly targeted in the method.  This is achieved by selecting specific ions and/or ion 
transitions associated with a particular molecule to reduce any noise relating to non-target 
compounds.  Mass spectrometry has been paired with liquid chromatography (LC) or gas 
chromatography (GC) for the separation and analysis of more polar and more volatile 
compounds, respectively.    
Preservation of drinking water samples for analysis is achieved by quenching any 
residual disinfectant to stop reactions that may be transforming BACs.   Methods have been 
developed for the analysis of surface and drinking water that utilize pH adjustment with 
sample clean-up and concentration using solid phase extraction (SPE) to extract a broad 
range of BACs by adsorption onto a hydrophilic-lipophilic balance (HLB) cartridge 
(Vanderford et al.,2003; Trenholm et al., 2006).  BAC analysis can be completed after 
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sample extraction and concentration using both gas chromatography-mass spectrometry (GC-
MS) and liquid chromatography (tandem) mass spectrometry LC-MS/(MS) methods with 
reporting limits between 1-10ng/L (Trenholm et al., 2006).  Sample preparation is minimized 
through the use of different analytical methods that use LC-MS/MS in both positive and 
negative electrospray ionization (+/-ESI) and positive atmospheric pressure chemical 
ionization (+APCI) with reporting limits of 1.0ng/L (Vanderford et al., 2003).  One major 
analytical challenge is maintaining up to date methods with the production of new 
pharmaceuticals.  Occurrence data for environmental samples depends on targeting known 
chemicals since LC-MS methods are, for the most part, unable to screen for unknowns at the 
low levels expected.  Identifying effective methods to screen drugs for environmental 
toxicity screening or persistence may help guide environmental sampling efforts.  
 
 
1.1.5 Presence of BACs in Natural Waters 
Occurrence studies have revealed that BACs are ubiquitous environmental 
contaminants being detected in both U.S. streams (Kolpin et al., 2002) and drinking water 
sources (Focazio et al., 2008).  This is a cause for public health concern because the effects 
of long-term exposure to low level contaminants are unknown.  Additionally, the impact of 
chronic low level exposure to BACs on aquatic life is not well understood, although some 
negative effects have been observed (Chambers and Leiker, 2006).  Many occurrence studies 
have been completed to determine the concentration of BACs in surface waters.  The U.S. 
Geological Survey (USGS) has completed nationwide occurrence studies on organic 
wastewater contaminants in U.S. streams (Kolpin et al., 2002) and data from this study is 
15 
 
summarized in Table 1.4.  It is important to note that in this study the selection of the 139 
sampling sites were biased towards those that were more likely to be impacted by both 
urbanization and livestock production. 
 
 
Table 1.4  Occurrence Levels of BACs in U.S. Streams 1999-2000 (Kolpin et al., 2002) 
    Compound Cmax(µg/L) Frequency (%) 
17-α-ethinyl estradiol (n=70) 0.831 15.7 
17β-estradiol (n=70) 0.093 10 
Acetaminophen (n=84) 10 23.8 
Caffeine (n=84) 6 61.9 
DEET (n=54) 1.1 74.1 
Erythromycin-H2O (n=104) 1.7 21.5 
Estriol (n=70) 0.051 21.4 
Estrone (n=70) 0.112 7.1 
Gemfibrozil (n=84) 0.79 3.6 
Ibuprofen (n=84) 1 9.5 
Mestranol (n=70) 0.407 10 
Sulfamethoxazole (n=104) 1.9 12.5 
Tetracycline (n=84) 0.11 1.2 
TCEP (n=85) 0.54 57.6 
Triclosan (n=85) 2.3 57.6 
Trimethoprim (n=104) 0.71 12.5 
 
 
The most frequently detected BACs in Table 1.5 were the PCPs caffeine, DEET, 
triclosan, and tris(2-carboxyethyl)phosphine (TCEP), and this is most likely a direct result of 
their high use (do not need a prescription to buy) and preference for the aqueous phase (see 
log Kow values in Table 1.4).  The non-prescription pharmaceuticals (acetaminophen and 
ibuprofen) were detected less frequently than the PCPs but acetaminophen was detected at 
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high concentrations.  Ibuprofen, due to its high log Kow value, likely migrates out of the 
aqueous phase and eludes detection.  Conversely, acetaminophen has a very strong affinity 
for the aqueous phase and is present at very high concentrations.  More hydrophobic BACs 
(compounds with higher log Kow values) including gemfibrozil and the steroid hormones 
were detected less frequently and this may be due to their ability to sorb onto soils.   
The antibiotics (erythryomycin-H2O, sulfamethoxazole, tetracycline, and 
trimethoprim) were detected at very low concentrations which may be the result of their 
sensitivity to light (Lam et al., 2004; Xuan et al., 2010).  It is interesting to note that the 
antibiotics sulfamethoxazole and trimethoprim, which are usually prescribed together, were 
both detected with the same frequency.  The least frequently detected BAC was tetracycline 
and this may be due to several factors.  It is known that tetracycline enters the environment as 
it is minimally metabolized in the body (80-90% unchanged) and, therefore, enters 
wastewater treatment plants as the result of human use or streams due to runoff as the result 
of animal use.  Therefore, the fate of tetracycline may be determined by physicochemical 
treatment including disinfection at WWTPs, chelation with metal ions in the environment 
(Halling-Sørensen et al., 2002), or photolysis (Xuan et al., 2010).  In the case of photolysis or 
chemical treatment such as disinfection the transformation of tetracycline into by-products 
not targeted by analysis would lead to an underestimation of their environmental impact. 
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1.1.6 Occurrence in Drinking Water Sources 
The result of high BAC use, their persistence through WWTPs and in the 
environment is that they are continuously being introduced into waters that may become 
sources for drinking water.  Many occurrence studies have been completed to determine the 
concentration of BACs in drinking water sources, and data from three different sampling 
studies are shown in Table 1.5.  One study completed by the U.S.G.S. sampled from only one 
DWTP source during a three week time period.  The source was located in a heavily 
populated, highly urbanized area with significant WWTP effluent entering the source water 
(Stackelberg et al., 2007).  Since this sampling event took place at only one source it could be 
expected that the same BACs would be detected due to usage patterns, and this information is 
reflected in Table 1.5 with the bias shown in relative high frequency of those compounds 
detected (42% or greater).  While this information does not provide representative 
information for a wide range of drinking water sources it does reveal that a particular 
drinking water source with upstream wastewater influences is constantly receiving detectable 
levels of particular chemical loads.   
Another study completed by the U.S.G.S. sampled from a wide range of drinking 
water sources (25 ground and 49 surface waters) of varying sizes of utilities and potential 
contaminant sources across the U.S.  It is important to note that sites were chosen that were 
known to have at least some upstream human and or animal wastewater inputs (Focazio et 
al., 2008).   The relatively low frequencies of detection shown in Table 1.5 from this study 
may be the result of sampling from a broad range of drinking water sources and/or sampling 
from many ground water sites.   
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The third study shown in Table 1.5 was completed by the Southern Nevada Water 
Authority and represents information gathered from an occurrence study on 19 US utilities.  
Source waters were selectively chosen based on their uses and upstream influences.  In this 
study one ground water site was sampled, one lake with upstream wastewater influences, 
four reservoirs with WWTPs upstream, six rivers with no WWTP influences, four reservoirs 
with no WWTP inputs but with recreational use, and three reservoirs with no WWTP inputs 
or recreational use (Benotti et al., 2009).  Correlations were observed between detecting 
BACs in drinking water sources and the direct input of wastewater and recreational use 
(Benotti et al., 2009).  This study represented a wide range of drinking water sources and the 
frequencies of detection in Table 1.5 from this study reflect site selection choice. 
Several of the BACs were targeted in all three discussed occurrence studies 
(carbamazepine, DEET, gemfibrozil, TCEP, triclosan, and trimethoprim) and trends based on 
the selection of sampling locations can be seen in these compounds.  For example, when the 
compounds were detected by Stackelberg et al. (2007) the frequencies of detection were 
always the highest (DEET, carbamazepine, and TCEP), and the opposite is true for those 
other compounds which were not detected (gemfibrozil, triclosan, and trimethoprim).  This 
suggests that a particular contaminant in a source water will most likely be chronically 
introduced due to usage patterns, but these may be subjected to seasonal variations.   
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Table 1.5  Occurrence Levels of BACs in Drinking Water Sources 
      
Compound Cmax(ng/L) n Frequency (%) Reference 
17-α-ethinyl estradiol 1.4 19 5.3 Benotti et al., 2009 
Acetaminophen 160 74 8.1 Focazio et al., 2008 
Acetaminophen 120 12 75 Stackelberg et al., 2007 
Atenolol 36 19 63 Benotti et al., 2009 
Atrazine 870 19 79 Benotti et al., 2009 
Caffeine 270 74 7.5 Focazio et al., 2008 
Caffeine 100 12 42 Stackelberg et al., 2007 
Carbamazepine 51 19 79 Benotti et al., 2009 
Carbamazepine 190 74 21.6 Focazio et al., 2008 
Carbamazepine 600 12 92 Stackelberg et al., 2007 
DEET <500 73 14 Focazio et al., 2008 
DEET 200 12 92 Stackelberg et al., 2007 
DEET 110 19 32 Benotti et al., 2009 
Diazepam 0.47 19 11 Benotti et al., 2009 
Diclofenac 1.2 19 21 Benotti et al., 2009 
Erythromycin-hydrate 300 73 8.1 Focazio et al., 2008 
Erythromycin-hydrate 10 12 58 Stackelberg et al., 2007 
Estrone 0.9 19 79 Benotti et al., 2009 
Gemfibrozil ND 74 0 Focazio et al., 2008 
Gemfibrozil ND 12 0 Stackelberg et al., 2007 
Gemfibrozil 24 19 58 Benotti et al., 2009 
Ibuprofen 270 74 1.4 Focazio et al., 2008 
Ibuprofen ND 12 0 Stackelberg et al., 2007 
Meprobamate 73 19 84 Benotti et al., 2009 
Sulfamethoxazole 60 12 83 Stackelberg et al., 2007 
Sulfamethoxazole 110 19 89 Benotti et al., 2009 
TCEP <500 73 20.3 Focazio et al., 2008 
TCEP 120 12 100 Stackelberg et al., 2007 
TCEP 530 19 53 Benotti et al., 2009 
Tetracycline ND 73 0 Focazio et al., 2008 
Tetracycline ND 12 0 Stackelberg et al., 2007 
Triclosan ND 12 0 Stackelberg et al., 2007 
Triclosan <100 73 8.1 Focazio et al., 2008 
Triclosan 6.4 19 32 Benotti et al., 2009 
Trimethoprim 20 71 6.8 Focazio et al., 2008 
Trimethoprim 11 19 58 Benotti et al., 2009 
Trimethoprim ND 12 0 Stackelberg et al., 2007 
ND=not detected 
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Of the six compounds targeted in all three studies the results from Benotti et al. 
(2009) have the second highest frequency of detection (carbamazepine, DEET, TCEP, 
triclosan, and trimethoprim) and this is most likely a result of site selection and sampling 
from mainly surface water sources.  The lowest frequencies of detection are from the study 
by Focazio et al. (2008) for these six compounds, and this may be the result of sampling from 
many ground water sites or selecting source waters with less anthropogenic impacts.   
The concentrations of all BACs in drinking water sources (Table 1.5) are lower than 
those in U.S. streams (Table 1.4).  This attenuation from streams to drinking water sources is 
most likely due to a combination of hydrolysis, photolysis, sorption onto soils, and 
biodegradation.  Another possible explanation is dilution of streams in larger reservoirs or 
degradation due to the half-lives of the BACs.  Also it should be noted that the sampling 
completed by Kolpin et al. (2002) had a greater bias towards impacted sites which may 
provide another explanation for this observation. 
The concentrations of the PCPs targeted (DEET and TCEP) were relatively high as 
were the concentrations of the non-prescription BACs (acetaminophen, ibuprofen, and  
caffeine), and this result is most likely due to high use and availability without a prescription.  
The compounds with the lowest concentrations or not detected were the steroid hormones, 
17-α-ethinyl estradiol and estrone, and this may be due to their use in lower quantities, 
affinity towards soils (see their high log Kow values in Table 1.3), and degradation by 
organisms in the water.   
The compound that was detected with the highest concentration and very high 
frequency was the agricultural compound, atrazine.  The concentration of atrazine detected in 
79% of the U.S. drinking water sources sampled is approximately one third of the Maximum 
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Contaminant Level Goal (MCLG)/Maximum Contaminant Level (MCL) for atrazine in 
drinking water which is 0.003mg/L (U.S. EPA, 2009a).  One particularly troubling result 
from occurrence studies is the ubiquitous nature of certain anthropogenic compounds.  
Atrazine, a widely used herbicide, is frequently detected in source waters close to and even 
those that are far removed from agricultural land (Benotti et al., 2009).  The widespread 
occurrence of atrazine in water poses a troubling public health concern and highlights the 
challenges associated with effectively managing persistent environmental contaminants.  
These occurrence studies are helpful to gather current information and guide future research 
studies and policy decisions.   
 
 
1.1.7 Fate of BACs during Drinking Water Treatment 
 Understanding the fate of BACs during drinking water treatment is important in order 
to effectively manage the risks associated with anthropogenic wastewater contaminants in 
drinking water supplies.  When discussing the fate of BACs during drinking water treatment 
careful attention should be placed on stating whether a particular compound is removed as 
some have been shown to transform during drinking water treatment (Gould and Richards, 
1984; Miyamoto et al., 1997; Dodd and Huang, 2004; Moriyama et al., 2004; Pinkston and 
Sedlak, 2004; Glassmeyer and Shoemaker, 2005; Ye, 2005; Bedner and MacCrehan, 2006; 
Nakamura et al., 2006; Dodd and Huang, 2007; Brix et al., 2008; Kotcharaksa, 2008; 
DellaGreca et al., 2009; Lee and Gunten, 2009; Quintana et al., 2010; Wulfeck-Kleier et al., 
2010; Krkošek et al., 2011; Soh et al., 2011; Wang et al., 2011) as is described in greater 
detail in Section 1.1.8. 
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The fate of BACs during drinking water treatment could be: 
1. Complete removal of the intact chemical by physical treatment processes (e.g., 
coagulation, powdered or granular activated carbon) 
 2. Complete removal by chemical processes (e.g., mineralization due to oxidation) 
 3. Incomplete removal by both physical and chemical treatment processes 
4. Incomplete removal and/or transformation due to both physical (e.g., ultraviolet) 
and chemical disinfectants (e.g., chlorination) 
 5. Transformation due to chemical treatments.  
 
The fate of BACs during drinking water treatment is not well understood although 
several studies have been completed including laboratory simulations (Ternes et al., 2002; 
Westerhoff et al., 2005; Simazaki et al., 2008), pilot scale studies (Ternes et al., 2002; Vieno 
et al., 2007), and studies at full-scale plants (Ternes et al., 2002; Stackelberg et al., 2007).  
Conventional drinking water treatment consists of various physical and chemical processes 
such as screening, coagulation/flocculation, sedimentation, filtration, and disinfection using 
chlorine or chloramines.  Table 1.6 shows the removal of BACs in a conventional drinking 
water treatment plant.  
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Table 1.6  Average concentration (Cave) of BACs during Conventional Drinking Water 
Treatment (n=12) (Stackelberg et al., 2007) 
Compound 
Source 
(ng/L) 
Clarified 
FeCl3 (ng/L) 
Disinfected 
NaOCl 
(ng/L) 
Filtered 
Sand/GAC 
(ng/L) 
Finished 
~1.2mg/L Cl2 
residual (ng/L) 
Acetaminophen 15 6 ND 1 0.3 
Caffeine 126 126 116 4 15 
Carbamazepine 191 186 149 4 29 
DEET 120 130 125 71 78 
Erythromycin-H2O 10 5.3 0.4 ND ND 
Gemfibrozil ND ND ND ND ND 
Ibuprofen ND ND ND ND ND 
Sulfamethoxazole 30 20 ND ND ND 
TCEP 95 94 92 ND 4 
Tetracycline ND ND ND ND ND 
Trimethoprim ND ND ND ND ND 
ND = not detected 
 
 
 It is interesting to note in Table 1.6 that two of the most non-polar compounds 
(gemfibrozil and ibuprofen) were not detected in source water.  This may be due to their 
sorption onto soils or other particulate matter as a result of their high log Kow values or 
presence as anionic species (see pKa and log Kow values in Table 1.3) in which case, they 
would elude detection in the aqueous phase.  Also it is interesting to note that the antibiotics 
tetracycline and trimethoprim are both not present in source water (the other antibiotics 
sulfamethoxazole and erythromycin-H2O are present at lower concentrations), and this may 
be due to either photolysis, microbial degradation, sorption onto soils, transformation during 
wastewater treatment, or a combination of the above.  Table 1.6 shows that for those BACs 
that were detected in the source water minimal removal is observed for most of the 
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compounds with the addition of the coagulant, iron chloride, (FeCl3), which may be the result 
of both high solubility of these compounds in water and low log Kow values.  FeCl3 removed 
erythromycin-H2O and acetaminophen most effectively which may be the result of sorption 
of BACs onto natural organic matter (NOM) that is removed during coagulation.  The 
removal of erythromycin-H2O can be explained due to its relatively high log Kow value and 
its low solubility in water.  The removal of acetaminophen due to coagulation is not well 
understood because it is a very hydrophilic compound, but may be due to the base or acid 
hydrolysis that results from the addition of FeCl3, but this remains to be studied (Stackelberg 
et al., 2007).  Disinfection using sodium hypochlorite (NaOCl) resulted in minimal removal 
for caffeine, DEET, and TCEP, while sulfamethoxazole, erythromycin-H2O, carbamazepine, 
and acetaminophen had measureable levels of removal.  These results are due to the 
molecular structure of the particular BACs and will be explained in greater detail in Section 
1.1.8.  Table 1.6 reveals that the most effective treatment step was the sand/granular activated 
carbon (GAC) filtration in which most compounds remaining the water were effectively 
removed (except DEET).  The low removal of DEET may be due to the chemical structure or 
it is outcompeted for adsorption sites on the GAC relative to other compounds.  The 
concentration of the detected compounds in finished water are lower than then source water, 
but some are higher than the levels observed in the sand/GAC filtered samples.  This may be 
due to sampling at only one of the eight GAC filter banks in operation and variability may 
exist in the plant between the filter banks (Stackelberg et al., 2007).  Another possible reason 
for this discrepancy is that although 24 hour continuous flow composite samples were 
obtained in this study the same plug of water was not monitored throughout its duration in 
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the water treatment plant and any change in influent levels would have contributed to 
variable levels of removal during treatment.    
 
 
Coagulation/Flocculation 
 Coagulation/flocculation involves the destabilization of suspended solid particles 
(<0.45µm) in source water with the use of either iron hydroxide or aluminum hydroxide.  
With the addition of these coagulants the suspended solids clump together to form flocs, 
which are removed from the water during sedimentation and filtration.  Settled solids have 
been analyzed for their concentration of BACs, and it has been found that hydrophobic 
compounds are removed during coagulation while hydrophilic compounds are not 
(Stackelberg et al., 2007).  Therefore, the octanol-water partition coefficient, Kow, can predict 
whether a compound will be effectively removed during coagulation/flocculation (Table 1.3), 
and BACs that associate with NOM will likely be more effectively removed.  Additionally, it 
has been observed in laboratory batch studies that compounds with relatively high polarity 
are not removed during coagulation using FeCl3 (Ternes et al., 2002).  Both simulated and 
plant sampling studies have shown that due to the chemical nature of many BACs 
(hydrophilic, polar, high solubility, ionic) coagulation is not a reliable treatment option for 
their removal (Ternes et al., 2002; Westerhoff et al., 2005; Stackelberg et al., 2007; Simazaki 
et al., 2008).  This can be seen in Table 1.6 with the low removal of most BACs except the 
most hydrophobic compound, erythromycin-H2O. 
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Adsorption onto Activated Carbon 
 Activated carbon is used during water treatment because many organic compounds 
can adsorb onto the carbon via van der Waals forces.  This makes activated carbon an 
attractive option for removal of compounds but lab-scale studies have shown that 
competition for active sites between BACs minimizes the removal of the more hydrophilic 
compounds (Simazaki et al., 2008).  It is hypothesized that DOM in raw water samples 
outcompetes with BACs during adsorption and minimizes BAC removal (Simazaki et al., 
2008).  Compounds more amenable to removal using activated carbon are those that are 
hydrophobic or neutral (Simazaki et al., 2008).  Simulated drinking water treatment studies 
have shown that increasing the powdered activated carbon (PAC) dose (Westerhoff et al., 
2005) or contact time (Simazaki et al., 2008) will increase the removal efficiency of BACs.  
Plant sampling studies have shown that adsorption onto PAC is a very effective strategy 
employed by conventional drinking water treatment plants to remove hydrophobic 
compounds (Ternes et al., 2002; Stackelberg et al., 2007), but the materials for this treatment 
option are very expensive relative to the use of ozone, UV/H2O2, or membranes.  The results 
in Table 1.7 show that PAC is most effective for the removal of the relatively hydrophobic 
steroid hormone compounds (17-α-ethinyl estradiol and estrone) and protonated bases 
(acetaminophen, trimethoprim, and caffeine (Westerhoff et al., 2005).  Conversely, Table 1.7 
shows that compounds with either low log Kow values or deprotonated acid functional groups 
are more difficult to remove (e.g., ibuprofen, diclofenac, and gemfibrozil) (Westerhoff et al., 
2005).   
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Table 1.7  Percent Removal of BACs using PAC (Westerhoff et al., 2005) 
Compound Percent Removal (5mg/L PAC, 4-hour contact time) 
17-α-ethinyl estradiol 77 
Acetaminophen 72 
Atrazine 60 
Caffeine 70 
Carbamazepine 74 
DEET 49 
Diazepam 67 
Diclofenac 39 
Erythromycin-hydrate 54 
Estrone 76 
Gemfibrozil 37 
Ibuprofen 16 
Meprobamate 33 
Sulfamethoxazole 36 
Trimethoprim 83 
TCEP 52 
 
 
Disinfection Using Chlorine 
Chlorine has been used as a disinfectant for water since the early 20th century in the 
United States.  Before that time there were no safeguards against the pathogens in water, the 
cause of many disease outbreaks, illnesses, and death.  The use of chlorine as a drinking 
water disinfectant has increased life expectancy and improved overall public health due to 
the removal of pathogens and other organic contaminants.   
The most commonly used disinfectants in the United States are sodium hypochlorite 
(NaOCl) and chloramines (NH2Cl).  To disinfect water chlorine is either added as chlorine 
gas (Cl2) or as sodium hypochlorite solution (NaOCl).  The reactive species of free available 
chlorine (FAC) are Cl2, HOCl, and OCl-, with HOCl being the most reactive species.  The 
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equilibrium of HOCl in water is dependent on whether the reaction is carried out above or 
below the pKa of HOCl (pKa = 7.54).  For example, when the pH of the water is lower than 
the pKa of HOCl, the acid is in its more reactive protonated state and as a result will react 
more with species in the water.  The equilibrium of HOCl in water is:  
 
 
 
 
Chlorine is a strong oxidant and it acts as an electrophile, attacking areas on a 
molecule that are rich in electron density.  Many studies have also shown that when chlorine 
reacts with dissolved organic matter or other organic compounds in drinking water 
disinfection by-products (DBPs) can be formed.   Dissolved organic matter, microbiological 
communities and anthropogenic compounds contribute to the chlorine demand of a particular 
water.  Chlorine demand is the dose of chlorine that can be applied to completely react with 
substances in the water before a residual will be present (AHPA, 1999). 
The effectiveness of chlorine on the removal of parent BACs has been studied in both 
simulated treatment scenarios and in plant scale studies (Table 1.8 shows results from a lab 
scale simulation).  Different parent BACs have removal efficiencies with chlorine based on 
their chemical structures (Section 1.1.8) and physicochemical properties (Table 1.3) which 
complicates managing the most effective strategies for their control (removals ranging from 
<10% to >90%) (Ternes et al., 2002; Westerhoff et al., 2005; Stackelberg et al., 2007; 
Simazaki et al., 2008).  There are several trends in reactivity observed under the conditions 
shown in Table 1.8.  For example, for parent BACs that are both weak acids (pKa> 9.7) and 
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have electron donating functional groups on the aromatic ring, such as acetaminophen, 17-α-
ethinyl estradiol, and estrone, high reactivity with free chlorine was observed.  This is the 
result of the BAC being in its neutral form and having the electron-donating phenol 
functional group on the aromatic ring, and most likely ring chlorination had occurred.  
Conversely, for compounds with aliphatic regions and/or very low pKa values such as 
meprobamate, DEET, TCEP, and atrazine, very low reactivity was observed.   
 
 
Table 1.8  Approximate Percent of Parent BAC Removed using 3.5 mg/L NaOCl as 
Cl2 at pH 5.5, Contact time 24 hours (Westerhoff et al., 2005) 
Compound Approximate Percentage Parent BAC Removed 
17-α-ethinyl estradiol 100 
Acetaminophen 95 
Atrazine 5 
Caffeine 60 
Carbamazepine 95 
DEET 5 
Diazepam 75 
Diclofenac 100 
Erythromycin-hydrate 100 
Estrone 100 
Gemfibrozil 100 
Ibuprofen 25 
Meprobamate 10 
Sulfamethoxazole 100 
TCEP 0 
Trimethoprim 100 
NT= Not tested 
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Disinfection using Chloramines 
 When hypochlorite is used as a disinfectant, natural organic matter (NOM) in the 
water has been found to be a precursor for disinfection by product (DBP) formation including 
trihalomethanes (THMs) (Rook, 1977) and haloacetic acids (HAAs) (Christman et al., 1983).  
Many utilities are switching to use a weaker disinfectant, chloramines, to meet DBP 
regulations for drinking water, under the U.S. Environmental Protection Agency Stage 1 
Disinfectants and Disinfection Byproducts Rule (U.S EPA, 2001).  Chloramines can exist as 
monochloramine or dichloramine, with the former being the primary disinfectant chosen by 
utilities. 
 
 
 
Chloramines are formed during drinking water treatment by utilities first adding 
chlorine to the water as a primary disinfectant and then adding ammonia as a secondary 
disinfectant later in the treatment train.   Since chloramine is a weaker disinfectant than 
hypochlorite it has been found to react slower with BACs and remove and/or transform them 
to a lesser degree (Pinkston and Sedlak, 2004).   
 
 
1.1.8 Reactive sites on BACs with free chlorine 
One result of BACs being exposed to free chlorine is the formation of by-products 
(Gould and Richards, 1984; Miyamoto et al., 1997; Dodd and Huang, 2004; Moriyama et al., 
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2004; Pinkston and Sedlak, 2004; Glassmeyer and Shoemaker, 2005; Ye, 2005; Bedner and 
MacCrehan, 2006; Nakamura et al., 2006; Dodd and Huang, 2007; Brix et al., 2008; 
Kotcharaksa, 2008; DellaGreca et al., 2009; Lee and Gunten, 2009; Quintana et al., 2010; 
Wulfeck-Kleier et al., 2010; Krkošek et al., 2011; Soh et al., 2011; Wang et al., 2011).  As 
described in section 1.1.7 free chlorine is an oxidant and reacts non-selectively with regions 
of electron density and/or regions of extended π conjugation, including anthropogenic 
contaminants such as BACs.  Aromatic regions are more likely to react with chlorine than 
aliphatic regions due to the electron density on the aromatic rings.  Another important factor 
to predict the reactivity of chlorine with BACs is steric hinderence; bulkier molecules, such 
as atrazine and caffeine, are expected to be less reactive.  In order to make predictions of the 
fate of BACs during disinfection, chlorination chemistry in aqueous solution will be briefly 
reviewed.  
 
 
Substituted Benzene Rings 
Substituted benzene rings act as a nucleophile and react with chlorine via 
electrophilic aromatic substitution.  The electron density on the aromatic ring (π electrons 
above and below the ring) makes it available to react with an electrophile, such as chlorine 
(McMurry, 2004).   Substituents on the benzene ring affect the reactivity of the aromatic 
structure, either activating or deactivating the ring for electrophilic attack and directing the 
electrophile to a particular position on the substituted benzene ring (Table 1.9)  
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Table 1.9 Electrophilic Aromatic Substitution-Substituent Effects (McMurry, 2004) 
    
Substituent Reactivity Orientation Inductive Effect 
-CH3 Activating Ortho, para Weak; electron-donating 
 
-OH, -NH2 Activating Ortho, para Weak; electron-withdrawing 
 
-Cl, Deactivating Ortho, para Strong; electron-withdrawing 
 
-N+(CH3)3 Deactivating Meta Strong; electron-withdrawing 
 
-NO2, -CN, CHO,  
-CO2CH3, -COCH3,  
-CO2H 
Deactivating Meta Strong; electron-withdrawing 
 
 
Table 1.9 helps in the understanding of the reactions between ring-substituted BACs 
and an electrophile such as chlorine.  For example, in a compound containing the ring-
activating phenol group (-OH) it can be expected that the electrophile will substitute on the 
aromatic ring and this explains the high reactivity of phenol containing compounds 
acetaminophen, estrone, and 17-α-ethinyl estradiol in Table 1.8.  This is the result of the 
phenol group donating electron density to the aromatic ring and making it more susceptible 
to electrophilic attack.   
 
 
Phenols 
The reaction between free chlorine, Cl2/HOCl/OCl-, and phenols under aqueous 
conditions proceeds via electrophilic aromatic substitutions and this reaction has been studied 
in the aqueous chlorination of 17-α-ethinyl estradiol (EE2) (Moriyama et al., 2004) (Figure 
1.3).  The mono-chlorinated transformation product was found to have similar estrogenic 
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activity as EE2, and the dichlorinated product was found to be less estrogenic (Moriyama et 
al., 2004).  In addition to estrogenic impacts of chlorination by-products of EE2 other 
biological endpoints such as toxicity remain unknown.  As indicated in Table 1.9, chlorine 
will substitute at the ortho- and/or para- positions to the OH- group on the benzene ring.  
Other BACs studied containing aromatic phenols which are expected to react in a similar 
manner are estrone, acetaminophen, and tetracycline.  The aqueous chlorination of 
acetaminophen has been shown to produce both mono- and di-chlorinated transformation 
products (Glassmeyer and Shoemaker, 2005) in addition to non-chlorinated by-products 
(Bedner and MacCrehan, 2006).  A kinetic study determining the rate constant for the 
reaction between the phenol group on acetaminophen and HOCl revealed that the reaction 
will proceed faster via the phenolate form of the compound due to the increased electron 
density on the aromatic ring (Pinkston and Sedlak, 2004).   
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Figure 1.3 Chlorination of 17-α-Ethynylestradiol (EE2), an Aromatic Phenol Compound 
 
 
Sulfonamides 
The chlorination of a sulfonamide pharmaceutical, sulfamethoxazole, under aqueous 
conditions showed that when the ratio of the initial concentration of chlorine to 
sulfamethoxazole is less than one, the free chlorine preferentially reacts with the aniline 
nitrogen to form a halogenated aniline ring product and an N-chlorinated product, as shown 
in Figure 1.4.  Conversely, when the initial concentration of chlorine to sulfamethoxazole is 
greater than one, the free chlorine ruptures the sulfonamide functional group as shown in 
Figure 1.5 (Dodd and Huang, 2004).  During the chlorination of sulfamethoxazole the 
structural moiety responsible for antibiotic activity is transformed and, therefore, changes in 
antibiotic activity or other biological endpoints of the chemical might be expected, although 
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this has not yet been confirmed.   In occurrence studies where only the parent BAC is 
targeted, the transformation products will not be detected, and the environmental and human 
health impact of the products may be underestimated.   
 
 
 
 
 
 
 
Figure 1.4 Reaction of the Sulfonamide Antibiotic, Sulfamethoxazole, with Free Chlorine.  
Molar Ratio of Sulfamethoxazole to FAC is Less Than One (Extracted from Dodd and 
Huang, 2004) 
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Figure 1.5 Reaction of Sulfonamide Antibiotic, Sulfamethoxazole, with a Molar Excess of 
Free Chlorine.  Species in Brackets Indicate Proposed Intermediates (Extracted from Dodd 
and Huang, 2004) 
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Amines 
When amines are chlorinated in aqueous solution, the reaction takes place via 
chlorine addition between the deprotonated amine and HOCl.   Therefore, the reactions are 
dependent on the pH of the solution, and the reaction will proceed fastest between the pKa 
values of HOCl and the amine (Pinkston and Sedlak, 2004).  Aliphatic amine groups (R2-
NH2) react with free chlorine in aqueous solutions through the transfer of chlorine from 
HOCl to the amine nitrogen as is shown in Figure 1.6 (Abia et al., 1998).  Chlorination of 
primary and secondary amines proceeds more quickly than chlorination of tertiary amines.   
 
 
Figure 1.6 Reactions of Amines with Free Chlorine. (Extracted from Abia et al., 1998). 
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1.1.9 Identification of transformation products of BACs due to chlorination 
 Wastewater and drinking water treatment have been simulated in laboratory studies to 
determine whether BACs are removed or transformed into by-products during chlorination 
(Gould and Richards, 1984; Miyamoto et al., 1997; Dodd and Huang, 2004;Moriyama et al., 
2004; Pinkston and Sedlak, 2004; Glassmeyer and Shoemaker, 2005; Ye, 2005; Bedner and 
MacCrehan, 2006; Nakamura et al., 2006; Dodd and Huang, 2007; Brix et al., 2008; 
Kotcharaksa, 2008; DellaGreca et al., 2009; Lee and Gunten, 2009; Quintana et al., 2010; 
Wulfeck-Kleier et al., 2010; Krkošek et al., 2011; Soh et al., 2011; Wang et al., 2011).  
Determining if BACs are removed or transformed is important to accurately assess the risk 
that these compounds pose to environmental and human health.  BACs that are not removed, 
but transformed into new products may have unknown health outcomes, and it is important to 
gain a greater understanding of these potential risks.  These reactions are usually conducted 
in aqueous media and use an initial molar excess of chlorine to BAC in order to simulate 
treatment conditions.   Determining the fate of BACs during drinking water treatment is a 
challenging task that requires the use sophisticated analytical instruments such as liquid 
chromatography or gas chromatography paired with detection such as: ultraviolet (UV), mass 
spectrometry (MS), nuclear magnetic resonance (NMR), or post-column reaction/reductive 
electrochemistry.   
Preparative or semi-preparative high pressure liquid chromatography (HPLC) has 
been utilized to isolate transformation products.  Both chlorinated samples and non-
chlorinated control samples are prepared to determine both the formation of new products 
and to calculate the decrease in parent compound concentration, respectively.  The formation 
of new chromatographic peaks using liquid chromatography paired with UV detection is used 
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initially to determine product formation and then followed by a separate LC-MS analysis to 
determine the identity of transformation products in many experiments.  A limitation of LC is 
that transformation products may not elute off the analytical column and the products will 
remain undetected, and a limitation of using MS analysis is that the transformation products 
may not ionize to a great degree.  Another technique used to determine the structure of 
transformation products and mechanism of reaction is to perform sub-structure analysis 
where sub-structures of the parent compound are reacted with free chlorine to determine the 
reactive sites (Dodd and Huang, 2004; Dodd and Huang, 2007).  Commercially available 
standards have been used to compare to potential transformation products of BACs with 
chlorine (Bedner and MacCrehan, 2006).  
 A mass spectrometer, an extremely sensitive analytical instrument, can be used to 
determine the identity of transformation products.  Ionization sources that have been used are 
both electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI).  
Techniques include full scan mass spectrometry to gather information on all ions that are 
ionized in the MS.  Additionally chlorine isotope ratios can be used to determine the number 
of chlorine substituents that are on a molecule.   
 One limitation of analytical techniques that are highly selective is that only specific 
analytes can be targeted, and a significant challenge is determining the concentration and 
identity of unknown species in a sample.   Total organic halogen (TOX) analysis is a useful 
tool that quantifies the concentration of organo-chlorine species in a sample.  Although TOX 
analysis has not yet been used to quantify unknown halogenated by-products of BACs, it has 
been used to quantify the unknown percentage of DBPs in drinking water (Krasner, et al., 
2006).  A literature summary focusing on the detection of transformation by-products of 
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some BACs due to aqueous chlorination and the impact of these by-products on biological 
effect is shown in Table 1.10. 
 
 
Table 1.10 Transformation of BACs in Reactions with Free Chlorine and Impact on 
Biological Effect 
 
Compound Reference Proposed by-
products/Location of 
Cl- Addition 
Analytical 
Instrumentation 
Used 
Impact to 
Biochemical 
Activity  
17-α-ethinyl 
estradiol 
Nakamura et 
al., 2006k; 
 Moriyama 
et al., 2004l 
 
Three mono- and di- 
chlorinated  derivatives 
isolated (carried out in 
organic solvent)k; 
Mono- and di-
chlorinated products 
formed (major) and 
four other minor 
productsl 
FAB-MS, 1H 
NMR, 13C NMR, 
HPLC-UV, 
preparative 
HPLCk; 
Preparative 
HPLC-UV,      
LC-(+/-)-APCI-
MS, 1H NMR, 
13C NMRl 
Yeast assays 
revealed 
chlorinated 
products less 
estrogenic 
than parent 
(more than 
BPA)k;  
ELISA test kit 
used for 
estrogen 
receptor and 
showed that 
mono-Cl 
product had 
similar 
activity and 
di-Cl was less 
estrogenic 
than parentl 
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Table 1.10 (continued) Transformation of BACs in Reactions with Free Chlorine and 
Impact on Biological Effect 
 
Compound Reference Proposed by-
products/Location 
of Cl- Addition 
Analytical 
Instrumentati
on Used 
Impact to 
Biochemical 
Activity  
Acetaminophen  Glassmeyer 
and 
Shoemaker, 
2005b 
 
Bedner and 
MacCrehan, 
2006i 
Mono- and di- Cl- 
addition to aromatic 
ring, 1,4-
benzoquinone and 
N-acetyl-p-
benzoquinone; 
transform back to 
acetaminophen with 
sodium sulfitei; 
mono- and di- 
chlorinated ring 
productsb 
LC-UV, LC-
UV-(+)-ESI-
MS, LC-UV-
ECi; 
 
LC-MSb 
LD50 toxicity 
testing in mouse 
reveals  
transformation 
products much 
more toxici 
Atenolol DellaGreca 
et al., 2009f 
N-chlorination; de-
chlorinated upon 
addition of sodium 
thiosulfatef 
HPLC-UV, 
HPLC-MS, 
1H NMR, 
TLC, (+)-
ESI-LC-MSf 
Chlorinated 
products more 
phytotoxic than 
atenololf 
Atrazine Wulfeck-
Kleier et. al., 
2010m; 
Brix et al., 
2008n 
N-chloro atrazine, 
transforms back to 
Atrazine with 
sodium sulfite and 
ascorbic acid 
(ammonium 
chloride does not 
reform Atrazine)m; 
No reaction 
observedn 
GC-MS, 
HPLC-(+)-
ESI-MS, 
HPLC-UVm;  
UPLC-Q-
ToF-MS/MS 
using 
Masslynx 
software 
(Waters 
Corp)n 
Chlorinated 
product retains s-
chlorotriazine 
moietym which is 
the cause of 
toxicity (EPA, 
2006) not yet 
studied; Toxicity of 
other chlorinated 
triazines studied 
using V.fischeri 
and found to be 
more toxic than 
parent compound  
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Table 1.10 (continued) Transformation of BACs in Reactions with Free Chlorine and 
Impact on Biological Effect 
 
Compound Reference Proposed by-
products/Location of 
Cl- Addition 
Analytical 
Instrumentation 
Used 
Impact to 
Biochemical 
Activity  
Bezafibrate Quintana et 
al., 2010e 
No reaction 
observede 
LC-MS, LC-
MS/MSe 
N/A 
Caffeine Glassmeyer 
and 
Shoemaker, 
2005b; 
 Gould and 
Richards, 
1984q 
No change observedb; 
 Many products 
formed-ring cleavage 
and rearrangement 
forming non-
aromatic nitrogen 
heterocycles. (8-
chlorocaffeine 
formed, but in small 
amount). No 
organochloramines 
detectedq 
LC-PB-MSb;  
GC-MS, TLC, 
UVq 
Unknown 
Carbamazepine Kotcharaksa, 
2008r;  
Lee and 
Gunten, 
2009s 
Four unchlorinated 
intermediatesr; 
Minimal reactivity 
observeds 
HPLC-UV, LC-
ITMSr; 
HPLC-UVs 
Unknown 
Clofibric acid Quintana et 
al., 2010e 
No reaction 
observede 
LC-MS, LC-
MS/MSe 
N/A 
DEET None  N/A NA NA 
Diazepam None  N/A N/A NA 
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Table 1.10 (continued) Transformation of BACs in Reactions with Free Chlorine and 
Impact on Biological Effect 
 
Compound Reference Proposed by-
products/Location 
of Cl- Addition 
Analytical 
Instrumentation 
Used 
Impact to 
Biochemical 
Activity  
Diclofenac Miyamoto et 
al., 1997h; 
 
Quintana et 
al., 2010e 
Cl- addition to 
aromatic ring 
and/or loss of CO 
from ringe; 
Cl- addition to 
aromatic ring 
among other non-
chlorinated 
productsh 
LC-MS, LC-
MS/MSe; 
 
HPLC-UV, LC-
MS, preparative 
HPLC, MS/MS,  
1H NMRh 
Unknown 
ecological 
impact of 
chlorination 
by-products, 
suspected 
hepatoxicity 
or bone 
marrow 
toxicityh 
Erythromycin-
hydrate 
Ye, 2005o N-chlorinated 
product and N-
demethylation 
producto 
ESI-MS, LC-
MS/MS, TOXo 
Unknown 
Estrone Nakamura et 
al., 2006k 
Five chlorinated 
derivatives isolated 
(carried out in 
organic solvent)k 
FAB-MS, 1H 
NMR, 13C NMR, 
HPLC-UV, 
preparative 
HPLCk 
Yeast assays 
revealed 
chlorinated 
products less 
estrogenic 
than parent 
(but more than 
BPA) 
Fenoprop None  N/A N/A NA 
Gemfibrozil  Krkošek et 
al., 2011c;  
Glassmeyer 
and 
Shoemaker, 
2005b 
Cl- addition to 
aromatic ringc; 
Mono-chlorinated 
productb 
GC-MS, 1H 
NMR, (-)-ESI-
MS/MS, (-)-ESI-
MS c; 
LC-PB-MSb 
Reduction in 
lipophilic 
character 
hypothesized 
to reduce 
activityc 
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Table 1.10 (continued) Transformation of BACs in Reactions with Free Chlorine and 
Impact on Biological Effect 
 
Compound Reference Proposed by-
products/Location 
of Cl- Addition 
Analytical 
Instrumenta
-tion Used 
Impact to 
Biochemical 
Activity  
Ibuprofen Pinkston and 
Sedlak, 
2004d; 
 Quintana et 
al., 2010e 
No reaction 
observedd,e 
 
 
LC-MS, 
LC-
MS/MSe; 
HPLC-UVd 
NA 
Meprobamate None  N/A N/A NA 
Sucralose Soh et al., 
2011g 
No reaction 
observedg 
LC-MSg NA 
Sulfamethoxazole Dodd and 
Huang, 2004j 
Degradation of 
sulfonamide moiety 
with excess of FAC 
to form 3-amino-5-
methylisoxazoleand 
N-chloro-p-
benzoquinoneiminej 
LC-MS; 1H 
NMR, GC-
EI-MSj 
Reduction of 
antibiotic activity 
hypothesized due 
to alteration of 
antibiotic moietyj 
TCEP None N/A N/A NA 
Tetracycline Wang et al., 
2011p; 
Ye, 2005o 
Cl- and OH- 
substituted products 
observed, no 
products 
identifiedp; 
New peaks 
observed in 
chromatogram due 
to transformation 
products, none 
identifiedo 
LC-(+)-ESI-
MSp; 
LC-(+)-ESI-
MSo 
Structural change 
to antibiotic 
moieties: activity 
unknownp 
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Table 1.10 (continued) Transformation of BACs in Reactions with Free Chlorine and 
Impact on Biological Effect 
 
Compound Reference Proposed by-
products/Location 
of Cl- Addition 
Analytical 
Instrumenta
-tion Used 
Impact to 
Biochemical 
Activity  
Trimethoprim 
 
Dodd and 
Huang, 
2007a;Glass
meyer and 
Shoemaker, 
2005b 
Cl- and OH-
substituted 
productsa; 
Non-chlorinated 
productb 
LC-(+)-ESI-
MSa; 
LC-PB-MSb 
 
Reduction of 
antibiotic activity 
hypothesized due 
to alteration of 
antibiotic moietya 
 
(a) Dodd and Huang, 2007; (b) Glassmeyer and Shoemaker, 2005; (c) Krkošek et al., 2011; 
(d) Pinkston and Sedlak, 2004; (e) Quintana et al., 2010; (f) DellaGreca et al., 2009; (g) Soh 
et al., 2011; (h) Miyamoto et al., 1997; (i) Bedner and MacCrehan, 2006; (j) Dodd and 
Huang, 2004; (k) Nakamura et al., 2006; (l) Moriyama et al., 2004; (m) Wulfeck-Kleier et. 
al., 2010; (n) Brix et al., 2008; (o) Ye, 2005; (p) Wang et al., 2011; (q) Gould and Richards, 
1984; (r) Kotcharaksa, 2008; (s) Lee and Gunten, 2009 
 
 
1.1.10 Policies 
In 1974, the Safe Drinking Water Act (SDWA) was created to protect the quality of 
drinking water and its sources in the U.S.  The U.S EPA is responsible for setting regulatory 
limits for contaminants in drinking water under the SDWA (P.L. 93-523, 1974).  Under the 
SDWA, the National Primary Drinking Water Regulations (NPDWRs) contain a list of 
contaminants (microbial, disinfection by-products, disinfectant residuals, inorganic and 
organic chemicals and radionuclides) whose concentrations in drinking water are subject to 
legal enforcement in public drinking water systems due to their potential negative health 
effects (U.S. EPA, 2009a).  Atrazine, a commonly used herbicide, is an example of a BAC 
that is regulated under the NPDWRs with a Maximum Contaminant Level Goal 
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(MCLG)/Maximum Contaminant Level (MCL) in drinking water of 0.003mg/L (U.S. EPA, 
2009a).  Also part of the SDWA are the National Secondary Drinking Water Regulations 
(NSDWRs) which contain a list of contaminants in water which may cause either aesthetic or 
taste/odor/color problems.  As part of the NSDWRs these contaminants are recommended for 
regulation in individual states by the Federal Government.   
 Under the SDWA there is also a list of unregulated chemicals called the Candidate 
Contaminant List 3 (CCL3) (U.S. EPA, 2009b) which was created to prioritize scientific 
research and policy making.  This daunting task is completed by screening a large set of 
unregulated contaminants for potential health effects and occurrence in drinking water 
supplies and selecting the ones with the greatest potential to pose a public health risk.  The 
CCL3 contains a list of 116 chemical and microbial contaminants that are currently 
unregulated under the NPDWRs, are known to be in drinking water, and may require 
regulation under the SDWA.  Included on this list are the steroid hormones 17-α-ethinyl 
estradiol and estrone (U.S. EPA, 2009b).    
 In March 2010 the EPA launched a new system to help protect public health and 
drinking water supplies called the Drinking Water Strategy (DWS).  The program’s objective 
was to focus decision-making, increase protection of water, and promote advancement of 
research to determine effective treatment technologies for public water supplies (U.S. EPA, 
2010).  The four goals of the DWS are to: 1) address contaminants as groups 2) encourage 
new drinking water treatment technologies 3) link authority of other statutes to apply to 
drinking water, and 4) work with states to share monitoring results (U.S. EPA, 2010).   
 Additional Federal Government agencies that have programs set up to regulate the 
exposure of BACs into the environment are the U.S. Food and Drug Administration (FDA) 
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and the USGS.  The FDA is responsible for the regulation of food, medicines cosmetics and 
other products.  The USGS conducts scientific research including national occurrence 
sampling studies of U.S. drinking water sources (Kolpin et al., 2002; Focazio et al., 2008).  
Despite agency efforts to highlight the presence of BACs in the environment, opposition 
from industry makes regulation difficult as, for example, the regulation of spray drifts from 
the application of atrazine to agricultural lands.  Although environmental regulators desire to 
set stricter regulations to protect water resources, the agricultural industry prioritizes 
maintaining high product yields and protecting job security (Erickson, 2011). 
 
 
1.1.11 Future management strategies 
It is clear that the impact of BAC residues in the environment is not an issue that can 
be ignored.  Recent media reports, (e.g., Shah, 2010), have highlighted dramatic events 
linked to BAC use such as mass die-offs of vultures in Asia due to ingestion of the anti-
arthritic drug diclofenac (Oaks et al., 2004), antibiotic-resistant pathogens (Khachatourians, 
1998), and the feminization of fish due to estrogenic compounds (Jobling et al., 1998).  
Additionally, the herbicide atrazine has also been in the media spotlight due to the re-
evaluation of its toxicity in order to set regulatory limits.   
Since the long term effects of BACs in the environment are unknown it is imperative 
that scientists, regulators and pharmaceutical companies agree on management strategies that 
allow for the safe use of BACs and protection of the environment.  In order to evaluate 
possible management strategies to control the release of BACs into the environment 
stakeholders from the government, academia, pharmaceutical industry, scientific community, 
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and policy and management experts from the US, Canada and Europe evaluated possible 
options (Doerr-MacEwen and Haight, 2006).  The opinions from the stakeholders were that 
the most effective management strategies to minimize the release of BACs were advanced 
wastewater treatment processes, education to reduce over prescription, pharmaceutical take-
back programs, and public education (Doerr-MacEwen and Haight, 2006).  The stakeholders 
also indicated that some of the gaps in scientific research were the uncertainties associated 
with mixture effects, low level chronic exposure, and risk assessment methods (Doerr-
MacEwen and Haight, 2006).  Additional management strategies that may reduce the release 
of BACs into the environment are regulation of prescription drug sales over the internet, 
careful monitoring of sewage biosolids used for land application, and development of more 
effective WWTP technologies to remove BACs (Daughton and Ternes, 1999).   
With countless BACs being introduced to the market there remains many research 
gaps in the understanding of the fate and impact of these anthropogenic compounds in the 
environment.  Careful planning of research is necessary in order to maximize time and cost 
of resources and to guide future regulations.  Several areas of research that need expansion in 
order to guide risk assessment and policy making include the improvement of sample pre-
concentration and analytical analysis, evaluation of chemical toxicity on aquatic organisms, 
assessment of mixture effects of BACs, and monitoring the fate of BACs including 
degradation products and metabolites (Daughton and Ternes, 1999).   
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1.2 Research Questions 
In summary, effectively managing BAC use and protecting water supplies is a 
complicated task due to widespread use, unknown fate in the environment, and 
transformation during physicochemical drinking water treatment.  Maintaining sensitive and 
current analytical methods is one challenging area of research because new BACs are 
constantly being introduced into the market.  Additionally, one area of challenging work is 
studying the fate of BACs and how to identify unknown degradation products.  Primary 
research questions remain to determine the occurrence of BACs in drinking water supplies, 
evaluate reactivity of BACs, and identify transformation products.  A greater understanding 
of the reactivity and fate of these chemicals will provide invaluable information for future 
occurrence sampling and toxicity testing. 
 
 
1.3 Research Objectives 
The hypotheses that validate the completion of this study are the following: 
1. Treatment processes employed at conventional drinking water treatment plants 
may not be effective in completely removing BACs. 
2.  The degree of chlorine reactivity with BACs can be measured using TOX analysis. 
3.  Chlorine reacts with BACs to form transformation products.  
4. BACs and/or their chlorination by-products may be present in treated drinking 
water.  
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These hypotheses are tested by the following experimental objectives in the same order as 
presented above: 
1.  Determine the occurrence and fate of BACs in North Carolina drinking water 
treatment plants. 
2. Study the incorporation of chlorine on the parent BAC molecule using total organic 
halogen (TOX) analysis and infusion mass spectrometry (MS).  
3. Assess the removal of BACs as the result of chlorination.  
4.  Relate the reactivity of BACs with chlorine to their molecular structure and 
presence in drinking water.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
2.  MATERIALS AND METHODS 
 
 
2.1 Materials 
BAC Standards 
Standards purchased from Sigma-Aldrich (St. Louis, MO) were tetracycline (>98%), 
tris(2-chloroethyl)phosphate (TCEP) (97%), 4-acetaminophenol (98%), diazepam, 
bezafibrate, gemfibrozil, diclofenac, erythryomycin-hydrate (96%), 17-α-ethinyl estradiol 
(98%), and estrone (U.S. Pharmacopeia grade).  Standards purchased from MP Biomedicals, 
LLC (Solon, OH) were atenolol, trimethoprim, and sulfamethoxazole.  Clofibric acid was 
purchased from Tocris Bioscience (Ellisville, MO).  Atrazine (97.5%) and anhydrous 
caffeine (>99%) were purchased from Fluka Analytical (Buchs, Switzerland). N,N-diethyl-
meta-toluamide (DEET) (97.3%) and 2-(2,4,5-trichlorophenoxy)propionic acid (fenoprop) 
(99%) were purchased from Riedel-de-Haën (Seelze, Germany).  Meprobamate (98%) was 
purchased from Cerilliant (Round Rock, TX).  Sucralose (98%) was purchased from Toronto 
Research Chemicals (TRC), Inc. (North York, Ontario).  Ibuprofen (99%) and 
carbamazepine (99%) were purchased from Acros Organics (Geel, Belgium).  HPLC-grade 
methanol was purchased from either Acros Organics (Geel, Belgium) or Fisher Scientific 
(Pittsburgh, PA).  Due to the countless number of BACs available on the market not every 
synthesized compound could be included in this study.  The BACs evaluated are shown in 
Table 2.1 and were chosen based on high usage, occurrence in the environment, persistence 
through drinking water treatment, and suspected toxicological importance.  
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Table 2.1   Studied BACs and Intended Uses 
Compound 
Molecular Weight 
(g/mol) Use 
Acetaminophen 151.2 Analgesic 
Atenolol 266.3 Beta-blocker 
Atrazine 215.7 Herbicide 
Bezafibrate 361.8 Lipid Regulator 
Caffeine 194.1 Stimulant 
Carbamazepine 236.3 Antiepileptic 
Clofibric acid 214.6 Lipid regulator 
N,N-Diethyl-meta-toluamide (DEET) 191.3 Insect Repellent 
Diazepam 284.7 Anti-anxiety 
Diclofenac 296.2 Analgesic 
17-α-ethinyl estradiol 296.4 Synthetic Estrogen 
Estrone 270.4 Steroid 
Erythyromycin 733.9 Antibiotic 
Fenoprop 269.5 Herbicide 
Gemfibrozil 250.3 Anti-cholesterol 
Ibuprofen 206.3 Analgesic 
Meprobamate 218.3 Anti-anxiety 
Sucralose 397.6 Artificial Sweetener 
Sulfamethoxazole 253.3 Antibiotic 
Tetracycline 444.4 Antibiotic 
tris(2-carboxyethyl)phosphine (TCEP) 285.7 Flame Retardant 
Trimethoprim 290.3 Antibiotic 
 
 
Chlorination  
Laboratory grade water (LGW) was prepared in the University of North Carolina 
laboratory using an in-house Dracor (Durham, NC) water purification system which pre-
filters inlet 7 MΩ house deionized water to 1 µm, removes residual disinfectants, reduces 
total organic carbon to less than 0.2 mg C/L with an activated carbon resin, and removes ions 
to 18 MΩ with mixed bed ion-exchange resins.  Sodium hypochlorite stock solution (NaOCl) 
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as 5.65-6% in water was purchased from Fisher Scientific (Pittsburgh, PA) and the 
concentration of the sodium hypochlorite stock solution prepared after diluting (1:50) was 
measured monthly using the Iodometric Titration 1 Procedure following Standard Method 
408 A (APHA, 1999).  Chlorine residuals were measured using a HACH test kit pocket 
colorimeter and HACH permachem DPD free/total chlorine reagents (HACH, Loveland, 
CO).  Excess chlorine in samples prepared for TOX analysis was quenched using analytical 
reagent (AR) grade anhydrous sodium sulfite (98.9%) (Mallinckrodt, Phillipsburg, NJ).  
Excess chlorine in samples prepared for MS/MS analysis was quenched with L-ascorbic acid 
(Sigma, St. Louis, MO). 
 
 
TOX Analysis 
TOX analysis used glacial acetic acid (99.8% Certified ACS Grade) and Certified 
ACS plus grade concentrated sulfuric acid both purchased from Fisher (Fair Lawn, NJ).  
Potassium nitrate (Certified ACS grade) for the nitrate rinse was also purchased from Fisher 
(Fair Lawn, NJ).  Sodium chloride (~80%) for cell performance check was purchased from 
Fluka Analytical (Buchs, Switzerland).  Sodium bicarbonate (99.9%) was purchased from 
Mallinckrodt AR (Paris, Kentucky).  Purified silver acetate was purchased from Fisher (Fair 
Lawn, NJ).  The performance check standard, 2,4,6-trichlorophenol (98%), was purchased 
from Sigma Aldrich (St. Louis, MO).  
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Mass Spectrometry 
HPLC-grade methanol and HPLC-grade acetonitrile (0.2µm filtered) were purchased 
for tandem mass spectrometry (MS/MS) from either Acros Organics (Geel, Belgium) or 
Fisher Scientific (Pittsburgh, PA).  The polypropylene glycol (PPG) tuning solution was 
purchased from Varian, Inc. (Santa Clara, CA).  High pressure liquid nitrogen, zero grade air, 
ultra high purity (UHP) nitrogen and UHP argon were purchased from National Welders 
Supply, Inc. (Morrisville, NC).  The isotopically labeled surrogate standard, caffeine-d3, was 
purchased from C/D/N Isotopes (Pointe-Claire, QC, Canada) 99.8% pure.  The internal 
standard, simeton, was purchased from AccuStandard (New Haven, CT) at 100µg/mL.   
 
 
Sample Collection and Preservation 
The tetradentate chelating agent, disodium ethylenediamine tetraacetic acid, 
(Na2EDTA) (99+%) was purchased from Sigma-Aldrich (St. Louis, MO).  The glassware 
silanizing agent, 5% dimethyldichlorosilane (DMDCS) in toluene (99% and 99.9% pure 
respectively), was purchased from Supelco Analytical (Bellefonte, PA).  Chlorine residuals 
were measured using a HACH test kit pocket colorimeter and HACH permachem DPD 
free/total chlorine reagents purchased from HACH (Loveland, CO).  pH adjustment of the 
aqueous samples for extraction used formic acid (98+%) which was purchased from Acros 
Organics (Geel, Belguim). 
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2.2 Methods 
2.2.1 Bench Scale Chlorination Experiments 
Preparation of Chlorination Samples 
 Stock solutions of studied BACs (Table 2.1) at a target concentration of 1000mg/L of 
each were prepared in HPLC grade methanol from neat analytical standards stored in a 
freezer at approximately -20°C, and used within five months in HPLC grade methanol.  On 
the day of sample preparation, 100µL of the stock solution was spiked into 100mL of LGW 
to achieve a target concentration of 1mg/L for subsequent dosing with chlorine.  In order to 
facilitate analysis of reaction products without excessive sample processing, the target initial 
concentration of each BAC was 1mg/L and a chlorine dose of about 25mg/L as Cl2 was used.  
Although this chlorine dose is larger than what is typically employed at a DWTP, the 
objective of the experiment was to simulate disinfection where an excess of chlorine is added 
relative to the concentration of organic microcontaminants, and using high enough doses of 
BACs that are well above limits of instrument detection.  The 100mL sample reactions took 
place in sealed 125mL amber glass jars (no mixing) with headspace in order to more 
accurately simulate DWTP conditions over 24 hours at 20°C in the dark.   
The pH of the reaction was not controlled during the course of the experiment in 
order to avoid adding interfering ions that would cause ion suppression during MS analysis 
but was in the range of 6-8.  After the 24 hour contact time, a 1mL aliquot of the chlorinated 
samples (diluted 1:10 in LGW) was removed for measurement of free chlorine residual using 
a HACH test kit pocket colorimeter based on Standard Method 4500-Cl G. (APHA, 1999), 
and the remaining sample quenched with a 40mg/mL sodium sulfite solution in LGW for 
TOX analysis or a 40mg/mL ascorbic acid solution in LGW for MS/MS analysis.  The 
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solutions mentioned above used for quenching the chlorine reaction were prepared 
immediately before addition into the sample.  Separate sets of samples were prepared for the 
different analyses because each analysis was completed on a different day.    
 The control samples included LGW blanks, free chlorine solutions prepared in LGW 
at a target concentration of 25mg/L and quenched with sodium sulfite, and BAC solutions in 
LGW at the target initial concentration of 1mg/L (same as the chlorinated samples).  All 
control samples were stored for the same reaction time and under the same conditions as the 
chlorinated BAC samples.  After the 24 hour contact time, a 10mL aliquot of the control 
samples was removed for measurement of free chlorine residual (typically a 1:10 or 1:20 
dilution) using a HACH test kit pocket colorimeter based on Standard Method 4500-Cl G. 
(APHA, 1999), and quenching agent was added to the remaining sample as described 
previously to ensure uniform conditions between the chlorinated and non-chlorinated 
samples.  Chlorine demand was calculated by subtracting the free chlorine residual from the 
concentration of the chorine dose applied (APHA, 1999), and since chlorine demand 
indicates that chlorine has reacted with species in the water, this value provides insight into 
the extent of the reaction that occurred.  The chlorine demand of the LGW control sample 
was determined to be negligible during the experiment.   Chlorine demand was used to 
determine the relative reactivity of the BACs with chlorine, TOX analysis was used to study 
the incorporation of chlorine onto the parent BAC molecule during the reaction, and MS/MS 
analysis was used to confirm transformation of select BACs.  The net chlorine demand was 
calculated by subtracting the chlorine demand of the relevant controls from the chlorine 
demand of the chlorinated samples.   
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Chlorine Demand Determination 
 The chlorine residual was determined for all chlorinated samples using a HACH test 
kit pocket colorimeter based on Standard Method 4500-Cl G (APHA, 1999) and N,N-
Diethyl-p-Phenylenediamine (DPD) packets.  If needed, samples were diluted to ensure the 
free chlorine residual was in the range of the colorimeter.  The free chlorine residual was 
then subtracted from the initial chlorine dose to calculate the chlorine demand of the sample.   
 
 
Total Organic Halide (TOX) Analysis  
TOX analysis was used to determine the extent to which chlorine had become 
incorporated into the parent BAC molecule during reaction.  After quenching the residual 
chlorine as described above, the samples were analyzed for TOX using a procedure adapted 
from Standard Method 5320 (APHA, 1999).  100mL samples were acidified using 20 drops 
of concentrated sulfuric acid to ensure optimal adsorption onto one glass-packed activated 
carbon (GAC) column using a Tekmar-Dohrmann AD-2000 Adsorption Module (Cincinnati, 
OH).  While the standard method calls for two carbon columns, preliminary experimental 
results showed that the amount of breakthrough of the analytes onto the second column was 
less than 5% and, therefore, in order to increase productivity, only one glass-packed carbon 
column was used (see Table 3.3).  The sample adsorption rate was 3mL/min and the sample 
volume adsorbed was 50mL.  Removal of inorganic halides adsorbed on the carbon was 
achieved by flowing 2mL of a ~5g/L NO3-N solution prepared from potassium nitrate at a 
rate of 0.5mL/min through the column after the sample.   
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After sample adsorption and removal of halides, the carbon was pyrolyzed using a 
Rosemount Dohrmann DX-2000 Organic Halide Analyzer (Cincinnati, OH).  The carbon 
columns were completely combusted at 850°C and the organohalogen component of the 
molecule converted to hydrogen halide which was then transported with the carrier gas, 
helium, to the coulometric cell containing silver electrodes.  As the current in the cell 
increases due to the presence of the halide ions the change in voltage is recorded.   The 
average TOX recovery of the performance check standard, 500ng Cl/µL trichlorophenol, was 
88.5% (n = 5; standard deviation: 18%).  The net increase in concentration of organic 
halogen was calculated by taking the difference between the unchlorinated BAC and 
chlorinated BAC samples.   
 
 
Ultraviolet-Visible  (UV-Vis) Analysis 
The fate of the aromaticity of the reacted tetracycline was monitored using a Hitachi 
U-3300 Spectrophotometer.  First the wavelength of maximum absorption of tetracycline was 
determined and then the parent compound and products in solution were scanned from 200-
750nm to provide some additional characterization of the reaction products.  Additionally, 
for a chlorinated sample a wider wavelength range was scanned, 200-750nm, to determine if 
new λmax associated with transformation products were formed. 
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Tandem Mass Spectrometry Analysis (MS/MS) 
A separate aliquot was prepared for MS/MS analysis by quenching residual chlorine in a 
100mL sample using a 40mg/mL solution of ascorbic acid in LGW and then infusing directly 
into a Varian 1200L mass spectrometer (Palo Alto, CA) using a Harvard Apparatus syringe 
pump (Holliston, MA) at a flow rate of 20µL/min.  Liquid nitrogen was used as the drying 
gas, argon was the collision induced dissociation (CID) gas in positive electrospray 
ionization mode (+ESI), while zero grade air was used as the CID gas in negative 
electrospray ionization mode (-ESI).  The API housing was at 50°C, and the drying gas was 
at 300°C.   The detector was set at 1300V, the shield at 600V, and the capillary between 40-
60V.  In order to increase analyte ionization in the electrospray interface, the quenched 
chlorinated samples was mixed with HPLC grade methanol at a volume ratio of 
sample:methanol of 9:1.  All samples were filtered through 0.45µm Laboratory Supply 
Distributors (Millville, NJ) syringe tip filters 0.45µm prior to MS/MS analysis.  All control 
samples were analyzed first followed by the chlorinated and unchlorinated BAC samples.  
While infusing the sample into the mass spectrometer, data was collected using Varian 
MSWS Software Version 6.8., and the full scan spectra ranging from m/z 50-700 was 
observed in real time in quadrupole 1 (Q1).  The full scan spectra were scanned in order to 
locate prominent ions.  The chlorinated tetracycline samples were compared to the 
unchlorinated tetracycline samples in order to identify new ions that may be associated with 
transformation products.  During infusion experiments it is possible to distinguish 
characteristic chlorine isotope ratios.  These chlorine isotope ratios are helpful searching for 
unknown chlorination by-products of BACs because they show, through characteristic 
patterns, the number of chlorine atoms on a molecule.  Prominent peaks observed in Q1 were 
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optimized and daughter ions were scanned in quadrupole 2 (Q2) by applying argon, the 
collision gas, at 2.00mTorr and increasing the collision energy from 5-50eV.   
 
 
 
2.2.2 Occurrence Sampling 
Sample Sites and Collection 
Aqueous samples were collected in silanized (5% DMDCS in toluene) amber glass 
jars ranging from 0.5L to 4L based on size of sample.  Silanization of the glassware was 
completed by allowing the silanizing agent to sit in the glassware for approximately 10 
minutes, rinsed three times with toluene, rinsed three times with methanol, rinsed three times 
with LGW, and then dried in an oven at 150°C overnight and capped immediately after 
cooling.  Na2EDTA was added to sample bottles before sample collection for sample 
preservation.  Either 24-hour composite samples or grab samples were collected headspace-
free, based on the needs of the study.  For 24-hour composite samples, approximately ¼ of 
the sample vessel was filled every six hours for a total of four sample collection events.  
Sample collection was completed by the operators at each plant following sample collection 
instructions (Appendix 1).  Samples were stored at ~4°C in a refrigerator at the DWTPs and 
transported back to the laboratory in a cooler with ice-packs.   
Samples were transported via automobile within one day of sample collection to the 
environmental chemistry laboratory in the Michael Hooker Research Center at the University 
of North Carolina at Chapel Hill in a cooler containing ice-packs, and immediately 
refrigerated at 4°C (temperature was evaluated weekly for quality control) and extracted 
within one week of receipt.   
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Samples were first filtered to 0.45µm, to remove suspended solids that would 
interfere with subsequent chlorine residual testing and pH analysis, using 47mm Whatman 
nylon filters (Fisher Scientific Pittsburgh, PA), and placed back into the rinsed sample 
collection bottles.  The suspended solids that were removed during filtration were not 
analyzed for BACs that may have associated with the NOM.  After filtration, aliquots of each 
sample were tested for free and total chlorine residuals with a HACH test kit pocket 
colorimeter using HACH permachem DPD free and total chlorine reagents.  The residual 
chlorine in the samples was then quenched with excess ascorbic acid, 25mg/L, regardless of 
the residual to ensure uniform conditions between samples (125g/L stock solution of ascorbic 
acid in LGW prepared fresh for each sample set) to stabilize samples.  Additionally, to 
ensure uniform extraction conditions, the pH was adjusted to approximately pH 6 using 2% 
formic acid in LGW (Ye, 2005) as described in the standard operating procedure (Appendix 
2).  Samples were processed and extracted within one week of sample collection.   
 
 
Solid Phase Extraction (SPE) 
Neat pharmaceutical standards were used to prepare stock solutions at a target 
concentration of 1000mg/L in HPLC grade methanol.  Stock pharmaceutical standards were 
stored in a freezer and used within five months of preparation.  Table 2.2 shows the 
concentration of the pharmaceutical stocks that were used for the duration of the entire 
occurrence study.  A 22 BAC mixture (1° dilution) was prepared at a target concentration of 
20mg/L in HPLC grade methanol by combining 200µL of each pharmaceutical stock and 
diluting to 10mL (Table 2.2).  This 22 BAC 1° dilution was stored in the freezer for use 
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within five months, and was used to prepare a 2° dilution on the date of sample extraction at 
a target concentration of 0.5mg/L by spiking 250µL of the pharmaceutical mixture into 
10mL of HPLC grade methanol (Table 2.2).  This 2° dilution BAC mixture was used to spike 
into the 250mL sample aliquots to create a standard addition curve for quantifying the BACs 
in samples.  The concentrations of each BAC in the various standard solutions is shown in 
Table 2.3 
All standards and extracting solutions used for sample extraction were prepared one 
day in advance including a 0.25g/L Na2EDTA stock solution in LGW and a 0.1% formic acid 
in methanol solution used for sample elution off the solid phase employed for extraction.  On 
the date of extraction a dilution of the internal standard, simeton, was prepared at 1.25mg/L 
in HPLC grade methanol.  A standard containing both surrogate standards, meclocycline and 
d3-caffeine, was prepared at a target concentration of 2mg/L in HPLC grade methanol.  
Extraction of the BAC analytes from pH-adjusted and 0.45µm-filtered aqueous 
samples was achieved through the use of solid phase extraction (SPE) using a Supelco 
visiprep (Bellefonte, PA) extraction manifold.  The Waters (Milford, MA) Oasis hydrophilic-
lipophilic balance (HLB) 3cc (60mg) SPE cartridges (Lot:W3156J4) were pre-conditioned 
with 6mL methanol followed by 1mL 0.1%formic acid in methanol and then 8mL LGW (Ye, 
2005).In order to quantify the concentration of the target analytes using the method of 
standard addition, collected water samples were split into six 250mL sample aliquots so as to 
present two unspiked samples (US) and four calibration samples (Cal) (Table 2.3).  
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Table 2.2 BAC Solutions used for Analytical Calibration 
    
BAC Stock (mg/L)  (1° dilution) (mg/L)  (2° dilution) (mg/L) 
    
17-α-ethinyl estradiol 1046 21 0.52 
Acetaminophen 1016 20 0.51 
Atenolol 1034 21 0.52 
Atrazine 1055 21 0.53 
Bezafibrate 1023 20 0.51 
Caffeine 1020 20 0.51 
Carbamazepine 1034 21 0.52 
Clofibric acid 1006 20 0.50 
DEET 971 19 0.49 
Diazepam 1000 20 0.50 
Diclofenac 1026 21 0.51 
Erythromycin-H2O 1020 20 0.51 
Estrone 1028 21 0.51 
Fenoprop 1008 20 0.50 
Gemfibrozil 1017 20 0.51 
Ibuprofen 1020 20 0.51 
Meprobamate 1000 20 0.50 
Sucralose 1435 29 0.72 
Sulfamethoxazole 1033 21 0.52 
TCEP 1079 22 0.54 
Tetracycline 1008 20 0.50 
Trimethoprim 1022 20 0.51 
 
 
 
 
 
 
 
 
 
 
64 
 
Table 2.3 Concentration of Standard Addition Levels used for Quantification 
   
 Raw Water Finished Water 
BAC Cal 1 Cal 2 Cal 3 Cal 4 Cal 1 Cal 2 Cal 3 Cal 4 
 (ng/L) (ng/L) 
         
17-α-ethinyl estradiol 5.2 10 52 105 2.1 5.2 10 21 
Acetaminophen 5.1 10 51 102 2.0 5.1 10 20 
Atenolol 5.2 10 52 103 2.1 5.2 10 21 
Atrazine 5.3 11 53 106 2.1 5.3 11 21 
Bezafibrate 5.1 10 51 102 2.0 5.1 10 20 
Caffeine 5.1 10 51 102 2.0 5.1 10 20 
Carbamazepine 5.2 10 52 103 2.1 5.2 10 21 
Clofibric acid 5.0 10 50 101 2.0 5.0 10 20 
DEET 4.9 10 49 97 1.9 4.9 10 19 
Diclofenac 5.1 10 51 103 2.1 5.1 10 21 
Erythromycin-H2O 5.1 10 51 102 2.0 5.1 10 20 
Diazepam 5.0 10 50 100 2.0 5.0 10 20 
Estrone 5.1 10 51 103 2.1 5.1 10 21 
Fenoprop 5.0 10 50 101 2.0 5.0 10 20 
Gemfibrozil 5.1 10 51 102 2.0 5.1 10 20 
Ibuprofen 5.1 10 51 102 2.0 5.1 10 20 
Sulfamethoxazole 5.2 10 52 103 2.1 5.2 10 21 
Tetracycline 5.0 10 50 101 2.0 5.0 10 20 
Trimethoprim 5.1 10 51 102 2.0 5.1 10 20 
Meprobamate 5.0 10 50 100 2.0 5.0 10 20 
Sucralose 7.2 14 72 144 2.9 7.2 14 29 
TCEP 5.4 11 54 108 2.2 5.4 11 22 
 
 
In order to chelate the metal ions in the samples and prevent them from binding to 
active sites on the solid phase cartridge which would lower analyte retention and recovery, 
1mL of the Na2EDTA stock solution was added to each sample aliqout.  In order to assess 
percent recovery of the extraction, 25µL of the surrogate standard mixture (meclocycline and 
d3-caffeine) was added using a micropipette under the surface of the liquid to each 250mL 
graduated cylinder-measured sample aliquot which was then capped and inverted three times 
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to mix.  After connecting the sample aliquots contained in 250mL amber glass bottles to the 
SPE cartridges through Teflon tubing, the samples were extracted at a flow rate of 
approximately 5mL/min.  After rinsing the sample aliquot bottles, lines, and cartridges with 
LGW just before the last part of the sample was pulled through the Teflon tubing, the 
cartridges were dried under vacuum (18 Hg) for five minutes to remove excess water.  
Sample elution was performed using 8mL of 0.1% formic acid in methanol by gravity in 
approximately 20 minutes, and sample extracts were collected in 10mL silanized clear glass 
conical vials.  Samples were then concentrated under ultra high purity (UHP) nitrogen 
(National Welders, Morrisville, NC) using a Pierce (Rockford, IL) Reacti-Vap Model 18770 
to a volume of approximately 50µL on a VWR Scientifics Products (West Chester, PA) 
Standards Heatblock, at ~45°C for approximately two hours.  Samples were then 
reconstituted to a target concentration of 250µL using 9/1 LGW/methanol and a glass syringe 
was used to add 10µL of the 1.25mg/L simeton internal standard solution.  The internal 
standard, which was chosen because it is not found in the environment, accounts for 
variability between sample volume injection during instrumental analysis, and the area of 
each analyte is normalized to this standard. Sample extracts were then vortexed using a 
Thermolyne type 16700 mixer (Dubuque, IA), and then filtered through 0.45µm Laboratory 
Supply Distributors (Millville, NJ) syringe tip filters into 250µL glass inserts in liquid 
chromatography (LC) autosampler vials.  Sample extracts were stored in the freezer up to a 
week until LC-MS/MS analysis.  
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Analytical Methods 
The MS was tuned with a Varian, Inc. (Santa Clara, CA) PPG tuning solution prior to 
occurrence sampling.  The PPG solution was infused into the MS using a Harvard Apparatus 
(Holliston, MA) Syringe Pump at 20µg/L.  First, the detector was optimized using the 
instrument software followed by tuning of both quadrupole 1 (Q1) and quandrupole 3 (Q3) in 
both (+/-) electrospray ionization (ESI).  This process ensures that the detector is operating at 
its optimum voltage for signal detection and that the masses detected are accurate.  Analysis 
of sample extracts was completed using a Varian (Walnut Creek, CA) ProStar solvent 
delivery module (Model 210) which used a gradient binary mobile phase system comprised 
of 100% acetonitrile (B), and 0.1% formic acid in LGW (A).  Table 2.4 shows the gradient 
program used for both positive electrospray ionization (+ESI) and negative electrospray 
ionization (-ESI) (Ye, 2005).  Both mobile phases were filtered through 0.2µm Whatman 
filters from Fisher Scientific (Pittsburgh, PA) before use.  The mobile phases were pumped 
through a Metachem Technologies, Inc. Degassit Unit (Torrance, CA), in order to remove 
any dissolved gases.  The flow rate of the mobile phase was 0.2mL/min.  A Varian ProStar 
autosampler (Model 430) (Walnut Creek, CA) injected 20µL onto a Varian C18 guard 
column (3cm x 2mm, 3µm) (Walnut Creek, CA) and a Varian (Torrance, CA) Pursuit C-18 
analytical column  (15cm x 2mm, 3µm) was used interfaced to a Varian (Walnut Creek, CA) 
1200L triple quandrupole mass spectrometer.  Varian MSWS Software Version 6.8 was used 
for data analysis. Liquid nitrogen (99.99%) was used as the drying gas, UHP argon the 
collision gas (CID) in positive ionization mode (+ESI), and zero grade air was used as the 
CID gas in negative ionization mode (-ESI).  Table 2.5 shows the mass spectrometer 
parameters used in the analytical methods (Ye, 2005). 
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Table 2.4 Mobile Phase Gradient used for LC-(+/-)-ESI-MS/MS (flow rate=0.2mL/min) 
   
Time (min) %A (0.1% Formic Acid in LGW) %B (100% Acetonitrile) 
   
0 90 10 
2 90 10 
25 10 90 
27 10 90 
28 0 100 
38 0 100 
47 90 10 
55 90 10 
 
 
Table 2.5 Source Dependent Mass Spectrometer Parameters  
   
Parameter +ESI -ESI 
   
CID gas Pressure (mTorr) 1.5 1.5 
Detector (V) 1320 -1320 
Drying gas Temperature (°C) 300 200 
Spray Chamber Housing (°C) 50 50 
Spray Shield (V) 600 -600 
Nebulizing gas Pressure (psi) 55 55 
Drying gas Pressure (psi) 18 18 
Needle (V) 5000 4500 
 
 
Mass spectrometry acquisition data for target analytes used in the analysis is shown in 
Tables 2.6-2.8.  The ion transitions and collision energies shown in Tables 2.6-2.8 were 
determined by infusing individual 1mg/L standards of each target BAC in 9/1 LGW/MeOH 
in the Varian 1200L MS (Palo Alto, CA) using a Harvard Apparatus syringe pump 
(Holliston, MA).  The molecular ion of the BAC was targeted in Q2 and as the collision gas 
increased from 0-50V the characteristic breakdown ions were determined.  The target 
analytes were broken up into several groups of compounds that were analyzed in separate 
sample injections in order to maximize sensitivity and increase analyte resolution.  Although 
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the same chromatography is used the MS is programmed using instrument software to target 
different ion transitions in each method.  To this end, target analytes will not co-elute or lose 
sensitivity due to increasing the target analyte transitions.  As a result, in order to analyze all 
BACs a total of three injections for each sample extract were made.  It can be seen in these 
tables that the presence of both a major and minor ion were used in the quantification and 
confirmation of an analyte, respectively. These major and minor ions are characteristic 
fragments (or daughter ions) of the parent compound under the utilized analytical conditions 
and confirmation is achieved by calculating the ratio of the daughter ions in a sample.  Table 
2.9 summarizes the acquisition data for the internal standard and surrogate standard.  
Optimized parameters for each compound were obtained through analysis of individual 
standards by directly infusing the standards into the mass spectrometer using a Harvard 
Apparatus syringe pump (Holliston, MA) and optimizing instrumental conditions.  The 
standard operating procedure (SOP) is presented in Appendix 2. 
Before the analysis of extracted drinking water samples several quality control 
measures were taken.  Several injections of the solvent, 9/1 LGW/methanol, were analyzed to 
ensure that the solvent and instrument were free of contamination.  In addition, the sensitivity 
of the instrument was verified using a BAC mixture standard and caffeine.  Finally, the 
method for each group was run with the BAC mixture at 50µg/L before sample analysis in 
order to evaluate retention times and analytical sensitivity. 
Percent recovery of the target BAC analytes in the samples was evaluated throughout 
the extraction procedure by determining the instrument response of a surrogate standard.  
That is, the area of the surrogate standard was determined in each sample to determine the 
variability between sample extracts. 
69 
 
Table 2.6 Optimized Acquisition Data for Group 1 (+ESI) Compounds 
 
BAC 
Retention Time 
major (minor)  
Parent 
Ion  
Major Ion 
(Collision Energy) 
Minor Ion 
(Collision Energy)  
 minutes m/z m/z(volts) m/z(volts) 
     
Acetaminophen 5.3 (N/A) 151.9 110.0 (11.5) N/A 
Caffeine 7.9 (7.97) 195.1 137.9 (11.5) 109.9 (16.5) 
Tetracycline 10.5 (10.95) 445.3 427.0.3 (8) 410.0 (16) 
Meprobamate 13.4 (N/A) 219.1 158.0 (6.5) N/A 
TCEP 18.2 (18.27) 285.0 160.8 (7.5) 222.8 (6.0) 
Erythromycin-H2O 17.3 (17.42) 734.6 158.0 (19) 82.9 (27) 
 
 
Table 2.7 Optimized Acquisition Data for Group 2 (+ESI) Compounds 
BAC  
Retention Time 
major (minor) 
Parent 
Ion 
Major Ion 
(Collision Energy) 
Minor Ion 
(Collision 
Energy) 
minutes m/z m/z (volts) m/z (volts) 
Atenolol 4.3 (4.2) 267.2 144.9 (17) 189.9 (10.5) 
Trimethoprim 9.2 (9.2) 291 229.9 (20.5) 122.9 (20.5) 
Sulfamethoxazole 13.6 (13.6) 253.9 155.9 (14) 107.9 (18.5) 
Atrazine 18.3(18.7) 216 173.9 (10.5) 95.8 (21) 
Carbamazepine 16.6 (16.6) 237 193.9 (12) 192.0 (18.5) 
DEET 16.6 (18.6) 192.2 118.9 (14) 90.8 (26) 
Diazepam 20.4 (20.4) 285 192.9 (27) 153.9 (24) 
Bezafibrate 20.8 (20.8) 362.2 138.9 (17) 120.9 (19.5) 
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Table 2.8 Optimized Acquisition Data for Group 3 (–ESI) Compounds  
     
BAC  
Retention Time 
major (minor) 
Parent 
Ion 
Major Ion 
(Collision Energy) 
Minor Ion (Collision 
Energy) 
 minutes m/z m/z(volts) m/z(volts) 
     
Ibuprofen 24.30/Not Seen 205.0 160.7 (6) N/A 
Clofibric Acid 19.90/Not Seen 213.1 126.7 (10.5) N/A 
Gemfibrozil 26.4 (26.5) 249.3 120.8 (8.5) 121.8 (10) 
Fenoprop 23. 0 (23.1) 268.7 196.6 (8) 160.4 (26.5) 
Diclofenac 23.7(23.6) 294.0 249.8 (8) 250.8 (8) 
 
 
Table 2.9 Optimized Acquisition Data for Internal and Surrogate Standards  
     
Standard 
Retention 
Time major 
(minor) 
Parent 
Ion 
Major Ion  
(Collision Energy) 
Minor Ion (Collision 
Energy) 
 minutes m/z m/z(volts) m/z(volts) 
     
Simeton 
(Internal) 9.8 (N/A) 198.0 123.9 (16) Not observed 
Caffeine-d3 
(Surrogate) 7.9 (8.0) 198.1 140.8 (12) 112.8 (16.5) 
Meclocycline 
(Surrogate) 9.3 (9.8) 477.0 459.9 (14.5) 234.4 (34.5) 
 
 
The instrument detection limit (IDL) is the lowest concentration that the instrument 
can detect for a particular analyte with a defined level of confidence above noise.  For this 
study, this limit was set so that the detector signal (S) compared to noise (N) was at least 30. 
By analyzing a 50µg/L BAC standard mixture in 9/1 LGW/MeOH using the appropriate 
method, the S:N value was determined and then, assuming linearity from zero concentration 
to 50µg/ L, the concentration that would give a S:N of 30 could then be calculated (Table 
2.10).  The IDL was used to determine the lowest concentration of each analyte that could be 
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detected in the water samples using the analytical method which employs a concentration 
factor of 1,000 (and assuming 100% recovery).  Therefore, this information was used to 
generate the calibration points used for sample quantification (Table 2.3). 
 
 
Table 2.10 Instrument Detection Limit for Targeted BACs  
   
BAC 
Instrument Calculated S:N at 
50µg/L in 9/1 LGW/MeOH  
Predicted 
Concentration (µg/L) 
giving S:N=30 
   
Acetaminophen  117 13 
Atenolol 242 6.2 
Atrazine  1431 1.1 
Bezafibrate  476 3.2 
Caffeine 107 14 
Carbamazepine 1153 1.3 
Clofibric acid 38 40 
DEET 447 3.4 
Diazepam 354 4.2 
Diclofenac 256 5.9 
Erythyromycin  7130 0.21 
Fenoprop  147 10 
Gemfibrozil  18 83 
Ibuprofen 1 1500 
Meprobamate  150 10 
Sulfamethoxazole  923 1.6 
Tetracycline 95 16 
TCEP 223 6.7 
Trimethoprim  472 3.2 
 
 
The limit of quantification (LOQ) is reported as the lowest detectable non-zero 
response from the extracted samples analyzed in the calibration curves shown in Table 2.3.  
The values are reported as the concentration in the appropriate calibration sample.  The 
LOQs for the BACs are shown in Table 2.11.   Although data was obtained for the BACs 
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analyzed in (-)-ESI in a 50µg/L standard in 9/1 LGW/MeOH, instrument response was 
limited in sample extracts due to lack of instrument sensitivity in this mode of ionization.  
Therefore, the analytes requiring ionization in (-)-ESI were not searched for in subsequent 
occurrence sampling. It was later determined that instrument sensitivity in (-)-ESI could be 
increased by using higher grade methanol for sample extraction.   
 
 
Table 2.11 Limit of Quantification for Targeted BACs in North Carolina Drinking 
Water 
   
BAC 
In raw water 
(ng/L) 
In finished water 
(ng/L) 
   
Acetaminophen  5.1 5.1 
Atenolol 5.2 2.1 
Atrazine  5.3 2.1 
Bezafibrate  5.1 5.1 
Caffeine 5.1 2.0 
Carbamazepine 5.2 2.1 
Clofibric acid Not seen Not seen 
DEET 5.0 1.9 
Diazepam 5.0 5.0 
Diclofenac Not seen Not seen 
Erythyromycin  Not seen Not seen 
Fenoprop  Not seen Not seen 
Gemfibrozil  Not seen Not seen 
Ibuprofen Not seen Not seen 
Meprobamate  Not seen Not seen 
Sulfamethoxazole  5.2 5.2 
Tetracycline 5.2 5.2 
TCEP 54 5.4 
Trimethoprim  5.1 2.0 
 
  
 
 
3. CHLORINATION OF BACs  -  INCORPORATION OF CHLORINE ONTO 
PARENT MOLECULE 
 
 
3.1 Introduction 
 Incomplete metabolism of BACs in the body, incomplete removal through 
wastewater treatment plants, and subsequent persistence in the environment allow for BACs 
to enter drinking water treatment plants.  What happens to these chemicals during drinking 
water treatment is yet another challenge for which little information is available.  During 
drinking water treatment, chemical processes such as disinfection using hypochlorite can 
transform the structure of the parent BAC molecule.  Several studies of the chlorination of 
BACs have shown that incorporation of chlorine onto regions with electron density are the 
most likely mechanism of reaction (Gould and Richards, 1984; Miyamoto et al., 1997; Dodd 
and Huang, 2004; Moriyama et al., 2004; Pinkston and Sedlak, 2004; Glassmeyer and 
Shoemaker, 2005; Ye, 2005; Bedner and MacCrehan, 2006; Nakamura et al., 2006; Dodd 
and Huang, 2007; Brix et al., 2008; Kotcharaksa, 2008; DellaGreca et al., 2009; Lee and 
Gunten, 2009; Quintana et al., 2010; Wulfeck-Kleier et al., 2010; Krkošek et al., 2011; Soh et 
al., 2011; Wang et al., 2011), as opposed to complete removal (or mineralization).  
Understanding the fate of BACs during drinking treatment is important in order to evaluate 
whether biochemically active species remain undetected in consumers’ drinking water.  In 
the experiments that follow the extent to which chlorine can affect the structure of targeted 
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BACs was determined using measurements of TOX and the fate of the parent compound 
determined using tandem mass spectrometry. 
 
 
3.2 Chlorination Experiments 
TOX Analysis 
Previous studies have shown the incorporation of chlorine onto BACs without 
significant degradation of the parent molecule and, therefore, measuring the concentration of 
incorporated chlorine is useful to determine the extent of substitution.  This can be achieved 
using TOX analysis where the carbon which has adsorbed the organic halogens in a sample is 
pyrolyzed and the halogens measured using a coulometric detector.  Therefore, the objective 
of these experiments was to measure the increase in organic halogens in the sample due to 
chlorination and relate this to the consumption of both free chlorine and parent BAC.  The 
molar ratio of chlorine to BAC is shown in Table 3.1.  Preliminary experiments on all 
targeted BACs (n = 1) were designed to determine relative reactivity.  Subsequent targeted 
reactions of four BACs that were highly reactive with free chlorine used triplicate analysis to 
allow for statistical analysis and verification of results.   
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Table 3.1  Studied BACs and Experimental Conditions (n = 1 unless noted) 
BAC Molar Ratio of Chlorine to BAC 
17-α-ethinyl estradiol 69.4 
Acetaminophen (n=3) 45 
Atenolol 69.7 
Atrazine 69.9 
Bezafibrate 110 
Caffeine 62.2 
Carbamazepine 66.5 
Clofibric Acid 38 
DEET 64.9 
Diazepam 93.8 
Diclofenac 54.4 
Erythromycin-hydrate 209 
Estrone 77.1 
Fenoprop (n=3) 75.2 
Gemfibrozil 74.4 
Ibuprofen 51.5 
Meprobamate 71.9 
Sucralose 136 
Sulfamethoxazole 80.8 
TCEP 61.2 
Tetracycline (n=3) 114 
Trimethoprim (n=3) 89.1 
 
 
Case Study on the Reactivity of Tetracycline 
The reactivity between tetracycline and free chlorine was studied in greater detail due 
to its high incorporation of chlorine during TOX experiments and the limited information 
available about its fate during chlorination.  Aqueous solutions of tetracycline were prepared 
in LGW at a target concentration of 22µM and reacted with free chlorine at a molar ratio of 
free chlorine to tetracycline ([HOCl]:[TC]) ranging from 1:1 to 20:1 in order to study the 
transformation of tetracycline and detect transformation products.  A high initial 
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concentration of tetracycline was used in order to aid in the detection of transformation 
products.  The higher doses of [HOCl]:[TC] were sufficient to ensure that the reaction 
between free chlorine and tetracycline went to completion.  Previous studies have shown that 
tetracycline compounds are very reactive with free chlorine and have an estimated half life of 
3 s at pH 7 (Ye, 2005).   
 
 
3.3 Results and Discussion 
3.3.1 Chlorine Demand 
 The results of chlorine demand are shown in Table 3.2.  The net chlorine demand is 
the chlorine demand of the BAC solutions with chlorine minus the average chlorine demand 
of the chlorinated LGW (control sample).  The net chlorine demand for fenoprop is negative 
indicating that the free chlorine residual for the sample is higher than the dose of chlorine 
that was applied to the sample.  This may be the result of fenoprop, a tri-chlorinated 
compound, losing some of its chlorine substituents during the reaction or may be due to the 
limitations of accuracy of the HACH test kits.  This would be subsequently confirmed by 
TOX analysis.  The results of multiple chlorinations of LGW reveal that the average value 
for chlorine demand by LGW was 3.8 + 1.58 mg/L as Cl2 with a coefficient of variation of 
0.42 (n = 9).   This high value is the result of the chlorine demand of the glassware used in 
the experiments due to organics that might have remained on the glass surface.  For the 
qualitative nature of the TOX experiments this chlorine demand of the glassware did not 
interfere with results, and the chlorine dose was applied in excess to ensure a residual was 
present. Chlorine demand of the BAC solution shows quantitatively the reactivity of each 
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BAC in contact with chlorine under the experimental conditions described above and can be 
used to calculate the number of moles of chlorine that have reacted during chlorination 
experiments.   
Table 3.2  Net Free Chlorine Demand of Chlorinated^ BACs (n = 1 unless noted) 
 
                   BAC    Net Free Chlorine Demand* 
Name 
Initial 
Concentration 
(µmoles) (mg/L as Cl2) (µmoles Cl2) 
 
17-α-ethinyl estradiol 0.475 1.5 2.1 
Acetaminophen (n=3) 0.851 3.8 + 1.5 3.4 + 1.4 
Atenolol 0.473 1.7 2.4 
Atrazine 0.472 <0.2 NA 
Bezafibrate 0.3 2.8 3.9 
Caffeine 0.53 3.9 5.5 
Carbamazepine 0.496 0.9 1.3 
Clofibric Acid 0.867 1.5 2.1 
Diazepam 0.351 1.3 1.8 
Diclofenac 0.606 2.4 3.4 
Erythromycin-hydrate 0.158 1.7 2.4 
Estrone 0.428 1.9 2.7 
Fenoprop (n=3) 0.51 -0.2 -0.2 
Gemfibrozil 0.443 1.2 1.7 
Ibuprofen 0.649 2.4 3.4 
Meprobamate 0.458 <0.2 NA 
Sucralose 0.242 0.4 0.56 
Sulfamethoxazole 0.408 4.3 6.1 
TCEP 0.539 <0.2 NA 
Tetracycline (n=3) 0.245 0.9 + 0.6 1.3 + 0.78 
Trimethoprim (n=3) 0.589 2.4 + 1.0 3.4 + 2.1 
* Net chlorine demand=chlorine demand of chlorinated BAC sample minus chlorine demand 
of chlorinated LGW sample  
^ Chlorine dose was ~20mg/L NaOCl as Cl2 
Free chlorine demand of LGW 3.8 + 1.58mg/L as Cl2 
DEET=N,N-diethyl-meta-toluamide 
TCEP=tris(2-carboxyethyl)phosphine 
NA=not applicable 
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3.3.2 Reactivity of Parent BACs with Free Chlorine 
TOX Analysis 
The results from analysis of breakthrough of analytes onto a second column are 
shown in Table 3.3. As described in Chapter 2 although the Standard Method 5320 (APHA, 
1999) calls for the use of two carbon columns, the percentage breakthrough was determined 
to be less than 5% and therefore only one carbon column was used in subsequent 
experiments to increase productivity.   
 
 
Table 3.3  Breakthrough Determination of Select Chlorinated BACs during TOX 
Analysis 
       
Chlorinated Sample* Raw Data# 
(µg Cl) 
Net 
Data@ 
(µg Cl) 
TOX 
Concentration^ 
(µg Cl/L) 
Breakthrough 
(%) 
     
Tetracycline Column 1 17.005 16.744 3.4x102 NA 
Tetracycline Column 2 1.047 0.816 16 4.6 
     
Acetaminophen Column 1 10.243 10.196 2.0x102 NA 
Acetaminophen Column 2 0.435 0.388 7.8 3.7 
      
Fenoprop Column 1 22.172 22.124 440 NA 
Fenoprop Column 2 0.486 0.439 8.6 1.9 
      
Trimethoprim Column 1 3.292 3.244 65 NA 
Trimethoprim Column 2 0.192 0.145 2.9 4.3 
*Target chlorine dose was 20mg/L as Cl2 and target BAC dose was 1mg/L 
#For a 50mL sample 
@After subtraction of LGW/NO3- carbon column rinse control sample 
^Net data/sample volume 
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The results from the TOX analysis of the chlorinated BACs are shown in Table 3.4 
and the TOX generated, which is a measure of the amount of chlorine incorporation into the 
parent BAC molecule during the chlorine reaction, is given on a weight and molar basis.  The 
molar ratio of the generated TOX to starting BAC indicates the extent to which a BAC 
molecule was chlorinated.  For example, in the case of tetracycline a molar ratio of 3 
indicates that three atoms of chlorine may have been added to each molecule of tetracycline.  
For trimethoprim the molar ratio of 0.4 may indicate that one atom of chlorine may be 
incorporated onto approximately every two molecules of trimethoprim.   
The results from TOX analysis shown in Table 3.4 and chlorine demand shown in 
Table 3.2 can be compared to determine the extent to which loss of chlorine in solution is 
accounted for by incorporation into the BAC molecule.  Among the most reactive BACs, 
relatively high values of net chlorine demand were recorded.  Conversely, results for a BAC 
that did not produce measureable TOX, such as atrazine, and where the net chlorine demand 
is very low confirm that no chlorine reaction had occurred.  For chemicals such as caffeine 
and bezafibrate, where there is a chlorine demand and no TOX generated it is possible that a 
chlorine reaction involving hydrolysis or oxidation rather than chlorine substitution, 
occurred.  Additionally, the net chlorine demand of BAC reactions is compared to the 
chlorine incorporation into the chemical to help evaluate the extent to which chlorine 
consumption is accounted for by formation of organo-chlorine products.    
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Table 3.4  Results from TOX Analysis of Chlorinated BACs (n = 1 unless noted) 
                         TOX generated 
BAC (µg/L Cl) (µmoles Cl)* 
Molar ratio of TOX 
to BAC** 
17-α-ethinyl estradiol 77 0.22 0.5 
Acetaminophen (n=3) 181 + 18 0.511 + 0.051 0.7 + 0.1 
Atenolol 33 0.092 0.2 
Atrazine <10 NA NA 
Bezafibrate <10 NA NA 
Caffeine <10 NA NA 
Carbamazepine 43 0.12 0.2 
Clofibric Acid <10 NA NA 
DEET <10 NA NA 
Diazepam 33 0.094 0.3 
Diclofenac <10 NA NA 
Erythromycin-hydrate 40 0.11 0.7 
Estrone 74 0.21 0.5 
Fenoprop (n=3) 8 + 7 0.021 + 0.019 0.05 + 0.1 
Gemfibrozil 26 0.073 0.2 
Ibuprofen <10 NA NA 
Meprobamate <10 NA NA 
Sucralose 36 0.1 0.4 
Sulfamethoxazole 69 0.19 0.5 
TCEP <10 NA NA 
Tetracycline (n=3) 334 + 25 0.940 + 0.071 3 + 0.3 
Trimethoprim (n=3) 53 + 10 0.149 + 0.29 0.4 +0.1 
*Based on a 100mL reaction solution 
** See Table 2.2 for initial molar concentration of BACs; calculations assume that 100% of 
the parent BAC was consumed during the reaction 
DEET=N,N-diethyl-meta-toluamide 
TCEP=tris(2-carboxyethyl)phosphine 
NA=not applicable 
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BACs Highly Reactive with Free Chlorine 
From the results shown in Table 3.4 of the TOX generated during chlorination 
experiments it can be seen that tetracycline, trimethoprim, acetaminophen, 17-α-ethinyl 
estradiol, sulfamethoxazole, and estrone (Figure 3.1) were the most reactive BAC species 
with chlorine.  These BACs have several characteristics in common: aromatic regions 
(extended π-conjugation), ring activating substituents (-OH,-NH2), and available positions for 
electrophilic attack on the aromatic ring.  In the literature, the reactivity of these compounds 
towards chlorine has been reported to be due to ring substitution with no significant 
degradation of the parent BAC molecule backbone.  For example, the aqueous chlorination 
of acetaminophen (Bedner and MacCrehan, 2006) and 17-α-ethinyl estradiol (Moriyama et 
al., 2004) have been studied and both mono- and di-chlorinated transformation products 
attributed to ring chlorination in the position ortho- to the phenol group were observed using 
mass spectrometry.  Due to its similar structure, the chlorination of estrone is expected to 
occur on the aromatic ring in the ortho- position of the phenol substituent.  Results from the 
current study (Table 3.4) show that acetaminophen, 17-α-ethinyl estradiol, and estrone 
incorporated 0.7, 0.4, and 0.4 moles of chlorine per mole of parent BAC, respectively.  These 
compounds contain a phenol group and it can be concluded that mono-chlorination occurred 
to approximately half of the starting BAC material under the conditions used during this 
experiment. The incorporation of chlorine onto acetaminophen was slightly higher than that 
of estrone and 17-α-ethinyl estradiol and this may be due to the higher solubility of 
acetaminophen in water (Table 1.3) or due to the aliphatic portions on the steroid hormone 
structures.  Studies have shown that the aqueous mono- and di- chlorination of trimethoprim 
is expected to occur at the 2,4-diamino-5-methylpyrimidine moiety (Dodd and Huang, 2007), 
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and the results from the current study show that for every two moles of trimethoprim one 
mole of chlorine was incorporated onto the molecule which agrees with Dodd and Huang 
(2007).  Trimethoprim was observed to incorporate less chlorine than any of the phenol-
containing compounds and this is most likely the result of the slower reaction rate between 
free chlorine and the parent compound which contains two amine groups and a highly 
substituted ring system.  The reactivity of sulfamethoxazole has also been previously 
investigated and yields N-chloro-p-benzoquinoneimine (Dodd and Huang, 2004).  The results 
from the current study show that for every two moles of sulfamethoxazole one mole of 
chlorine is incorporated which agrees with the work of Dodd and Huang (2004). 
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Figure 3.1 Structures of BACs Studied which Showed the Greatest Degree of Chlorine 
Incorporation during Reaction with Free Chlorine 
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The most reactive BAC based on TOX analysis in this current study was tetracycline 
and limited information is available in the literature concerning its reactivity with free 
chlorine.  One preliminary study on the aqueous chlorination of tetracycline showed the 
appearance of transformation products in the chromatogram using LC-MS in full scan mode, 
but no chlorinated products were identified (Ye, 2005).  In another study tetracycline was 
found to react very rapidly with free chlorine, and LC-MS analysis showed that 
transformation products with Cl- and OH- substituents were formed, but no product 
structures were proposed (Wang et al., 2011).   
The results from the current study show that for every mole of tetracycline three 
moles of chlorine are incorporated.  This level of incorporation is significantly higher than 
that of any of the previously mentioned BACs, and based on the structure of tetracycline it 
can be anticipated this is due to its extended π-conjugation, phenol, and tertiary amine 
groups.  The chlorination of tetracycline will be discussed in greater detail in a case study.   
The high reactivity of these compounds is a cause for concern because the exposure 
to these compounds and/or their transformation products may be underestimated.  These 
compounds may transform into chlorination by-products in WWTPs that use chlorine as a 
disinfectant, and these transformed BACs may enter receiving streams and elude detection.  
Another possible fate of these BACs is that they may transform during drinking water 
treatment and will not be detected using analytical methods that only target parent BACs.  
The result is that the reaction of chlorine with the parent molecule could be generating 
undetected biochemically active by-products leaving the potential impact on water quality 
significantly underestimated.  An additional implication is that that the biological activity of 
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these chlorinated transformation products of these compounds remains not well understood.  
Additional studies should be undertaken to determine the bioactivity of these compounds 
after chlorination to determine their risk to the environment, aquatic organisms, and humans.   
 
 
BACs Unreactive with Free Chlorine 
The results from TOX analysis reveal that many of the BACs studied have very 
limited reactivity with free chlorine under the experimental conditions employed.  The results 
from the current study agree with the available literature where caffeine (Glassmeyer and 
Shoemaker, 2005), ibuprofen (Pinkston and Sedlak, 2004; Quintana et al., 2010), clofibric 
acid, and bezafibrate (Quintana et al., 2010) were all observed not to react with chlorine.  The 
chlorination of atrazine has been observed in the literature and it was observed that the use of 
the quenching agent, sodium sulfite, dechlorinates transformation products back into atrazine 
(Wulfeck-Kleier et al., 2010).  During this study the quenching agent used was sodium sulfite 
and in future studies a different chemical should be used when evaluating reactivity.  The 
pKa values of the compounds with low reactivity towards free chlorine are typically <6.1 (see 
Table 1.3) and therefore these compounds exist in their deprotonated forms.  The 
deprotonation of these compounds increases resonance across the BACs and stabilizes the 
molecular structure, minimizing reaction.  While additional studies are needed to confirm the 
persistence of the parent BACs shown in Figure 3.2 during chlorination, there are several 
structural characteristics of the compounds that may help drive hypotheses on reactivity and 
guide future studies. Among all of the BACs studied, the two compounds without any 
regions of aromaticity (TCEP and meprobamate) were not reactive with free chlorine, which 
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confirms that chlorine reacts most easily in aqueous solutions with organics through 
electrophilic attack.  Compounds with aliphatic regions lack sufficient electron density and, 
therefore, react less with free chlorine.  Another characteristic prevalent among the least 
reactive compounds is the presence of chlorine on the parent BAC (fenoprop, atrazine, 
diclofenac, bezafibrate, and clofibric acid) which as a highly electronegative species, 
withdraws electron density from the aromatic ring and deactivates it from reacting with an 
electrophile.  Additionally, another common characteristic in this group is highly substituted 
aromatic rings (fenoprop, caffeine, and atrazine) in which steric hindrance may prevent 
chlorine substitution from occurring.  Another example of steric hindrance is seen in 
ibuprofen where the bulky aliphatic chain on the aromatic ring inhibits the substitution of 
chlorine. 
The low reactivity of these compounds with free chlorine highlights a problem in the 
effective management of anthropogenic compounds.  Many of these compounds have been 
found to be ubiquitous environmental contaminants and, therefore, more effective treatment 
technologies are needed in order to protect both drinking water consumers and the 
environment from chronic low level exposure.  If these compounds are not effectively 
removed during drinking water treatment then their use should become more regulated in 
order to prevent consumers from being exposed to persistent contaminants.    
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Figure 3.2 Structures of BACs Studied with the Lowest Degree of Chlorine Incorporation 
During Reaction with Free Chlorine 
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BACs Moderately Reactive with Free Chlorine 
The results from TOX analysis reveal that several compounds have moderate 
reactivity with free chlorine (Figure 3.3) in reference to the least and most reactive BACs.  
Both erythromycin-hydrate and sucralose lack aromaticity, in which the lack of electron rich 
aromatic rings decreases the possibility for reaction with chlorine.  While electrophilic 
aromatic substitution reactions are the most significant to occur between free chlorine and 
organic structures in water, other reactions such as addition and oxidation are also possible.  
In the case of erythromycin-hydrate it is possible that the tertiary amine group may react with 
chlorine.  The TOX results from Table 3.4 show that if all of the erythromycin-hydrate was 
consumed during the reaction with free chlorine approximately 1 (0.7) mole of chlorine 
would be incorporated into each parent molecule.  Therefore, it is possible that the chlorine is 
added to the tertiary amine group forming an N-chloro transformation product of 
erythromycin and because reactions with tertiary amines are less kinetically favorable (Abia 
et al., 1998) not all of the erythromycin-hydrate is chlorinated after the 2 hour contact time.  
The reaction kinetics of the chlorination of erythromycin-hydrate was observed to have a 
strong dependency on pH, with reaction proceeding slower when the molecule was in its 
protonated form (Ye, 2005) as it would be under the conditions employed in this experiment.  
Mono-chlorination of the amine of erythromycin-hydrate has been observed previously (Ye, 
2005) and agrees with the current TOX study.   
Both diazepam and carbamazepine contain several fused aromatic rings and although 
these regions of electron density are possible locations for electrophilic aromatic substitution 
of chlorine, electron withdrawing substituents (Cl- and amides) reduce the reactivity of these 
BACs. Carbamazepine has been observed to form un-chlorinated transformation by-products 
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when chlorinated (Kotcharaksa, 2008), and the minimal reactivity observed with TOX (Table 
3.4) experiments may indicate that other products are also forming. Atenolol and gemfibrozil 
also contain aromatic rings where substitution of chlorine is the most likely mechanism of 
reaction with chlorine, but the reactivity of this ring is deactivated due to electronegative 
species (i.e. oxygen) in the alpha position to the aromatic ring.  Additionally, the long 
aliphatic chains increase steric hindrance and minimize the availability of the ring for 
reaction.  Mono- ring chlorination of gemfibrozil has been observed in reactions with free 
chlorine (Glassmeyer and Shoemaker, 2005; Krkošek et al., 2011) and an N-chlorinated 
product of atenolol has also been reported (DellaGreca et al., 2009).  The results from the 
current study show that while chlorination of atenolol and gemfibrozil occurs, it is only to a 
small degree.  In summary, although these BACs contain structures and functional groups 
that may react with chlorine, the moderate reactivity of these BACs is most likely the result 
of electron withdrawing functional groups and the result is slow reaction rates and only 
moderate reactivity with free chlorine.   
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Figure 3.3 Structures of BACs Studied with Moderate Chlorine Incorporation During 
Reaction with Free Chlorine 
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3.3.3 Removal of Parent BAC 
MS/MS Analysis 
In order to confirm the reactivity of the parent BAC during chlorination, infusion 
based tandem mass spectrometry (MS/MS) experiments were performed to monitor that 
parent BAC concentration. Based on their observed reactivity with chlorine (see Table 3.4), 
two BACs were chosen to confirm the extent to which the parent compound had reacted 
using infusion-based tandem MS/MS.  Table 3.5 shows the results of targeting the parent 
molecule and breakdown of the ions as well as their daughter ions in Q2 of the mass 
spectrometer before and after chlorination of the compound.  The parent ion counts are a 
measure of the concentration of the parent molecule while the daughter ions are the 
fragments of the corresponding parent molecule used to confirm the identity of the parent 
compound.  Each chemical has a characteristic fragmentation pattern based on its chemical 
properties and applied experimental conditions. Therefore, this “fingerprint” is often used to 
confirm the identity of a parent compound.  This structural confirmation is completed by 
selecting two prominent daughter fragments.  These two daughter ions are shown in Table 
3.5 for the atenolol and tetracycline that have not undergone a chlorination reaction.  The 
presence of the daughter ions confirms the identity of the parent compound.  It can be seen 
from Table 3.5 that in both the chlorinated and unchlorinated atenolol samples the same two 
daughter fragments were detected.  Additionally, the parent ion counts for atenolol show that 
in the unchlorinated and chlorinated samples, the concentration of atenolol did not change 
significantly.  These results indicate that chlorination did not transform atenolol to a 
significant degree and these results are consistent with the findings from TOX and chlorine 
demand experiments. 
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Table 3.5 (+)-ESI-MS/MS Results of Targeting Parent BAC Before/After Chlorination 
 
 
   
Sample Name 
Concentration* 
(mg/L) 
Parent ion 
counts 
Daughter 1 
m/z 
Daughter 2 
m/z 
 
 
   
Atenolol unchlorinated 1.0 6679 145 190 
Atenolol chlorinated A 0.97 6248 145 190 
Atenolol chlorinated B 0.98 6330 145 190 
 
 
   
 Sample Name 
Concentration* 
(mg/L) 
Parent ion 
counts 
Daughter 1 
m/z 
Daughter 2 
m/z 
 
 
   
Tetracycline unchlorinated 1.0 1276 428 410 
Tetracycline chlorinated A 0.23 297 not seen not seen 
Tetracycline chlorinated B 0.12 153 not seen not seen 
*Concentration is based on the number of parent BAC ion counts 
 
 
Table 3.5 also shows the results of analysis of the tetracycline after chlorination.  The 
results for the unchlorinated tetracycline sample show the ion counts and characteristic 
daughter fragments of the parent molecule which were absent in the chlorinated samples.  
The absence of the characteristic daughter ions of tetracycline and the low ion counts for 
tetracycline indicates that the concentration of tetracycline is significantly reduced in the 
chlorinated samples, approximately 82% consumed.  Hence the formation of TOX can be 
assumed to be as a result of complete chlorination if matched by the chlorine demand and 
these results are shown in Table 3.7.  This result is consistent with the findings from the TOX 
and chlorine demand experiments which showed a high degree of incorporation of chlorine 
into the tetracycline molecule.  The results show the benefit of combining TOX and MS/MS 
measurements for determining the extent of chemical reactions with chlorine.   
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3.3.4 Case Study of Tetracycline Reactivity with Free Chlorine 
TOX analysis and preliminary MS/MS infusion analysis revealed that tetracycline 
(Figure 3.1) was highly reactive with free chlorine.  In the case of TOX, a high level of 
incorporation of chlorine into the parent tetracycline molecule was revealed (36% of the 
applied chlorine dose incorporated).  In summary, this was indicated by a significant 
incorporation of chlorine into the parent molecule (3 chlorine atoms per tetracycline 
molecule), an 82% decrease in tetracycline concentration, and the absence of the daughter 
ions of tetracycline during collision induced dissociation (CID) experiments in quadrupole 2 
(Q2).  Confirmation of these preliminary results and elucidation of reaction products is now 
described. 
 
 
 Impact of Free Chlorine Dose 
Figure 3.4 shows results from the reactivity study between free chlorine and 
tetracycline where a single contact time was used for varying doses of chlorine (shown in 
Table 3.6) to determine the impact on the transformation of tetracycline.  In this figure the 
free chlorine residual in the chlorinated samples containing tetracycline is superimposed with 
the tetracycline ion counts from MS/MS direct infusion analysis.    
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Table 3.6 Concentration of HOCl Used during Experiment and Corresponding Molar 
Ratio 
Concentration of HOCl (µM as Cl2) [TC]:[HOCl] 
22.5 1:1 
22.5 1:1 
45 1:2 
45 1:2 
112 1:5 
112 1:5 
450 1:20 
450 1:20 
 
 
 
 
Figure 3.4 Reactivity of Tetracycline (C0 = 22.5µM) as a Function of Free Chlorine Dose and 
Measured by Chlorine Residual (Right-Hand y-axis) and MS/MS Ion Intensity (Left Hand y-
axis) 
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As the free chlorine dose increases, the tetracycline (TC) ion counts as measured by 
MS/MS analysis decreases.  At a molar ratio of [HOCl]:[TC] = 1 there is a large drop in the 
concentration of tetracycline as measured by ion counts.  The concentration of TC remains 
constant up to a [HOCl]:[TC] ratio of 5 only decreasing further when a chlorine residual is 
measured at [HOCl]:[TC] = 20.  This is an indication that although tetracycline is reactive 
with chlorine at lower doses the reaction may not be complete until a large excess of chlorine 
is added which may demonstrate either a two-step reaction or simply that insufficient 
chlorine was available to react with all the tetracycline at the lower doses.  In the former 
case, the initial chlorination of the molecule could be providing stabilization or steric 
hindrance could be inhibiting the further substitution of the molecule until a large excess of 
chlorine is applied.  Table 3.7 shows the chlorine dose that would be required to completely 
mono-, di-, and tri-chlorinate the parent tetracycline molecule in LGW.  Comparing these 
calculated doses to the applied doses used in the experiment (Table 3.6) and the results 
shown in Figure 3.4 it can be seen that at the molar ratio [HOCl]:[TC]  = 5  the  chlorine dose 
is sufficient to add three chlorine substituents onto parent TC, but the reaction is not 
complete as evidenced by the absence of a chlorine residual.  The TOX experiments 
described previously utilized a very large molar ratio excess of chlorine, [HOCl]:[TC] of 
135, which is well above the dose demonstrated here to have completed the reaction.  
Chlorine doses employed to disinfect wastewater and drinking water (mg/L) are likely to be 
in significant molar excess of the concentration of tetracycline that may be present (sub-µg/L 
or ng/L), and, therefore, it can be expected that the reaction between tetracycline and chlorine 
at full-scale plants will effectively transform the tetracycline molecule into chlorinated by-
products.   
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Table 3.7 Chlorine Dose (mg/L as Cl2) Required for Mono-, Di-, and Tri- Substitution 
of Tetracycline (C0 = 22µM) in LGW Assuming All Chlorine is Consumed  
Chlorine substitution (µmoles Cl/L) in 100mL sample 
Mono- Di- Tri- 
22.5 45 67.5 
Chlorine substitution (µmoles Cl2/L) in 100mL sample 
Mono- Di- Tri- 
11.3 22.5 33.8 
Chlorine Dose Required (mg/L as Cl2)  
Mono- Di- Tri- 
0.788 1.58 2.36 
 
 
Figure 3.4 shows that a residual is not observed until the highest chlorine dose when 
the parent tetracycline molecule remaining is only 3% of its initial concentration.  These 
results indicate that the reaction between free chlorine and tetracycline is not complete until a 
chlorine residual is detected.  An interesting observation during the experiment was that 
when samples of tetracycline in LGW were chlorinated at the highest dose ([HOCl]:[TC] 
=20:1) a rapid color change from clear to light yellow occurred immediately upon addition of 
free chlorine to the sample.  This color change was not observed for any of the samples with 
lower concentration doses of free chlorine.  This observation led to an evaluation of the 
reaction of tetracycline with free chlorine using UV analysis, to confirm the transformation 
of the molecule (Ahuja et al., 2001).       
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Change in Aromatic Structure of Tetracycline 
An ~100µM tetracycline solution in LGW was scanned in a UV-Vis 
spectrophotometer in the range of 200-400nm to provide a baseline against which chlorinated 
solutions were compared.  Energy absorbed in the UV spectrum by the chemical corresponds 
to the nature of the conjugated π electron systems, and as conjugation increases less energy is 
needed to promote an electron (McMurry, 2004).  As can be seen in the spectrum of 
tetracycline in LGW in Figure 3.5 there are two wavelengths at which maximum absorbance 
occurs, 274nm and 356nm.  It can be concluded from the spectrum that the absorption at 
274nm corresponds to the tricarbonyl-amide side of the molecule while the absorption at 
356nm corresponds to the conjugation on the phenolic-diketone side of the molecule (Figure 
3.1).  The aqueous solution containing the highest chlorine dose used in reactions with 
tetracycline (450µM HOCl), was scanned from 200-700nm to ensure that the presence of a 
chlorine residual did not impact absorbance.  Figure 3.6 of this sample shows absorbance at a 
λmax of 290nm.  This absorbance would interfere with the analysis of chlorinated tetracycline 
only if a residual was present which was not the case for the [TC]:[HOCl] = 1:1 and 1:5 in 
LGW samples shown in Table 3.4.  For the samples where a chlorine residual was present, 
the absorbance at 356nm was monitored to confirm the disappearance of tetracycline.  When 
scanning for transformation products of tetracycline the residual chlorine absorbance will not 
interfere with analysis as chlorinated by-products will absorb at higher wavelengths.  
Additionally a lower residual of chlorine was analyzed in LGW (22µM) and no absorption 
was observed.  
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Figure 3.5 UV-Vis Spectrum of Tetracycline in LGW 
 
 
 
Figure 3.6 UV-Vis Spectrum of 450µM Free Chlorine in LGW 
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When tetracycline in LGW is treated with a chlorine dose at a molar ratio of 1:1, only 
the absorption at 356nm decreases while that of 274nm remains the same as shown in Table 
3.8.  This is an indication that the first site of chlorination is on the phenolic-diketone side of 
the molecule.   This is most likely due to the chlorination of the ring via electrophilic 
aromatic substitution.  When the chlorine dose is increased to a molar ratio of 5:1 (chlorine to 
TC) the absorption at both wavelengths decreases, with the amount of decrease at 356nm the 
same as observed in the [TC]:[HOCl] 1:1 sample.  This is an indication that after chlorination 
of the ring the site of subsequent chlorination of the molecule is on the tricarbonyl-amide 
side of the molecule.  The incorporation of chlorine may either be on the amide group or on 
the tertiary amine group.  At the highest chlorine doses there is no absorption at either 356nm 
or 274nm which indicates that the conjugation of tetracycline has changed and the parent 
tetracycline molecule has been completely transformed.   
 
 
Table 3.8  Effect of Chlorination on the UV Absorbance of Tetracycline at Different 
Chlorine Doses with Contact Time of 24 Hours  
 
Sample 
Tetracycline 
Concentration  
(mg/L) Absorbance 
Free Chlorine 
Residual (mg/L as 
Cl2 
 
 at 
356nm 
at 
274nm 
 
LGW control  0 0 0 
22µM HOCl in LGW control NA 0 0 0 
22µM TC in LGW control 10mg/L 0.134 0.163 0 
[TC]:[HOCl] 1:1 in LGW 8mg/L 0.117 0.163 0 
[TC]:[HOCl] 1:5 in LGW 8mg/L 0.117 0.145 0 
[TC]:[HOCl] 1:10 in LGW 0mg/L 0 0 3 
[TC]:[HOCl] 1:20 in LGW 0mg/L 0 0 5 
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This disappearance of tetracycline correlates to the appearance of a free chlorine 
residual which indicates that the reaction between tetracycline and free chlorine is nearing 
completion, as described previously.  In summary, three different transformations of 
tetracycline were observed with the increases in chlorine doses.  This supports the TOX data 
(Table 3.2) in which tetracycline was found to incorporate three chlorine atoms per molecule.  
A wider wavelength range, 200-750nm, was scanned for the highest chlorine dose in order to 
evaluate the yellow product formation described earlier, but no additional absorption was 
observed (Figure 3.7).  This sample was quenched with sodium sulfite prior to analysis and 
the control sample of quenched chlorine is shown in Figure 3.8.  It can be seen that no 
interference would result from the quenched chlorine in solution.  This indicates that the 
transformation products are tetracycline either lack aromatic character or that the 
concentration of the transformation products was too low to be detected during UV analysis.  
Future studies using the double-beam UV-Vis Spectrometer to study the transformation of 
tetracycline due to aqueous chlorination should use a quenched chlorine solution in the 
reference cell in order to discern any transformation products in the sample from the 
background. 
The decrease in characteristic UV peaks at 275 and 350 nm associated with 
tetracycline due to reaction with ozone has also been reported in the literature, and it was 
concluded that the chemical structures of the products retained similar aromatic character to 
tetracycline (Dalmázio et al., 2007).  HPLC-UV studies using detection at 275nm showed the 
disappearance of the tetracycline peak during the course of the reaction and the formation of 
more polar transformation products (Dalmázio et al., 2007).  Future studies on the fate of 
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tetracycline with chlorine should be monitored using HPLC-UV in order to separate potential 
transformation products from tetracycline. 
 
 
 
Figure 3.7 UV-Vis Spectrum of Chlorinated Tetracycline [HOCl]:[TC] = 20 in LGW after 
Quenching with Sodium Sulfite 
 
 
Figure 3.8 UV-Vis Spectrum of Sodium-Sulfite Quenched Chlorine (450µM) in LGW 
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Reaction Kinetics 
The rate of reaction of a chlorinated tetracycline sample in which all of the chlorine is 
observed to be consumed ([HOCl]:[TC] 5:1) was monitored at t = 0, 10, 100, and 1420 
minutes.  This sample was chosen for analysis because the chlorine is completely consumed 
and, therefore, the entire reaction could be monitored.  The samples were stored in amber 
glass vials with headspace in the dark at 20°C.  An aliquot of the sample was removed at the 
specified time for chlorine residual analysis.  Figure 3.9 shows the measured free chlorine 
residual (mole/L as Cl2) in the sample as a function of time where it can be seen that the 
reaction of tetracycline with free chlorine is initially very fast and then slows down.  This 
rapid reaction has also been reported in the literature (Wang et al., 2011).    
An integrated rate law analysis was completed to determine the order of the reaction 
between tetracycline and free chlorine with respect to free chlorine by determining the 
mathematical expression that accurately describes the reaction.  A zero-order reaction is 
linear in a plot of residual vs. time.  A first-order reaction is linear in a plot of ln[residual] vs. 
time, and a second-order reaction is linear is a plot of the inverse of residual vs. time.  The 
results of this analysis showed that the reaction is second order, as is shown by the linear 
relationship between the inverse of free chlorine residual and time in Figure 3.10.  The 
mathematical expression that describes a second order reaction is shown below where [A] is 
the concentration of the free chlorine residual, k is the rate constant, and t is time.   
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Figure 3.9 Free Chlorine Residual (mole/L as Cl2) as a Function of Reaction Time for a 5:1 
Molar Ratio of Free Chlorine to Tetracycline  
 
 
Although these results monitor the depletion of chlorine in contact with tetracycline 
and not the depletion of tetracycline itself the reaction is estimated to be second order, and 
second order rate constants for this reaction have been previously reported (Wang et al., 
2011).  The rate constant, k, is the slope of Figure 3.10, which is 8.397 M-1s-1.  Wang et al., 
2011 have reported rate constants for reactions between tetracycline and free chlorine to be 
much larger, 2.83 x 106 M-1 s-1.  This is an indication that the tetracycline is consumed at a 
much faster rate than chlorine and the tetracycline will be the limiting reagent.  These results 
indicate that the length of time used for the TOX experiment (24hours) is sufficient to ensure 
that the reaction has gone to completion, and that the reaction is dependent on both the 
concentration of tetracycline and free chlorine.   
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Figure 3.10 Integrated Rate Law Analysis of the Reaction between Free Chlorine and 
Tetracycline   
 
 
Analysis of an Unquenched Chlorinated Sample with No Free Chlorine Residual 
One complexity in using mass spectrometry as a tool for the analysis of 
transformation by-products involving free chlorine is the interference between quenching 
agents (and/or chlorine residual) and chemical ionization in the source of the mass 
spectrometer.  Signal suppression from the presence of residual chlorine in the sample was 
avoided by adding the quenching agent (ascorbic acid), and ions associated with quenched 
chlorine, m/z 214.8, 406.8, and 475.4, were observed in the mass spectra, as shown in Figures 
3.12-5.13.  Figure 3.11 shows the full scan mass spectra of the unchlorinated tetracycline 
sample (22µM) where only the molecular ion of tetracycline [M+1]+ at m/z 445.1 of 
tetracycline is observed.  Figure 3.12 shows the mass spectra of the quenched chlorinated 
tetracycline sample ([TC]:[HOCl] = 1:20); a new mass spectra is observed and the molecular 
ion for tetracycline is absent.  Figure 3.13 shows a similar mass spectrum with prominent 
ions at m/z 215 and 407, when a quenched chlorinated control sample is analyzed.  Therefore, 
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in order to identify transformation products without the presence of quenching agent ions a 
chlorinated sample which left no free chlorine residual after 24 hours was analyzed which 
meant that the reaction most likely did not proceed to completion, as described earlier.  In the 
experimental results that follow the chlorinated sample that was analyzed by (+)-ESI was that 
from Table 3.8 where the molar ratio of tetracycline to free chlorine was 1:5. 
 
 
 
Figure 3.11 Full Scan Spectra of 22µM Tetracycline in LGW. Prominent Ion at m/z 445.1 is 
that of [M+H]+for Tetracycline 
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Figure 3.12 Full Scan Spectra of a Quenched Chlorinated Tetracycline Sample [TC]:[HOCl] 
= 1:20. Prominent Tetracycline Ion (m/z 445.1) is Missing and a New Spectra is Observed. 
 
 
 
 
 
 
Figure 3.13 Full Scan Spectra of HOCl in LGW Quenched with Ascorbic Acid. Prominent 
Ions m/z 215 and 407 are Seen in Both Chlorinated Tetracycline Sample (Figure 3.11) and 
Chlorinated Lab Grade Water Control Sample. 
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Figure 3.14 Full Scan Mass Spectra (50-1000 m/z) of Chlorinated Tetracycline ([HOCl]:[TC] 
= 1:5) in LGW After 24 Hours Contact Time Leaving No Cl2 Residual.  
 
 
 
 
The possible chlorination by-products of tetracycline were identified in real time 
using direct infusion-based tandem mass spectroscopy by comparing the full scan mass 
spectra of the unchlorinated and chlorinated tetracycline samples.  Figures 3.11 and 3.14 
show the differences in the mass spectra observed between an unchlorinated and chlorinated 
tetracycline sample, respectively.  The mass spectrum for the chlorinated tetracycline sample 
(Figure 3.14) contains many more ion peaks which may be due to the presence of 
transformation products of chlorinated tetracycline.  In both samples the molecular ion of 
tetracycline (m/z 445) was targeted in Q2 of the mass spectrometer and dissociated using 
argon gas to determine the change in ion counts of tetracycline due to reaction with chlorine, 
and the results are shown in Figures 3.15 and 3.16.  The counts of tetracycline in the 
unchlorinated sample shown in Figure 3.15 are 1.4 x 107.  Prominent daughter fragment ions 
are m/z 428, 427, and 410.  In the chlorinated tetracycline sample ([HOCl]:[TC] = 1:5) shown 
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in Figure 3.16 the counts of tetracycline are 2.5 x 106; that is, a decrease in 1.2 x 107counts of 
tetracycline is observed due to chlorination.  Prominent fragment ions of m/z 428, 427, and 
410 are still observed which indicates that the parent tetracycline remaining has not 
completely transformed.  Comparison of these two figures shows that although the 
concentration of tetracycline decreases as the result of chlorination, the structure of 
tetracycline is not degraded because the same daughter fragments are observed.  This is an 
indication that while a small portion of the tetracycline remains unchanged a large percentage 
of the tetracycline, 83%, has transformed.  
The prominent ions observed in the chlorinated tetracycline sample (m/z 467, 477, 
483) and ions found during previous work from preliminary LC-MS analysis (m/z 399, 456, 
461, 485) (Ye, 2005) were targeted in additional infusion based tandem mass spectroscopy 
experiments in order to obtain more structural information about the chlorination products of 
tetracycline.  Figures 3.17, 3.18, 3.19, and 3.20 show the results obtained from targeting 
potential transformation products of tetracycline in quadrupole 2 (Q2) of the mass 
spectrometer.  Figure 3.17 shows the collision induced dissociation of prominent fragment 
m/z 483 (ion counts: 3.8 x 104) of a potential transformation product of tetracycline in Q2 of 
the mass spectrometer.  A prominent daughter ion of the parent is m/z 466.  Figure 3.18 
shows the collision induced dissociation of molecular ion m/z 477 (ion counts: 4.0 x 104) of a 
potential transformation product of tetracycline in Q2 of the mass spectrometer.  A prominent 
daughter ion of the parent is m/z 459.4.  Figure 3.19 shows the collision induced dissociation 
of molecular ion m/z 467 in Q2 (ion counts: 9.2 x 104) of a potential transformation product 
of tetracycline of the mass spectrometer.  A prominent daughter ion of the parent is m/z 
449.7.  Figure 3.20 shows the collision induced dissociation of molecular ion m/z 461 (ion 
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counts: 4.3 x 104) of a potential transformation product of tetracycline in Q2 of the mass 
spectrometer.  A prominent daughter ion of the parent is m/z 444.1.  
The ‘smooth’ lines obtained during collision induced dissociation experiments in Q2 
are indicative of a molecule that is present and the numbers in parenthesis are the ion counts 
associated with the transition labeled on top of the curve.  Table 3.9 summarizes the results 
of the targeted tetracycline (ion counts) and breakdown ions (ion counts) in both the 
unchlorinated and chlorinated tetracycline sample.  Table 3.10 summarizes the results of the 
targeted potential transformation by products of tetracycline due to reaction with free 
chlorine. 
 
 
 
Figure 3.15 22µM Tetracycline in LGW. Collision Induced Dissociation of the Molecular Ion 
(m/z 445) of Tetracycline in Q2 of the Mass Spectrometer.   
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Figure 3.16 Chlorinated Tetracycline ([HOCl]:[TC] = 1:5) in LGW After 24 Hours Contact 
Time and 0mg/L as Cl2 Residual. Collision Induced Dissociation of Molecular Ion (m/z 445) 
of Tetracycline in Q2 of the Mass Spectrometer (n = 1).   
 
 
 
 
Figure 3.17 Chlorinated Tetracycline ([HOCl]:[TC] = 1:5) in LGW After 24 Hours Contact 
time and 0mg/L as Cl2 Residual.  Collision Induced Dissociation of Prominent Fragment m/z 
483 of a Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer (n 
= 1).   
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Figure 3.18 Chlorinated Tetracycline ([HOCl]:[TC] = 1:5) in LGW After 24 Hours Contact 
Time and 0mg/L as Cl2 Residual.  Collision Induced Dissociation of Molecular Ion m/z 477 
of a Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer (n = 
1). 
 
 
 
 
 
Figure 3.19 Chlorinated Tetracycline ([HOCl]:[TC] = 1:5) in LGW After 24 Hours Contact 
Time and 0mg/L as Cl2 Residual.  Collision Induced Dissociation of Molecular Ion m/z 467 
in Q2 of a Potential Transformation Product of Tetracycline of the Mass Spectrometer (n = 
1).   
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Figure 3.20 Chlorinated Tetracycline ([HOCl]:[TC] = 1:5) in LGW After 24 Hours Contact 
Time and 0mg/L as Cl2Residual.  Collision Induced Dissociation of Molecular Ion m/z 461 of 
a Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer (n = 1).   
 
 
Table 3.9 Direct Infusion MS/MS Results of Tetracycline Before and After Reaction 
with Chlorine [HOCl]:[TC] = 1:5 in LGW 24 hours after Reaction of Tetracycline with 
Free Chlorine with a Residual of 0mg/L as Cl2 
Fragment ion mass loss Unchlorinated Tetracycline  Chlorinated Tetracycline 
  
m/z ion counts m/z ion counts 
445 1.4 x 107 445 2.5 x 107 
-17 [-NH2] 428 1.1 x 107 428 1.1 x 105 
-18 [-H2O] 427 3.5 x 107 427 4.5 x 105 
-35 [-NH2-H2O] 410 3.8 x 107 410 7.2 x 105 
 
  
The results in Table 3.10 show the characteristic breakdown data for the 
transformation products of tetracycline due to reactions with free chlorine.  In the literature 
both Cl- and OH- substituted products were observed in the reaction between tetracycline 
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and free chlorine (Wang et al., 2011).  While not enough structural information was obtained 
to identify the transformation products in Table 3.10, several hypotheses can be made.  The 
loss an ion fragment mass of 17 corresponds to the loss of NH3 from the amide group.  
Therefore, if this loss is not observed in a transformation product (such as for TC+32) this 
suggests the transformation of the amino functional group, possibly by loss of NH2 and the 
substitution of Cl.  Conversely, if the loss of mass fragment 17 is still observed (TC+38, 
TC+22, and TC+16) it can be assumed that the amino group is intact and the transformation 
(Cl- and/or OH- substitution) of the molecule was elsewhere.   
 
 
Table 3.10 Direct Infusion MS/MS Results of Targeted Potential Transformation 
Products from [HOCl]:[TC] = 1:5 in LGW 24 hours after Reaction of Tetracycline 
with Free Chlorine with a Residual of 0mg/L as Cl2 
  
Chlorinated Tetracycline (TC) 
Fragment 
ion mass 
loss TC+38 TC+22 TC+32 TC+16 
m/z 
ion 
counts m/z 
ion 
counts m/z 
ion 
counts m/z 
ion 
counts 
483 3.8 x 104 467 9.2 x 104 477 4.0 x 104 461 4.3 x 104 
-17 466 3.8 x 103 450 2.7 x 104 - - 444 9.0 x 103 
-18 - - - - 459 5.9 x 103 - - 
-35 - - - - - - - - 
-53 - - - - 424 - - - 
-80 - - 387 6.5 x 103 - - - - 
-105 - - - - - - 3.6 x 102 4.7 x 102 
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Analysis of Quenched Chlorinated Sample-Reaction to Completion 
 While the previous experiment was completed without the use of a quenching agent, 
it can be seen from Table 3.9 that the reaction between tetracycline and chlorine was not 
complete.  Therefore, to target potential transformation products of a reaction that was driven 
to completion the chlorinated tetracycline sample with the highest dose the [TC]:[HOCl] = 
1:20 in LGW (mol/mol) was analyzed.  The full scan mass spectra for the unchlorinated 
tetracycline (22µM) sample can be seen in Figure 3.11.  A control sample containing the 
quenched chlorine with the same excess of ascorbic acid as used in the chlorinated samples is 
shown in Figure 3.13., and prominent peaks m/z 215 and 407 are observed due to the 
quenching agents (or quenched chlorine).  Figure 3.21 shows the full scan mass spectra of the 
[TC]:[HOCl] = 1:20 in LGW sample in which the prominent peaks at m/z 215 and 407 are 
observed in addition to many prominent peaks which are transformation products due to the 
chlorination of tetracycline.  It can be seen that the prominent ion at m/z 445 for tetracycline 
is no longer observed in the mass spectrum, and at values of m/z larger than 445 many ions 
are observed, which may be potential transformation products of tetracycline.  Tetracycline 
was targeted in both samples to determine the relative ion counts, and the results of the 
collision induced dissociation of the molecular ion in Q2 of the mass spectrometer are shown 
in Figures 3.9 and 3.22 for unchlorinated and chlorinated tetracycline, respectively.  The 
counts of tetracycline in Figure 5.16 are 4.2 x 105. That is, a decrease in 1.4 x 107 counts of 
tetracycline is observed due to chlorination.  A summary of these results are shown in Table 
3.11. 
Prominent ions observed in the mass spectra of the [TC]:[HOCl] = 1:20 in LGW 
sample (m/z 477 and 451) were targeted in Q2 of the mass spectrometer as well as potential 
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transformation products from previous work; m/z 461, 399, 485, and 456 (Ye, 2005).  The 
results from targeting these potential transformation ions in Q2 revealed that m/z 456, 399, 
461, 477, and 451 (no data was obtained for m/z 485) were detected in Q2, and the 
breakdown curves are shown in Figures 3.23-3.27, respectively.  The sum of the targeted 
molecular ions shown in Figures 3.23-3.27 add up to 1.3 x 106 which represents only a small 
fraction of the total amount of tetracycline that was transformed (1.4 x 107)  (only 9% of the 
transformed tetracycline is accounted for from this analysis).  Therefore, many other 
transformation products of tetracycline remain undetected.  One explanation is that they may 
be below the limits of detection of the instrument and sample concentration techniques may 
be necessary so that the product can be observed.  
 
  
 
Figure 3.21 Full Scan Mass Spectra (50-1000 m/z) of Chlorinated Tetracycline  
([HOCl]:[TC] = 1:20) in LGW After 24 Hours Contact Time and Quenched Chlorine 
Residual. 
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Figure 3.22 [TC]:[HOCl] = 1:20 in LGW. Collision Induced Dissociation of Molecular Ion 
(m/z 445) of Tetracycline in Q2 of the Mass Spectrometer.  
 
 
 
 
Figure 3.23 Chlorinated Tetracycline ([TC]:[HOCl] = 1:20) in LGW After 24 Hours Contact 
Time and Quenched Chlorine. Collision Induced Dissociation of Molecular Ion m/z 456 of a 
Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer (n =1 ).   
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Figure 3.24 Chlorinated Tetracycline ([TC]:[HOCl] = 1:20) in LGW 24 Hours Contact Time 
and Quenched Chlorine. Collision Induced Dissociation of Molecular Ion m/z 399 of a 
Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer. 
 
 
 
 
 
Figure 3.25 Chlorinated Tetracycline ([TC]:[HOCl] = 1:20) in LGW 24 Hours Contact Time 
and Quenched Chlorine. Collision Induced Dissociation of Molecular Ion m/z 461 of a 
Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer. 
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Figure 3.26 Chlorinated Tetracycline ([TC]:[HOCl] = 1:20) in LGW 24 Hours Contact Time 
and Quenched Chlorine. Collision Induced Dissociation of Molecular Ion m/z 477 of a 
Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer. 
 
 
 
 
 
Figure 3.27 Chlorinated Tetracycline ([TC]:[HOCl] = 1:20) in LGW 24 Hours Contact Time 
and Quenched Chlorine. Collision Induced Dissociation of Molecular Ion m/z 451 of a 
Potential Transformation Product of Tetracycline in Q2 of the Mass Spectrometer. 
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Table 3.11 Direct Infusion MS/MS Results of Tetracycline in the Unchlorinated 
Sample and the [HOCl]:[TC] 1:20 in LGW 24 hours after Reaction of Tetracycline 
with Free Chlorine with a Residual of 0mg/L as Cl2 due to the addition of quenching 
agent 
Fragment ion mass loss Unchlorinated Tetracycline  Chlorinated Tetracycline 
  
m/z ion counts m/z ion counts 
445 14,053,998 445 423,485 
-17 428 1,095,393 428 Not seen 
-18 427 3,519,928 427 92,521 
-35 410 3,806,626 410 111,515 
 
 
Chlorine Isotope Ratios 
Chlorine isotope ratios in the [TC]:[HOCl] = 1:20 sample were targeted to obtain 
structural information to enhance the results from TOX analysis (Table 3.4).  Results from 
TOX analysis showed the incorporation of three chlorine substituents onto the parent 
tetracycline molecule.  Based on the experiments described above several potential 
transformation products of tetracycline (m/z 461, 467, 477, 483) were targeted in quadrupole 
1 of the mass spectrometer as defined by the instrument software to determine the extent to 
which chlorine was incorporated onto the parent molecule.  These ions [M] and the chlorine 
isotopes ([M+2], [M+4], and [M+6]) were targeted in the [HOCl]:[TC] 1:20 in LGW sample 
to determine the degree of chlorine substitution based on the presence of peaks 
corresponding to 35Cl, 37Cl, 39Cl, and 41Cl, respectively.  Preliminary experiments on 
chlorinated BACs revealed the characteristic chlorine isotope ratios that can be expected for 
a mono-, di-, and tri- chlorinated compound (Appendix 4).  A mono-chlorinated compound 
has an isotope ratio of 35Cl:37Cl of 3:1.  A di-chlorinated compound has an isotope ratio of 
35Cl:37Cl:39Cl of 9:6:1 while  a tri-chlorinated compound has an isotope ratio of 
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35Cl:37Cl:39Cl:41Cl of 27:27:9:1.  These characteristic chlorine isotope ratios were not 
observed for the targeted molecular ions as shown in Figures 3.28 and 3.29 of m/z 477 and 
m/z 467.   Therefore, if the chlorinated organics are formed as indicated from the TOX results 
and higher molecular weight species correlating to chlorinated tetracycline are not observed 
then it can be concluded that the parent tetracycline has broken apart into smaller chlorinated 
species that lack aromaticity which was suggested by the absence of absorbance during UV 
analysis.  Although LC-MS analysis can be used to target specific species it is very difficult 
to analyze every ion that the MS detects.  Additionally while UV analysis is helpful to 
determine the aromatic character of a species it cannot provide information when aromaticity 
is lost.  In conclusion, other tests are needed in order to evaluate the fate of tetracycline after 
chlorination.  Most useful would be the evaluation of biochemical activity of the product 
species in order to assess the risk from the transformation of tetracycline. 
 
 
Figure 3.28 Chlorinated Tetracycline [TC]:[HOCl] = 1:20 in LGW After 24 Hours Contact 
Time with Quenched Chlorine.  Chlorine Isotopes [M], [M+2], [M+4], and [M+6] of 
Potential Transformation Product m/z 477 Targeted in Q1 of the Mass Spectrometer.  The 
average ion counts are shown below each ion. The ratio of 476.9 : 478.9 is 2.5:1. 
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Figure 3.29 Chlorinated Tetracycline [TC]:[HOCl] = 1:20 in LGW After 24 Hours Contact 
Time and Quenched Chlorine.  Chlorine Isotopes [M], [M+2], [M+4], and [M+6] of Potential 
Transformation Product m/z 467 Targeted in Q1 of the Mass Spectrometer.  The average ion 
counts are shown below each ion.  The ratio of 467.0 : 468.9 is 2.3 : 1. 
 
 
3.4 Conclusions 
Summary of Tetracycline Case Study 
 The results from the analysis of the reaction between the antibiotic tetracycline and 
free chlorine revealed that a rapid reaction occurs that can significantly transform the parent 
tetracycline molecule into by-products at high chlorine doses (mol/mol).  Monitoring the fate 
of the parent molecule revealed that tetracycline undergoes a multistep reaction that is 
dependent of the dose of chlorine applied.  Additionally UV analysis showed three separate 
stages in the transformation of tetracycline that was dependent on chlorine dose.  TOX 
results showed the incorporation of three chlorine substituents into the parent molecule, and 
future experiments using TOX analysis could be used to evaluate incorporation of chlorine as 
a function of chlorine dose applied. 
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 Results from a previous LC-MS study show the formation of transformation products 
of tetracycline due to reactions with free chlorine (Ye, 2005), and the current MS analysis 
confirmed the presence of these ions and others (m/z 467, 477, 483), but the identity of these 
products remain unknown.  Chlorine isotope ratios of potential molecular ions of 
transformation products were targeted, and transformation products at m/z 477 and 467 were 
found to have isotope ratio of [M] : [M+2] of 2.5:1 and 2.3:1, respectively.    Although mass 
spectrometers are highly sensitive analytical tools for the detection of known and optimized 
target compounds, sensitivity is significantly reduced when searching for unknown 
compounds.  A major analytical challenge is determining how to scan for chemical 
substances for which the structure is not known.  Completing product isolation and/or 
concentration prior to MS analysis may aid in the analysis of transformation products.     
The results from this study show that if tetracycline is present at WWTPs or DWTPs 
it can be expected to react with free chlorine and transform to a high degree under conditions 
employed since tetracycline is present at nano- to submicro-gram/L levels and, therefore, can 
be expected to face a large molar excess of chlorine (mg/L).   The implications are that 
tetracycline will undergo transformation into unknown chlorination by-products that elude 
detection during occurrence studies and have unknown biochemical properties.  This rapid 
and high degree of transformation may be one reason (in addition to chelation with metals 
(Halling-Sørensen et al., 2002) )  why tetracycline is infrequently found in surface waters 
(Kolpin et al., 2002), source drinking waters (Stackelberg et al., 2007; Focazio et al., 2008) 
and drinking waters (Stackelberg et al., 2007) during occurrence studies.  
 As a widely used antibiotic that is highly reactive with free chlorine, understanding 
the environmental fate of tetracycline is very important to guide future occurrence and 
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toxicity studies.  Since the tetracycline molecule undergoes a rapid and rather complex 
transformation, understanding the resulting biochemical properties of the transformation by-
products is very important in order to determine risk.  Additionally, potential transformation 
products should be scanned during occurrence studies in order to determine if waters are 
impacted by these chemicals.   
 
 
General Conclusions 
 The results from TOX analysis show that the reactivity of BACs with free chlorine 
depends on the structure of the compound.  High reactivity was observed for compounds 
with extended regions of π-conjugation and ring activating functional groups on the aromatic 
ring.  Conversely, low reactivity was observed for aliphatic compounds and compounds that 
already contained chlorine.  The varying degrees of reactivity highlight the cumbersome task 
of effectively managing countless anthropogenic contaminants in drinking water.  How can 
those compounds that persist through treatment with free chlorine be removed?  One area of 
research is in the evaluation of different treatment technologies for their effectiveness in the 
removal of BACs.  Also, how can the fate of BACs highly reactive with free chlorine be 
monitored during water treatment?  Is it possible that the environmental and human health 
impacts of these BACs are being underestimated as their transformation into by-products is 
not accounted for by current monitoring?  Additional areas of research to answer these 
questions require a study of the biological activity of BACs after chlorination as well as the 
targeting of chlorination transformation by-products in future occurrence studies.  Chapter 4 
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describes an occurrence study completed at several North Carolina drinking water plants, and 
the presence of BACs detected is related to their reactivity observed with free chlorine.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
4. OCCURRENCE OF BIOCHEMICALLY ACTIVE COMPOUNDS DURING 
DRINKING WATER TREATMENT 
 
 
4.1 Introduction 
High use of biochemically active compounds (BACs) paired with their incomplete 
metabolism in the body (Table 1.1), incomplete removal during wastewater treatment (Table 
1.2), and transport through the environment results in BACs impacting drinking water 
sources (Table 1.5).  While full-scale occurrence studies have been completed (Stackelberg et 
al., 2007), limited information is known about the occurrence and fate of BACs in the State 
of North Carolina.  North Carolina is a rapidly growing state and it is imperative to water 
utilities that their treatment technologies can withstand the impact of a growing population.  
There are many origins of BACs in the State’s surface waters from point (wastewater 
treatment plant, processing waste from medical, health-care and manufacturing industries) 
and non-point sources (concentrated animal feeding operations, landfill leachate, failed septic 
tanks, and land runoff).  Providing up-to-date information on sources and causes of impaired 
water quality for water treatment utilities is essential to evaluate current treatment 
performance, identify areas to improve, and determine the most effective management 
strategies.  In order to provide a snapshot of BAC fate and occurrence in North Carolina 
drinking water treatment plans an occurrence study was undertaken whose objectives were 
to: (1) complete an initial broad screen of various BACs to determine their fate and 
occurrence in North Carolina Drinking Water Treatment Plants (2) to relate the occurrence of 
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BACs to their fate during final disinfection at these plants, and (3) to relate the presence of 
BACs to potential upstream water quality impacts.    
 
 
4.2 Sample Collection Site Information 
Sampling was completed between July 2010 to October 2010, from three different 
drinking water treatment plants; DWTP1: Orange Water and Sewer Authority (OWASA) 
(Carrboro, NC), DWTP2: J.D. Mackintosh Drinking Water Treatment Plant (Burlington, 
NC), and DWTP3: Williams Drinking Water Treatment Plant (Durham NC).  Each plant was 
studied once during this time period.   
Each DWTP obtains source water from surface water reservoirs and employs 
treatment processes including screening, powdered activated carbon (PAC) (DWTP1), 
potassium permanganate (DWTP1), coagulation/flocculation, sedimentation, granular media 
filtration, chlorine primary disinfection, chlorine secondary disinfection (DWTP2), and 
treatment with chloramines for secondary disinfection (DWTP1, DWTP3).  After treatment, 
water travels through the distribution system to consumers.  Figures 4.1 to 4.3 show the 
schematics of the treatment plant processes employed at each DWTP and include chemical 
doses and detention times used on the dates of sample collection as provided by plant 
personnel. 
During the current study 24 hour composite samples (four sample fractions every six 
hours) were collected with the only exception being the settled water from DWTP3 where 
grab samples were collected from each settling basin due to lack of feasibility of composite 
sample collection.  Since temporal variability can occur, composite sampling provides a more 
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accurate measure of occurrence.  Sampling points were untreated source water, conventional 
settled water, and finished water.  Additionally, one distributed water sample was collected 
from a residence that received water from DWTP1.  Table 4.1 provides water quality data on 
the dates of sample collection, which was provided by utility personnel.   
Samples were collected from DWTP1 between 7/20/2010 and 7/21/2010.  The first 
set of chemicals including aluminum sulfate, powdered activated carbon, and potassium 
permanganate were flash mixed and added to the screened raw water.  The water was 
subsequently mixed for approximately 30 minutes in the flocculation basin before entering 
the conventional sedimentation basin.  The detention time of the pre-disinfectant (sodium 
hypochlorite), which was added on top of the filters, varied from 15-25 minutes depending 
on the filter column.  Post-chlorine was added after filtration and prior transport to the 
clearwell which took approximately 150 minutes.  The ammonia was added at the end of the 
clearwell to form chloramines prior to release into the distribution system.   
Samples were collected from DWTP2 between 8/31/2010 and 9/1/2010.  The aluminum 
sulfate added to the screened raw water for coagulation/flocculation had an approximate 
contact time of 73 minutes. Samples were collected from DWTP3 between 9/16/2010 and 
9/17/2010.  The coagulant, ferric sulfate, is added to screened raw water for a contact time of 
2.2 minutes.  The detention time of flocculation is 15 minutes and the detention time in the 
settling basin in 2.2 hours.  Sodium hypochlorite is added both before and after filtration and 
the contact time is 2.6 hours.  Ammonia, to form chloramines, is added after the clearwell 
and has a contact time of 2.6 hours.  
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Table 4.1 Water Quality Data of Source and Finished Waters of DWTPs 1-3 Provided 
by the Utility 
DWTP1 DWTP2 DWTP3 
Water Source 
Cane Creek 
Reservoir Lake Mackintosh 
Lake 
Michie/Little 
River Reservoir 
Source Location Carrboro, NC Burlington, NC Durham, NC 
Source Type Surface Water  Surface Water Surface Water 
Raw Water 
pH (average) 6.7 NT 6.7 
TOC (mg/L as C) 5.2 6.9 6.28 
Average flow rate through 
plant (MGD) 8.43 7.14 10 
Temperature (°C) 25.5 30 25 
Finished Water 
pH (average) 8.4 NT 7.7 
TOC (mg/L as C) 0.95 2.9 1.9 
Residual Free Chlorine 
(mg/L as Cl2) NT 1.3* 0.1 
Residual Total Chlorine 
(mg/L as Cl2) 3.46 NA 3.1 
Collection date 
July 20/21, 
2010 
August 31/September, 
2010 
September 
16/17,2010 
Sample Type 
24 hour 
composite 
samples 
24 hour composite 
samples except settled 
(grab) 
24 hour 
composite 
samples 
*Data from analysis at UNC 
NA=Not Applicable 
NT=Not Tested 
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Figure 4.1 Plant Schematic of DWTP1 including Chemical Doses on 17/20/2010 and 
27/21/2010.  (PAC: Powdered Activated Carbon) 
 
 
 
 
 
 
 
 
Source Water 
Coagulation/Flocculation 
Sedimentation 
Aluminum sulfate (50.01 mg/L)1 
        (50.44 mg/L)2 
PAC (17.27 mg/L)1 
         (20.96 mg/L)2 
Potassium Permanganate (1.79 mg/L)1 
                   (2.03 mg/L)2 
Filtration-Sand/Anthracite Coal 
Sodium hypochlorite (8.95 mg/L as Cl2)
1
 
                                    (10.69 mg/L as Cl2)
2
 
Clearwell 
Sodium hypochlorite (1.33 mg/L as Cl2)
1
 
                                    (1.94 mg/L as Cl2)
2
 
Distribution system 
Ammonia (0.87 mg/L NH3-N)
1
 
                 (0.85 mg/L NH3-N)
2
 
Detention time = 30 minutes 
Contact time = 15-25 minutes 
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Figure 4.2 Plant Schematic of DWTP2 including Chemical Doses. Values are approximate 
because annual average doses were obtained from the City of Burlington, NC 2009 Water 
Treatment Annual Operations Report.  
 
Source Water 
Coagulation/Flocculation 
Sedimentation 
Aluminum sulfate (~50mg/L) 
Filtration-Sand/Anthracite Coal  
Sodium hypochlorite (~4.7 mg/L as Cl2) 
Clearwell 
Sodium hypochlorite (~1.6mg/L as Cl2) 
Distribution system 
Contact time 1.13 hours 
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Figure 4.3 Plant Schematic of DWTP3 including chemical doses, contact time of chemicals 
and detention times.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
 
4.3 Results and Discussion 
4.3.1 Fate of BACs during Drinking Water Treatment  
Table 4.2 shows the concentration of the BACs detected in the sampled source waters 
during the occurrence study.  The underlined values indicate that both daughter fragment ions 
of the parent BAC were detected which means a higher level of confidence is associated in 
reporting the detection of these compounds.  BACs that are not listed were not detected.   
 
 
Table 4.2 Concentrations (ng/L) of BACs Detected in Drinking Water Sources in 
North Carolina 
    
BAC DWTP1 DWTP2 DWTP3 
 Concentration (ng/L) 
    
Date July 20/21, 2010 
August 31-September 1, 
2010 
September 16/17, 
2010 
    
Atrazine 190 260 110 
Caffeine <5.1 11 <5.1 
DEET 2.5 8.2 10 
TCEP <45 18 <45 
"_" indicates that the detection of the analyte is confirmed by the ratio of the two targeted 
MS/MS daughter fragment ions 
Analytes not detected are reported as <LOQ 
 
 
Both DEET and atrazine were detected in the source waters of all three DWTPs 
sampled.  This occurrence may be the direct result of their high use during the sampling 
period (summer months). DEET has been reported as among the most prevalent 
contaminants in Germany (Quednow and Püttman, 2009) and atrazine in Canada (Byer et 
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al., 2011).  Insect-repellents containing the active ingredient DEET are commonly used 
during the summer and may wash off the user in the shower or excreted in urine after 
absorption through the skin and has been found to be in urine 5.6% unchanged (Selim et al., 
1995).  In either case, DEET will be transported to WWTPs where incomplete removal has 
been reported (Sui et al., 2010).  Occurrence studies have shown that DEET is present in 
wastewater effluents at average levels of 27ng/L (5 detections; n = 7) (Kim et al., 2007) and 
98ng/L (11 detections; n = 11) (Ryu et al., 2011) that are subsequently released into the 
environment.  Another possible route of exposure of DEET into surface water is direct 
deposition from persons using DEET-containing insect-repellants while boating and fishing.   
Atrazine, a widely used herbicide, may have contaminated these source waters either 
as the result of surface water runoff from agricultural land (Thurman et al., 1992), or from 
aerial deposition of atrazine that had transported through the atmosphere during rain events 
(Goolsby et al., 1997).  While the land directly surrounding the source waters is not 
extensively used for agriculture (see Figures in Appendix 3.1, 3.3, and 3.5), land use in the 
watersheds of the sampled source waters includes row crops (NC SWAP, 2010a; 
NCSWAPb, 2010; NCSWAPc, 2010).  Other potential contaminant sites (PCS) in the 
watersheds include animal operations, isolated pollution incidents, non-discharge permits, 
minor national pollutant discharge elimination system (NPDES) (DWTP2 and WWTP3), 
airports (DWTP2 only) (see Figures in Appendix 3.2, 3.4, 3.6). Table 4.2 also shows that 
caffeine and TCEP were detected in the source water used by DWTP2.  Caffeine can be 
used as an indicator for WWTP effluent (Ferreira et al., 2005), and the source water used by 
DWTP2 is impacted by an upstream discharging WWTP while DWTP1 and DWTP2 are not 
(NC SWAP, 2010a; NCSWAP, 2010b; NCSWAP, 2010c).   
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Table 4.3 shows the concentration of detected BACs in settled water as well as the 
percent removal from raw water.  The most dramatic decrease in concentration is observed 
for the detected analytes in DWTP1, which is the only plant of the three to use both 
powdered activated carbon (PAC) and potassium permanganate (for taste and odor control) 
in addition to the chemical coagulants.  Organic compounds have been found to adsorb very 
effectively onto PAC due to its high surface area, and studies have shown effective removal 
of BACs with PAC (Ternes et al., 2002; Westerhoff et al., 2005; Stackelberg et al., 
2007)including DEET and atrazine at, 49% and 60%, respectively (Westerhoff et al., 2005). 
The results from this current study are consistent with these published values.  The use of 
PAC more effectively removed atrazine relative to DEET which is the result of its greater 
hydrophobic character (Table 1.3), and this correlation has been studied in the literature 
(Simazaki et al., 2008).  In contrast it can be seen that a significantly smaller reduction in 
parent BAC is observed in settled water for DWTP2 and DWTP3, where only coagulation is 
used.  The removal of atrazine during coagulation in all DWTPs was greater than DEET 
which can be explained by the greater hydrophobic character of atrazine (Table 1.3), and 
this has been observed previously (Stackelberg et al., 2007). 
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Table 4.3 Concentrations (ng/L) of BACs Detected in Settled Drinking Water in 
North Carolina (and percentage decrease from surface water) 
    
BAC DWTP1 DWTP2 DWTP3 
 Concentration (ng/L) 
    
Atrazine 36 (81%) 240 (9.7%) 98 (8.1%) 
Caffeine <5.1 9.1 (14%) <5.1 
DEET 1.6 (38%) 8.2 (0.22%) 11 (0%) 
TCEP <54 11 (36%) <54 
"_" indicates that the detection of the analyte is confirmed by the ratio of the two targeted 
MS/MS fragment ions 
Analytes not detected are reported as <LOQ 
 
 
 
Table 4.4 shows the concentration of the detected BACs in finished drinking water, 
as well as the percent removal between settled and finished water, which can be attributed to 
filtration and the addition of chemical disinfectants.  The removal of the detected BACs is 
variable, and this may be due to temporal variability within the plant, the age of the filters 
being used, and the contact time of chemical disinfectants.  Since caffeine, DEET, atrazine, 
and TCEP were observed to incorporate minimal amounts of chlorine onto the parent BAC 
molecule as described in Chapter 3 and minimal reactivity has been reported in the literature 
(Glassmeyer and Shoemaker, 2005; Brix et al., 2008), it can be concluded that any decrease 
in the concentration of these BACs may be due to filtration, hydrolysis, biological 
degradation, or a combination of these factors.   
Atrazine was found to have the largest percent removal and this may be due to 
transformation by reaction with free chlorine.  Although the results from Chapter 3 indicated 
minimal incorporation of chlorine onto the parent molecule, a study by Wulfeck-Kleier et. 
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al., (2010) showed that upon the addition of the quenching agent (sodium sulfite) the 
chlorinated product of atrazine, N-chloro atrazine, can transform back into its original form, 
atrazine.  Since this quenching agent was not added at DWTP1 but was added during the 
TOX experiments in Chapter 3, this finding may explain the larger percent removal of 
atrazine during disinfection than would be hypothesized based on TOX results. 
 
 
Table 4.4 Concentrations (ng/L) of BACs Detected in Finished Drinking Water in 
North Carolina (and percentage decrease from settled water) 
    
BAC DWTP1 DWTP2 DWTP3 
 Concentration (ng/L) 
    
Atrazine 13 (64%) 230 (1.9%) 84 (15%) 
Caffeine <2.0 5.8 (36%) <2.0 
DEET 1.3 (15%) 8.3 (0%) 6.4 (40%) 
TCEP <5.4 <6.7 (100%) <4.5 
"_" indicates that the detection of the analyte is confirmed by the ratio of the two targeted 
MS/MS fragment ions 
Analytes not detected are reported as <LOQ 
 
 
Table 4.5 shows the concentration of the detected BACs in a distributed water 
sample from DWTP1, as well as the percent removal between finished and drinking water, 
which can be attributed to the reactions with residual chemical disinfectants.  The 
attenuation of DEET was observed to be minimal which is supported by its minimal 
reactivity with free chlorine as described in Chapter 3.  The removal of atrazine observed in 
Table 4.5 can be attributed to reactions with residual disinfectants and transformation of the 
parent molecule to form N-chloro atrazine (Wulfeck-Kleier et. al., 2010).   
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Table 4.5 Concentrations (ng/L) of BACs Detected in Distributed Drinking Water in 
North Carolina (and percentage decrease from finished water) 
    
BAC DWTP1 DWTP2 DWTP3 
 Concentration (ng/L) 
    
Atrazine 5 (58%) NT NT 
Caffeine <2.0 NT NT 
DEET 1.3 (0.36%) NT NT 
TCEP <5.4 NT NT 
"_" indicates that the detection of the analyte is confirmed by the ratio of the two targeted 
MS/MS fragment ions 
NT=not tested   
 
Analytes not detected are reported as <LOQ 
 
 
In summary, Table 4.6 shows the total percent removal of the detected BACs from 
source water to finished drinking water.  The largest percent removal for DEET and atrazine 
was observed for DWTP1 where PAC is used, and this efficient removal has been observed 
in previous laboratory studies (Westerhoff et al., 2005). For the BACs in DWTP2 and 
DWTP3 the observed removal shown in Table 4.6 is the result of the chemical properties of 
the analytes, the characteristics of the source water, temporal and special variability within 
the plant, and the interactions with the physico-chemical treatment processes employed.  The 
graphical representations of the removal of the detected BACs at each plant are shown in 
Figures 4.4-4.6. 
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Table 4.6 Percent Removal of BACs from Source to Finished Water (%) 
 
   
BAC DWTP1* DWTP2 DWTP3 
Atrazine 97 11 22 
Caffeine NA 45 NA 
DEET 47 0 36 
TCEP NA NA NA 
NA= not applicable 
*Removal is from source to distributed water 
 
 
 
Figure 4.4 Removal of Detected BACs from DWTP1 
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Figure 4.5 Removal of Detected BACs from DWTP2 
 
 
 
Figure 4.6 Removal of Detected BACs from DWTP3 
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4.4 Conclusions 
 The results from the occurrence study of three DWTPs in North Carolina reveal that 
DEET and atrazine were present in all study sites, that their removal during treatment is 
dependent on their chemical properties, and that they persist into consumers’ drinking water.  
The presence of DEET and atrazine in all source waters may be the result of the sampling 
being conducted during the summer months when these chemicals are more widely used.  
Further investigation would be required in order to determine if they are present throughout 
the year.   
Atrazine and DEET have been detected in many surface waters in the U.S., (Kolpin et 
al., 2002; Benotti et al., 2009).  Atrazine, a member of the triazine pesticide group and 
containing an s-chlorotriazine moiety is under review by the U.S. EPA for toxicity (U.S. 
EPA, 2006).  Additionally, chlorinated transformation products of atrazine have been 
detected which still contain the s-chlorotriazine moiety (Wulfeck-Kleier et. al., 2010), and 
the toxicity of these species remains unknown.  DEET has been observed to have acute 
toxicity in birds and aquatic organisms (U.S. EPA, 1998). Therefore stricter regulations 
should be placed on the use of these persistent anthropogenic contaminants to minimize their 
release into the environment.   
Removal of the detected compounds, DEET and atrazine, was observed to the highest 
extent when PAC was used, but this still did not eliminate them completely from drinking 
water.  PAC, usually employed for taste and odor control, was observed to be the most 
effective treatment option in this current study for the removal of BACs, and this has been 
observed in previous studies (Ternes et al., 2002; Stackelberg et al., 2007).  Incentives should 
be given to utilities in order to expand the use of PAC for BAC removal such as the 
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production of information leaflets in monthly bills to raise awareness with consumers about 
the importance of this treatment technology.   
 The results from the occurrence study can be explained by the reactivity of the 
studied BACs with chlorine (Chapter 3).  For those compounds with low reactivity towards 
free chlorine (i.e. caffeine, atrazine, and DEET) it can be expected that their removal during 
disinfection using chlorine will be low.  As a result, these compounds persist into drinking 
water and the long-term impacts are not well understood.  On the other hand, compounds 
highly reactive with chlorine were not detected in any of the sampled source waters.  One 
possibility is that these compounds may be transforming during wastewater treatment into 
chlorinated by-products that elude detection when only the parent compounds are targeted in 
analytical methods.  For example, the wastewater treatment plant upstream of DWTP2 uses 
chlorine as a terminal disinfectant and only those compounds with low reactivity towards 
chlorine were detected in the source water at DWPT2.  On the other hand, the wastewater 
contaminant, sulfamethoxazole, which is commonly found in surface waters (Kolpin et al., 
2002) and drinking water sources (Stackelberg et al., 2007; Benotti et al., 2009), has been 
observed to react with free chlorine to produce chlorinated by-products in both the literature 
(Dodd and Huang, 2004) and in the current study (Chapter 3).  An implication of chlorinated 
BACs eluding detection is that the environmental and health impacts of BACs may be 
underestimated and the risk associated with exposure to these transformation by-products 
should be evaluated during toxicity studies.  Additionally, in future occurrence studies 
scanning samples using full scan mass spectrometry for chlorination by-products of BACs 
may provide insight onto the occurrence of these compounds into drinking water.    
  
 
5. CONCLUSIONS 
 
 
The impact of chlorine on the structure of parent BACs was evaluated in controlled 
laboratory experiments using TOX analysis, which has been used only to a limited extent for 
studying the transformation of antibiotics (Ye, 2005).  TOX analysis was used to determine 
the extent to which chlorine was incorporated onto the parent BAC, and the variability was 
determined to be a direct result of the chemical structure of the BACs.  Those with aliphatic 
regions (TCEP and meprobamate), electronegative substituents (fenoprop, atrazine, 
diclofenac, bezafibrate, and clofibric acid), bulky side chains (ibuprofen) or highly 
substituted aromatic structure (fenoprop, caffeine, and atrazine) were found to have minimal 
reactivity with chlorine.  On the other hand those with aromatic regions (extended π-
conjugation), ring activating substituents (-OH, -NH2), and available positions for 
electrophilic attack on the aromatic ring (estrone, 17-α-ethinyl estradiol, acetaminophen, 
tetracycline, sulfamethoxazole, and trimethoprim) were found to have high reactivity with 
chlorine which was observed by high levels of chlorine incorporation.  The high reactivity of 
tetracycline was investigated in detail and its disappearance was observed using UV and 
MS/MS analysis.  Although the parent tetracycline molecule was not observed after 
chlorination no transformation products were identified.  Future UV-Vis experiments should 
employ a different control sample in the double-beam spectrophotometer which may allow 
for transformation by-products to be distinguished from the background signal associated 
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with the control sample.  Additionally, future MS/MS experiments should aim to target lower 
molecular weight fragments of the tetracycline molecule since the UV results point to a loss 
of aromaticity.  While both UV-Vis and MS/MS experiments are helpful in monitoring a 
known chemical compound there are limitations encountered when looking for unknowns.  
Directing risk-assessment of transformation products and guiding sampling efforts would be 
aided by determining the biochemical activity of the transformation by-products, and in 
future studies the antibiotic activity of tetracycline should be monitored.  TOX analysis 
revealed that several compounds have moderate reactivity with free chlorine (erythromycin-
hydrate, sucralose, gemfibrozil, atenolol, and carbamazepine) which is attributed to a 
combination of chemical structure and slow reaction rates. 
An occurrence study was completed in the state of North Carolina to determine the 
presence of targeted BACs in three source, settled, and finished (and one disturbed) water 
samples.  The results of the study revealed that DEET and atrazine were persistent 
contaminants that were detected in the source waters of each DWTP.  This high occurrence is 
most likely the result of sampling during the summer months when these compounds are 
used in higher quantities.  TCEP and caffeine were only detected at one of the DWTPs, 
which is impacted by upstream WWTP effluent.  Although the upstream WWTP uses 
chlorine as a disinfectant, TCEP and caffeine were not removed or transformed and this can 
be expected since they were observed to have low levels of reactivity with free chlorine 
during TOX experiments.   
The removal of the detected BACs in each sampled DWTP was found to be 
dependent of the treatment processes employed.  The most effective treatment for the 
removal of the DEET and atrazine was found to be PAC, but even with this treatment 
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technology the compounds were not completely removed from consumers’ drinking water.  
This highlights the importance of determining the most effective treatment options for the 
removal of persistent contaminants or the enforcement of stricter regulations on the usage of 
these contaminants.  Even more troubling are the unknown impacts of the transformed BACs 
that are not detected when only the parent BAC is targeted.  Only those BACs with low 
reactivity towards chlorine were detected in drinking water sources and it is possible that 
those BACs with high reactivity have transformed into unknown products that elude 
detection using the employed analytical method.  Challenging future work would be to 
develop ways to screen waters for the presence of unknown contaminants and transformation 
products.  Additionally, the transformation of those BACs with high reactivity towards 
chlorine should be studied in greater detail in order to provide more information for both 
occurrence studies and toxicity studies.   
 
 
 
 
 
 
 
 
 
 
 
144 
 
Appendix 1: 
 
 Composite Sample Collection Procedure 
 
 
Points of Collection: Raw, conventional settled and finished water.  
Procedure to collect composite samples: The glass amber bottles contain a solid preservative 
(ethylenediaminetetraacetic acid).   
Composite Samples: In order to collect the composite samples, approximately 1/4 of the 
sample bottle will be filled every 6 hours for a total time of 24 hours.  The total sample 
volume of the larger bottles are 4L, the medium is 2.5L and the small bottles are 1L.   
Sample collection procedure: 
1. The bottles do not need to be rinsed before sample collection. Choose the correct 
bottle labeled for the specific tap in the lab for sample collection. 
 
2. To collect the sample fraction at each time, hold the bottle at an angle close to the 
sample tap to prevent dust from the air to enter the bottle and fill approximately to the 
premarked line. Cap the bottle, mark the time of each fraction’s collection on the 
bottle label and place in a fridge until the next time of sample collection. At that time 
repeat the procedure until 4 samples have been collected in each bottle. DO NOT use 
sharpies, pencil is best to use. 
 
 
3. DO NOT mix the sample until the last sample fraction has been collected.  
 
4. For the final sample collection fill the bottle headspace free, replace the cap, invert 
the bottle three times, and place immediately in the fridge.   
 
5. The bottles will be collected as per initial discussion. 
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Appendix 2: 
 
 Standard Operating Procedure (SOP) 
 
Title: Analysis of Antibiotics in Surface and Drinking Water Samples 
Purpose: This standard operating procedure (SOP) describes the analysis of 25 antibiotics 
including 6 tetracyclines, 7 sulfonamides, 7 (fluoro)quinolones, 3 macrolides, trimethoprim, 
and lincomycin in surface and drinking water samples at ng/L levels using solid phase 
extraction and liquid chromatography electrospray tandem mass spectrometry.   
 
1. Preparation of solutions  
1.1. Preparation of antibiotic solutions  
 
Equipment: 
- balance  
- 10 and 25 mL volumetric flasks 
- beakers and funnels  
- 10 and 40 mL amber vials 
- 250 mL amber bottles 
- spatula 
- weighing dishes 
- pasteur pipettes 
 
Reagents:  
Antibiotic standards (Figure 1) stored in Freezer D.   
 
Solvents: 
- methanol 
- LGW/methanol (1:1, 0.2% HCl, v/v) 
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- acetonitrile (2% NH4OH, v/v) 
Table A.2.1. Preparation of Stock Solutions of Antibiotics 
  
mol. 
Weight 
HCl or 
salt 
form 
stock 
conc. 
(mg/L) 
weigh 
amount 
(g) solvent  
volume 
(mL) 
minocycline 457.5 494.0  1000 0.0108 methanol 10 
oxytetracycline 460.4 496.9 1000 0.0108 methanol 10 
tetracycline 444.4 480.9 1000 0.0108 methanol 10 
demeclocycline 464.9 501.4 1000 0.0108 methanol 10 
chlortetracycline^ * 478.9 515.4 400 0.0135 methanol 25 
doxycycline 444.4 480.9 1000 0.0108 methanol 10 
meclocycline 476.9 695  1000 0.0146 methanol 10 
            
sulfamerazine* 264.3 287.3 400 0.0109 methanol 25 
sulfathiazole 255.3 278.3 1000 0.0109 methanol 10 
sulfamethazine* 278.3   400 0.0100 methanol 25 
sulfamethizole 270.3   1000 0.0100 methanol 10 
sulfachlorpyridazin
e 284.7   1000 0.0100 methanol 10 
sulfamethoxazole 253.3   1000 0.0100 methanol 10 
sulfadimethoxine 310.3   1000 0.0100 methanol 10 
trimethoprim* 290.3  400 0.0100 methanol 25 
ciprofloxacin 331.3 367.8 1000 0.0111 LGW 10 
Norfloxacin* 319.3  400 0.0100 
LGW/methanol 
1:1, 0.2% HCl, 
v/v  25 
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enrofloxacin* 359.4 395.9 400 0.0110 
LGW/methanol 
1:1, 0.2% HCl, 
v/v  25 
sarafloxacin* 385.4  80 0.0080 
90% LGW : 
10% methanol 100 
pipemidic acid* 303.3   400 0.0100 
LGW/methanol 
1:1, 0.2% HCl, 
v/v 25 
oxolinic acid* 261.2  400 0.0100 
Acetonitrile 
(2% NH4OH, 
v/v) 25 
Flumequine 261.2   1000 0.0100 
Acetonitrile 
(2% NH4OH, 
v/v) 10 
Tylosin 916.1 1066 1000 0.0116 methanol 10 
erythromycin 733.9  1000 0.0100 methanol 10 
roxithromycin 837.1  1000 0.0100 methanol 10 
Lincomycin 406.5 443.5 1000 0.0109 methanol 10 
^: purity: 80% *: not easily soluble 
 
 
1.1.1. Stock solutions  
1. For an EASILY soluble antibiotic (listed on Figure 1 without a “*”): 
  - Tare the scale after placing the weighing dish on the balance 
 - Close the glass door of the balance before weighing 
- Use the spatula to transfer certain amount (Figure 1) of antibiotic reagent to the 
 weighing dish (listed weights are ideal – get as close as possible but not critical 
 to be exact) 
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 - Record the weight to 4 decimal digits 
- Use small (5 ¾”) pasteur pipettes to transfer appropriate solvent into the weighing 
dish (start with 2 pipettes of solvent) 
 - Use a different pipette and gently stir in dish to dissolve antibiotic 
 - Transfer the antibiotic solution into a volumetric flask of appropriate volume 
 - Transfer all remaining antibiotic in the dish to the volumetric flask by adding  
solvent and transferring a few times 
 - Fill up the volumetric flask up to the line with the solvent 
 - Cap the volumetric flask and invert 3 times 
 - Calculate the actual concentration of the prepared stock solution using the 
 following equation: 
  )/(
)/(
)(
)(
LmgC
LmgC
gW
gW
actual
ideal
actual
ideal =
 
               W: weight; C: concentration 
 
 - Transfer the solution into an amber vial and cap it 
 - Label the vial with antibiotic name, concentration, initials, and date of  
preparation 
            - Clean the spatula thoroughly (with LGW and then methanol) and dry thoroughly  
with Kimwipes 
            - Brush off scale gently between uses 
 
2.  For an antibiotic that is DIFFICULT to dissolve (listed on Figure 1 with a “*”): 
 - Tare the scale and then weigh the volumetric flask without lid 
 - Add antibiotic directly into the volumetric flask using a spatula 
 - Subtract weight of the flask from the total weight of flask plus antibiotic to get  
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the weight of antibiotic 
 - Continue adding antibiotic into the flask until the desired weight is achieved 
 - Add appropriate solvent directly into the flask 
- Can pour some solvent into the flask up to the neck and add solvent with pipette  
up to the line 
 - Cap the flask and invert many times until the antibiotic dissolves 
- If the antibiotic still does not dissolve, cover the flask in aluminum foil (to prevent 
photodegradation) and let the flask sit on bench for a while, or put a small stir bar 
into the flask and use magnetic stir until it dissolves 
 - Once the antibiotic fully dissolves, transfer the solution into an amber vial (for a  
25 mL sample use 40 mL vial) 
 - Calculate the actual concentration (same as described in step 3 above) 
 - Label the vial with antibiotic name, concentration, initials, and date 
 
3.  Another technique to prepare stock solutions 
 - Weigh out antibiotic in a weighing dish 
 - Add some solvent into the dish 
 - Transfer the antibiotic solution from the dish to the beaker by pouring carefully 
(try to get all solids in) 
 - Once the solution is in the beaker, put a small stir bar into the beaker and use  
magnetic stir to help it dissolve 
 - Place a funnel on top of the flask and transfer the antibiotic solution from the  
beaker to the flask (use glass rod to help control flow on the way down to the     
funnel)  
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Store all solutions in the freezer.   The stock solutions are stable for at least 3 months 
(tetracyclines, quinolones, macrolides, and lincomycin) and 1 year (sulfonamides and 
trimethoprim) when stored in freezer.   
 
Notes: 
- Usually takes ~ 1-2 days to prepare stock solutions of 25 antibiotics  
- Antibiotic standards are stored in the little tub in freezer  
- Antibiotic solutions are stored on ZY’s shelf in freezer  
 
- For ciprofloxacin ONLY, take 5 mL of the prepared 1000 mg/L stock solution to another 
volumetric flask and fill to 10 mL with methanol.  This prevents the solution from being 
frozen because the solvent is LGW. 
 
 
1.1.2. Mixture of each antibiotic group  
Group 1: six tetracyclines (TCs) —minocycline, oxytetracycline, tetracycline, 
demeclocycline, chlortetracycline, doxycycline 
 
Group 2: seven sulfonamides (SAs) and trimethoprim (TMP) —sulfamerazine, sulfathiazole, 
sulfamethazine, sulfamethizole, sulfachlorpyridazine, sulfamethoxazole, sulfadimethoxine, 
trimethoprim 
 
Group 3: seven (fluoro)quinolones (QLs) —ciprofloxacin, norfloxacin, enrofloxacin, 
sarafloxacin, pipemidic acid, oxolinic acid, flumequine 
 
Group 4: three macrolides (MAs) and lincomycin (LIN) — tylosin, erythromycin, 
roxithromycin, lincomycin 
 
151 
 
 
 
 
Procedure 
 
1. Calculate the volume of antibiotic stock solution to be added to 10 mL of methanol  
 mixturemixturetakenstock CVVC ** =  
 
For example, to prepare a mixture at 20 mg/L for each antibiotic (typical concentration) in 10 
mL methanol: 
 
Cstock * Vtaken = 20 mg/L * 10 mL 
 
2. Get the antibiotic stock solutions from freezer, 10 mL volumetric flask, 50-250 µL 
micropipette, capillary tubes, HPLC grade methanol, waste bucket, and rinsing methanol 
 
3. Fill the flask with some methanol (estimate total volume of solution that will be added and 
make sure there is more than enough room for it) 
 
4. Pipette the stock solutions (Vtaken) and inject to the flask (begin with ones that need the 
largest Vtaken) 
 - Adjust the micropipette volume setting to the desired value 
 - Clean the micropipette tip with methanol and dry with Kimwipe 
 - Insert capillary tube, tighten, and check 
 - Withdraw antibiotic solution (Vtaken) 
 - Wipe off solvent outside of capillary with Kimwipe 
 - Inject under liquid level and shake the pipette gently 
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 - Remove glass capillary 
 - Rinse tip with methanol 
 - Repeat process for each injection 
 
5. Fill the volumetric flask up to the line with methanol, cap and invert 
 
6. Repeat for all antibiotic groups 
 
7. Store the solutions in amber glass vials in freezer 
 
 
1.1.3. Mixture of 25 antibiotics   
1. Calculate volume taken from each mixture to certain volume of methanol (usually 10 mL) 
2525 ** mixtureofmixtureoftakenmixture CVVC =  
Cmixture: concentration of antibiotic in the mixture of each group (see 1.1.2) 
 
For example, to prepare a mixture of antibiotics at 0.5 mg/L in 10 mL methanol from each 20 
mg/L mixture:  
20 mg/L * Vtaken = 0.5 mg/L * 10 mL 
                  Vtaken  = 0.25 mL 
2. Prepare the mixture of 25 antibiotics using the same technique as described in step 4 above 
 
 
1.2. Preparation of Surrogate and Internal Standard Solutions 
1.2.1. Mixture of surrogate standards 
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1. Calculate the volumes of stock solutions of surrogate standards (13C6-sulfamethazine and 
meclocycline) to be taken to prepare a mixture of the two surrogates at an individual 
concentration of 0.5 mg/L in 5 or 10 mL of methanol. 
For example, to prepare a 5 mL solution:  
 
Cstock * Vtaken = 0.5 mg/L * 5 mL 
 
Cstock (13C6-sulfamethazine) = 5.9 mg/L in methanol  
Cstock (meclocycline) = 10 mg/L in methanol 
 
2. Prepare the mixture in methanol using the same technique as described for preparation of 
antibiotic solutions.   
 
 
1.2.2. Internal standard (I.S.) solution 
- The concentration of the internal standard simatone reagent solution is 100 µg/mL (i.e.100 
mg/L) 
 
- ALWAYS clean micropipette thoroughly with methanol to avoid contamination of the I.S. 
with antibiotics  
 
- Make dilution of the simatone reagent solution to a desired I.S. concentration of 1.25 mg/L 
in 10 mL methanol 
 
 
1.3. Preparation of other solutions  
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1.3.1. 0.1% Formic acid in methanol 
Measure 200 mL methanol into a 250 mL amber bottle and add 200 µL formic acid with 
glass pipette.  Cap the bottle and mix. 
 
1.3.2. 0.25 g/L Na2EDTA stock solution in LGW 
Weigh 0.025 g Na2EDTA, transfer to a volumetric flask, and dissolve in 100 mL LGW. 
 
1.3.3. Solvent mixture of LGW and methanol (9:1) 
 
Measure 180 mL LGW and 20 mL methanol, respectively, and mix in a 250 mL amber 
bottle. 
 
2. Sample processing  
2.1. Filtration 
1. The 1st bench left side in MHRC 1210 is designated for filtration 
2. Use filtration glassware designated for the appropriate type of water sample 
3. The natural/raw water samples are filtered through glass fiber filters (0.7 µm pore size) and 
then nylon filters (0.45 µm).  For drinking water or LGW, use nylon filter (0.45 µm) only 
4. Attach the vacuum and place the filter into the system 
5. Wet the filter with a small amount of LGW 
6. Switch on vacuum 
7. Pour water sample into the sample reservoir and let it filter through under vacuum and 
make sure water in flask does not exceed 1000 mL to prevent it from being sucked into the 
vacuum (this will damage the vacuum!) 
8. Rinse the sample bottle (1 L amber) with a small amount of the filtered sample and pour 
the filtered water back into the bottle 
9. Replace the filter with a 0.45 µm pore size filter (get from drawer, blue paper is waste, the 
white is the actual filter)  
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10. Re-run the sample through the 0.45 µm filter (this will take a longer time due to its 
smaller pore size) 
 
 
 
2.2. Solid phase extraction (SPE)  
2.2.1. Sample Preparation 
- Samples are collected in amber glass bottles to prevent photodegradation 
- Each 1 L sample is divided into four portions: two for the original unspiked samples and the 
other two for spiked samples (four 250 mL amber bottles are needed) 
- At least two spiked levels are needed for the method of standard addition  
 
Procedures: 
1. Label 250 mL amber bottles 
 For example: 
 0-1   non-spiked sample 1 
  0-2   non-spiked sample 2 
  S-50  spiked sample with 50 ng/L 
  S-100  spiked sample with 100 ng/L 
 
2. Divide 1 L sample evenly into four 250 mL amber bottles (line near neck of bottle 
indicates 250 mL) 
 
3. Addition of surrogate standards 
- The surrogate standard mixture is a mixture of 2 surrogates including 13C6-sulfamethazine 
and meclocycline with an individual concentration of 0.5 mg/L 
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1) Calculate the volume of surrogate mixture to add 
Example: uLmL
L
ug
mL
L
ug
C
VC
tockSurrogateS
samplesurrogate 25025.0
500
25005.0
==
⋅
=
⋅
 
2) Use appropriate pipette with an appropriate volume range (i.e., 10 – 50 µL) and adjust to 
the desired level (i.e., 25 µL) 
 
3) Inject surrogate mixture (from nonspiked to spiked samples with increasing 
concentrations) using the same technique as described in section 1.1.2 
 
4. Spike of antibiotics  
Notes: 
- Prepare the 25-analyte mixture (see section 1.1.3) on the day of extraction 
- 0.5 mg/L is usually a good concentration for the analyte mixture, depending on how much 
volume you want to spike 
- The spike levels for raw water are usually 10, 50, and 100 ng/L 
- The spike levels for finished water are usually 2, 5, and10 or 20 ng/L 
- Spike surrogate prior to analyte to avoid contamination and for surrogate to monitor the 
entire sample processing 
 
1) Calculate the amount of analyte mixture to spike 
 
Example: uLmL
L
mg
mL
L
ng
C
VC
mixtureof
sampleanalyte 25025.0
5.0
25050
25
==
⋅
=
⋅
 
 For S-50 sample, inject 25 µL 
 For S-100 sample, inject 50 µL 
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2) Inject the analytes mixture in the same way as for the surrogate mixture 
 
 
5. Addition of Na2EDTA at 1 mg/L 
Note:  Na2EDTAis added to prevent complex formation between the analytes and the metals 
in water samples (instead EDTA forms the complex).  The surrogates and analytes are spiked 
into the sample before EDTA addition so that they will undergo the same procedure as the 
analytes present in the original sample) 
 
1) Prepare 0.25 g/L Na2EDTA stock solution (section 1.3.2) 
 
2) Calculate the amount of Na2EDTA stock solution to add: 
 
Example: mL
L
mg
mL
L
mg
C
VC
stockEDTA
sampleEDTA 1
250
2501
_
=
⋅
=
⋅
 
 
2) Addition ofNa2EDTA: 
 a. Fill a 10 mL pipette and add 1 mL solution per sample on top of the liquid level 
of the sample  
 c. Cap and invert the amber bottle once 
 d. Repeat for every sample 
 
6. pH adjustment 
Notes: 
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- The pH meter is located in the first bench 
- When not in use, store the electrode in buffer storage solution and the meter in standby 
mode 
 
 
1) Calibration of pH meter 
 a. Remove the electrode from the buffer storage solution and rinse thoroughly  
with LGW 
 b. Dab electrode dry gently using Kimwipe 
 c. Set “slope” on meter to 100 and “temperature” at room temperature in the lab   
(usually ~22 deg C) 
 d. Insert the electrode into a pH 7 buffer 
 e. Switch mode from “standby” to “pH” 
 f. Shake the buffer gently to equilibrate the electrode 
 g. Adjust the “standardize” knob until the reading reaches 7.00 (wait a while for  
pH to stabilize) 
 h. Switch mode back to “standby” 
 i. Rinse bulb with LGW and dry again with Kimwipe 
 j. Use pH 4 buffer and adjust the “slope” knob only to pH 4.00 (get as close as    
possible) 
 l. Switch back to “standby” mode and insert the electrode to storage solution (pH 
 4 buffer)  
 
2). Measure pH of samples from nonspiked to spiked samples with increasing concentrations 
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3). Adjust to pH 6.0 (range from 5.8 – 6.0 is acceptable) as described below: 
 
- To lower the pH, use ~2% formic acid; To increase pH, use diluted NaOH solution (but this 
is rare) 
- Due to buffer capacity of environmental water samples, it is impossible to calculate the 
exact amount of acid to add, so slowly add drops of diluted acid until the sample pH reaches 
the desired value 
- It is important to adjust all samples to approximately the same pH so that the co-extracted 
matrix is the same for each sample from solid phase extraction 
- ALWAYS adjust pH from unspiked to spiked samples, then it is not necessary to rinse the 
electrode each time 
 
 a. Add ~ 5 drops of ~2% formic acid using Fisher 5 ¾” pipettes 
 b. Cap, invert, and measure pH 
 c. Continue adding acid until the pH reaches 6.0 
 - If the pH of the nonspiked sample goes below 5.8, mix it with the other portion of 
the unspiked samples and readjust pH 
d. COUNT the total number of drops added into one sample to reach the desired  
pH and add the same drops to each of the other samples 
e. It is best to then check pH on each subsequent sample 
 f. After pH measurement, store the electrode in the pH 4 buffer solution 
 
 
2.2.2. Solid phase extraction 
Preparation work 
1. Equipments 
 a. vacuum manifold (Supelco Visiprep 24) 
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 b. cartridges (one 6cc HLB cartridge per sample) 
 
2. Place cartridges on the manifold (open valves where cartridges are) 
3.  Close all other valves on top of the manifold 
Procedure 
1. Preconditioning of SPE columns  
Notes: 
- Start preconditioning before sample pH adjustment because it takes ~10 minutes 
- Precondition using methanol which cleans and activates HLB sorbent and acidified 
methanol which is later used as the eluting solvent 
- LGW is used to wash methanol out of the cartridge 
 
1) Add ~ 6mL methanol into each cartridge and let it run through by gravity 
2) Connect the SPE manifold to the waste container which is connected to the vacuum  
3) When methanol almost goes through the cartridge, add ~1 mL of acidified methanol (0.1% 
formic acid) (one squeeze of 5 ¾” pasteur pipette) 
4) If the sample drips through cartridge really slowly, use a 10 mL syringe filled with air to 
push solvent through a little bit 
5) Apply 6 mL of LGW to each cartridge twice and try not to introduce any air bubbles 
7) Label each cartridge according to the sample I.D. 
 
2. Extraction  
1) Insert a T adapter between each cartridge and the valve on the manifold 
2) Open each amber bottle, insert one small tubing into each bottle (try to get tubings that 
have equal length if possible), and connect the tubing fittings to the HLB cartridge (with ~ 3 
mL LGW remaining in the cartridge) 
3) Apply vacuum pressure to initiate the sample extraction 
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5) Record start time (it takes approximately 1 hour for extraction of 250 mL sample) 
6) Adjust flow rate to be at approximately 5 mL/min 
 - Estimate flow rate by extraction for 10 minutes and watch the water level in 
 amber bottles (it should be down to ~50 mL) and the level should be the same in  
 each bottle 
7) Complete checks 
 a. tubings at very bottom of amber bottles 
 b. no leaks 
 c. each cartridge is labeled and labels match with bottles 
 d. equal flow through each cartridge 
 
8) Continue to monitor and adjust flow rate using the T-connectors 
9) After all samples have gone completely through the cartridges, rinse each cartridge with 6 
mL LGW at least twice to remove salts remaining in cartridge 
10) Let the cartridge dry for 5 minutes with a vacuum pressure of 15 ~ 18 Hg 
11) Turn off vacuum and remove each cartridge from the manifold 
12) Tap cartridges on bench surface to get rid of any extra water 
13) Rinse methanol through each orange valve on the manifold that was used (where each 
cartridge was connected) 
14) Wipe off water underside of the manifold cover 
 
15) Dry inside of manifold by first applying vacuum and tilting manifold, and then wiping 
off remaining water with paper towels 
16) Pour extraction waste into sink 
 
3. Elution  
(~ 15 minutes) 
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Notes: 
- Use acidified methanol (0.1% formic acid) prepared no longer than 1 week prior to use 
because formic acid may evaporate over time 
 
1)Collect ~10 mL test tubes with conical ends (1 per sample) and one cap for each tube 
2)  Label test tubes to match sample I.D. 
3) Place white plastic rack inside of the manifold 
4)Place cartridges on the manifold without T connectors (try to put them in the same position 
as for extraction) 
5) Place conical test tubes into the rack according to the corresponding labels 
6) Add 2 mL of acidified methanol to each cartridge using a 10 mL pipette, allow to go 
through the cartridge by gravity, and refill (do this 4 times for a total of 8 mL elution volume 
for each sample) 
7) If necessary, apply some pressure with air-filled syringe or apply some low vacuum 
pressure to initiate the elution process (for the first 2 mL ONLY) 
8) At the end of elution, apply vacuum pressure to pull through the last drops of the eluting 
solvent out of the cartridge 
9) Place used cartridges in labeled and taped bag in freezer.  Do NOT throw away cartridges 
until all analysis is complete 
 
 
2.3. Solvent reduction 
Notes: 
- This process takes ~ 2 hours 
- Can begin to set up blow down during elution  
 
2.3.1. Blow down procedure  
1. Place all test tubes with SPE eluent into a beaker and bring it to the blow down setup 
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2. Get small plastic tubes from the antibiotic drawer under the LC-MS computer monitor 
3. Check the nitrogen tank in advance (to make sure there is enough nitrogen to use for blow 
down) by opening valve on top of the tank and checking to see  if the pressure on the right 
pressure gauge is > 500 psi.  Stop using the nitrogen tank after its pressure is below 500 psi 
4. Set the heating block at “low temperature” at 4 ~ 5 (closer to 5), which means the 
temperature will be between 40 and 50 deg C 
5. Wait ~ 5 minutes to heat up 
6. Connect tubes to the top (number of tubes = number of samples, close the unused ones 
with metal cap) 
7. Place test tubes in the heating block 
8. Lower and secure the top 
9. Put the plastic tubes into the test tubes and make sure that the plastic tubes are above the 
liquid surface of the SPE eluent 
10. Turn on nitrogen and adjust flow rate to blow gently with minimum disturbance of the 
liquid surface  
 - More samples necessitate higher flow rate because the pressure is distributed  
over open valves) – for example, for 4 samples the pressure was ~ 10 – 15 psi 
 - Pressure is measured by left gauge and is regulated by adjusting the two valves  
on the left of the tank) 
11. Pull hood down as low as possible 
12. Wrap aluminum foil around sample test tubes to prevent photolysis 
13. Check the liquid level in the test tubes approximately every 15 minutes, and lower the  
top if necessary 
14. Blow down to ~50 µL in the test tube (~ ¼”) NEVER blow down to dryness! 
15. After the desired volume is achieved, turn off heating and close the valves of nitrogen 
tank 
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2.3.2. Reconstitution    
1. Estimate the residual volume of SPE eluent: 
 1) Add 50 µL of a solvent mixture of LGW/ methanol (9:1) to an empty conical test tube and 
compare its liquid level to that of the SPE eluent to estimate the remaining volume in each 
sample tube.  If the estimated sample volume is > 50 µL, make another test tube with 70 µL 
of LGW/methanol solvent mixture, and try to estimate the level of the sample (it might be ~ 
60 µL) 
2) Record estimated volume on the label of each test tube 
(Note: the sample extract after blow down often looks slightly yellow due to the presence of 
natural organic matter in water) 
 
2. Reconstitute each sample to a final volume of 250 µL with the LGW/methanol solvent 
mixture (9:1) using a thoroughly cleaned 500 µL syringe.  Add reconstituting solvent above 
the liquid level of the sample and avoiding touching the sides of the test tube to avoid 
contamination of the syringe 
 - For example, if the recorded estimated sample volume was50 µL, then add 200  
µL of reconstituting solvent to make a total volume of 250 µL 
 - Syringe doesn’t need to be washed each time if care is taken not to contaminate  
 
2.3.3. Addition of internal standard simatone 
1. Clean a 10 µL syringe with methanol and then rinse with internal standard solution at least 
3 times by drawing in and discarding to waste. 
2. Add internal standard (I.S.) solution at 1.25 mg/L (see section 1.2.2) into each sample and 
into internal standard blank. 
 1) Calculate the volume of internal standard solution needed to add (using same 
 equation) (10 µL for a spike concentration of 50 µg/L) 
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2) Make I.S. blank by adding same amount of I.S. to 250 µL of reconstituting 
solvent (LGW/methanol).  This should be done before adding I.S. into the 
unspiked samples 
Technique:  
 a.  Draw I.S. slowly into the 10 µL syringe (if doing 10µL injection) 
 b.  Inject I.S. under the liquid surface 
 c.  Rinse outside of needle using methanol between every injection 
            d. Add I.S. from unspiked sample to spiked samples with increasing  
concentrations  
3. Vortex each sample 
4. After vortex, turn around test tube to cover area in the test tube with the extract liquid that 
is not reached by vortex 
5. Let each sample sit for 10-15 minutes to allow liquid settle all the way down to the bottom 
of the conical tube. 
 
 
2.3.4. Filtration of sample extracts    
1. Preparation  
1) Gather a vial rack from the cabinet at the end of the second bench, vials (1 per 
sample + 1 for solvent blank) on left side of the second bench, 250 µL inserts (1 per 
sample + 1 for solvent blank), and a cap for every vial 
2) Place an insert into each vial 
3) Label each vial (sample identification, initials, and date) 
2. Filtration of extracts  
1) Get 0.45 µm pore size syringe filters from the LC-MS drawer 
2) Use a 500 µL syringe to slowly draw sample from the test tube 
3) Measure the total volume to verify that it is ~250 µL 
166 
 
4)Record the measured volume on the label on the test tube 
5) With sample still in syringe, remove the needle and attach a syringe filter 
6)Slowly push sample through the syringe filter directly into the insert in the vial 
7) After sample is filtered as much as possible, take filter off the syringe, draw in air, 
re-attach the filter, and push back through to push last drops into the vial 
8) Close the vial with cap 
9) Flick the vial to get rid of bubbles in the insert 
10) Rinse syringe twice using the same LGW/methanol mixture 
11) Repeat steps 1 – 10 for each sample 
Cleaning: rinse syringe 3 times with solvent, then rinse syringe with methanol in the hood, 
take apart and again rinse each part individually, lay syringe (still taken apart) on Kimwipe in 
hood to dry 
 
Store all prepared sample extracts in vials in the freezer until LC-MS/MS analysis.   
 
 
2.4. Lab cleaning 
1. Collect all dishes/parts/tubes/etc in a bucket and bring to sink 
2. SPE tubing: squeeze LGW through one end without connector and let LGW run through 
the tubing for at least 30 seconds  
3. Pipettes:  
 1) Rinse with tap water and then with LGW, inside and outside 
 2) Rinse tips and the whole pipette with methanol while turning the pipette 
 3) Leave the pipettes to dry on paper towel in hood overnight 
 4) Sign and date paper towel 
4. T-connectors: rinse with LGW and put back to the SPE drawer 
5. Amber bottles (don’t need to be acid-washed if it is cleaned right after use): 
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 1) Use soap to clean the raw water sample bottles 
 2) Put a bit of soap in each bottle and fill with tap water, shake 
 3) Rinse the bottle with tap water at least 3 - 5 times 
 4) Rinse at least 3 times with LGW from black sprayer  
 5) Dry in oven overnight (do not change oven temp) 
6. Caps: rinse with tap water and then LGW, air dry in hood 
 
 
3. LC-MS/MS analysis  
3.1. Equilibration of LC system 
1. Check mobile phase levels (at least 3 inches of liquid from bottom of the bottle), and if not 
enough prepare more 
-mobile phase A: 0.1% formic acid in LGW (2 mL formic acid into 2 L LGW, filtered 
to 0.45 micron with nylon filter) 
 -mobile phase B:  acetonitrile  
2. Whenever the mobile phase bottles are changed, the user needs to remove the air bubble as 
described below and then prime the system. 
 1) For mobile phase A, attach a 10 mL plastic syringe to the fitting that is facing  
the user 
 2) Switch T valve so it is facing to the left (which is opposite of normal) 
 3) Slowly pull out mobile phase trying to get all bubbles out 
 4) Return T valve to the normal position (facing to the right) 
 5) Repeat for mobile phase B 
 
Priming: 
 1) Loosen black B valve so that mobile phase won’t go to the LC column and will  
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instead go to waste (this is important!) 
 2) Prime A pump first 
 3) Push “Stop” on the screen of the pump 
 4) Push “Prime” (max flow on pump should be 5 mL/min) 
 5) Prime for ~2 minutes 
 6) Push “Stop” again 
 7) Repeat process for B 
 8) Retighten the black B valve to return mobile phase to column (also important!) 
 
3. For routine operation, before starting the pumps, always check the mobile phase lines to 
make sure there are no air bubbles.  If there are air bubbles, prime the system until they are 
removed. 
4. Need to flush the system as described below if there has been user change or the LC-MS 
has not been used for more than one week. 
 
Flushing: 
 1) Remove the column 
 2)Connect red tubes directly using a union (in drawer under LCMS) 
 3)On the main window, open file  activate method  go to methods directory  
under Varian WS flushing  open 
 4)Maximize the Prostar/Dynamax window to monitor the flow rate and mobile 
phase composition (should be the same as those in the method) 
 5) Flush for ~10 minutes 
 6)Maximize Prostar/Dynamax window again 
 7)Click “Stop Pumps” to stop flushing 
 8)When pressure on screen drops back down to zero, attach column (Pursuit C18) 
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5. Wash autosampler needle – do this every time before injecting samples 
 1) Open auto sampler window 430.25 
 2) Click “Wash” and do this twice 
 3) Minimize window 
6. Attach LC guard and analytical column: Pursuit C18 (15 cm, 2.0 mm, 3µm) 
 1)Make sure the guard column is tightly connected to the analytical column 
 2) Attach in the direction of flow (guard column on left) 
 3) Tape column down to secure 
 4) Put the caps in the little blue bag in the drawer 
7. Check to see if shield is clean, if not: 
 1) Use LGW and wipe shield with Kimwipe, ensuring that no water enters the MS 
 2) Squirt methanol onto shield and into hold on shield 
 3) Clean needle tip with methanol 
 
3.2 LC-MS/MS analysis  
Method Activation 
-The 25 antibiotic analytes are separated by three different LC runs, which means that each 
sample extract is injected at least 3 times 
-The three different LC runs are based on combining analytes of similar structure and must 
be independently run  
-The order of analysis is sulfanomides/macrolides (SAMA)  fluoroquinolones  
tetracyclines 
 
Note: The windows control the instrument components as follows: 
 - Prostar/Dynamax.24  LC 
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 - 430.25  Autosampler 
 - 1200.42  Mass Spec ESI 
 - Prostar 430  Sequence 
1. Click the view/edit method button on the top of the screen 
 - Open an existing method  
 - ZY folder  antibiotic analysis  click on a specific method 
 
2. Make configuration adjustments to the method if necessary 
 - For the SAMA method: 
  - Click on configuration tab on the left 
  - Adjust needle height to avoid breaking the needle: 
   - For 250 µL inserts, set the needle height at 6 mm 
   - For 50 µL inserts, set the needle height at 10 mm 
   - Needle height measures the distance from the bottom of the vial 
up to the tip of the needle (i.e., a needle height of 10 mm will not  
go as far into  the vial as a needle height of 6 mm)  
  - Save the method every time you make any change 
  
- May also need to change the needle tubing volume (ntv) 
  - Check ntv value listed on configuration tab 
- Check ntv value on 430.25 (subwindow of system control)  hardware  
ntv 
  - If the values are not equal, adjust the hardware value to be   
  consistent with the value on the configuration tab in the method 
 
3. Check MS settings: 
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 - On the “Scan method” window (under Method Window) select: 
  - ion source: ESI 
  - mode: centroid 
  - CID gas: on  
  - polarity: positive 
 - Save method and close 
 
4. Activate method 
- System Control Window  Mass Spec subwindow  File  Activate method  
open method 
- Note: if unable to activate, go to Automation  Stop Automation and try 
again 
 - On the main screen (1200.42) when the quadrupole 2 (collision cell) turns  
orange, it means that the collision gas is on  (make sure it is) and the pressure  
should be ~2 mTorr.  If not, adjust the pressure by turning the CID gas  
valve very carefully 
 - Minimize the main screen 
 - Open the LC Prostar screen 
 - Watch the pressure increase until it reaches and stabilizes at ~ 1800 -2000 psi  
 
5.  Set up sequence 
- File  new sample list  Varian WS  data  Laura  create new folder using 
the date (e.g., 112005) 
 - Enter sequence parameters: 
  - Sample name: solvent blank, etc 
  - Injection mode: µL pickup 
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  - Injection volume: 20 µL 
 - Well vial: begin with A1 (wherever the vials are placed in the rack) 
 - Click on Data File (bottom right) and save data under the user’s directory  
Note: the first sample should always be solvent blank. Make 2 or 3 injections of blank to 
equilibrate the LC column and to check the solvents for contamination.  If there are any 
peaks on the chromatogram at the retention times of the analytes (indicating contamination), 
continue running solvent blank samples until there is no more contamination. 
 
Also, if the methods have not been run in a while, make a test solution of ~10 ug/L of 
antibiotics to check if the retention times on the method are still correct. 
 
6. Set up instrument parameters and turn on the ESI-MS (before you start the sequence)  
 - Select API auto 
 - drying gas temp at 300 deg C 
 - API house temp at 50 deg C 
 - Click OK 
 - Click icon with green arrow in the upper left to turn on electrospray 
- Wait until drying gas temperature gets to 160 deg C, then click “turn on the 
instrument” icon to turn on the detector (when the light is green, it is on). Wait  
until the temperature stabilizes before starting the sequence  
 - Make sure the MS valve is in the “Load” mode 
 
7. Last minute checks (before you start the sequence) 
 - Make sure samples are in the autosampler tray with the correct vial number on 
 the sequence  
- Make sure samples have been in the tray for at least 30 minutes after being 
taken out of freezer  
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 - Check that the clear glass solvent vial (called transport vial) behind the rack is 
 full of the reconstituting solvent (90% LGW 10% methanol) 
 
8. Start sequence 
 - Return to Prostar 430 sequence window  click begin on bottom left  click  Ok 
- Each run takes ~ 30 minutes 
 
9. Check the chromatograms of the solvent blank to see if there is contamination   
 
10. If there is NO contamination, add all samples to the sequence following the same scheme 
in step 5 above 
 
11. After putting all samples in the sequence, activate the second method by browsing the 
method in the method files 
 Sample type: Activate method 
 Auto link: select method 
 
12. Repeat the sample sequence for the second method   
 
13. At the end of the whole sequence, put in one line saying: 
 Sample type: Activate method 
 Auto link: methods  ZY  stop run 
 Do one analysis of solvent to initiate the “stoprun” method. 
4. Data Analysis 
 
4.1. Integration of analyte peaks 
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4.1.1. Manual integration  
Software: Varian WS Work station 6.4.   
Notes: analytes must be integrated one by one 
 
1. Click on the window of Review/Process MS Data 
 - Find data file 
 - Open chromatogram on the screen 
 
2. Input 
- Select the file names to be analyzed 
- Data  Ion 
- Channels  Scan  selected scan channels 
 
3. Use ZY’s method document to find certain ions 
 - i.e., for sulfathiazole one of the two product ions is m/z 156 and the scan channel 
 is m/z 256 to m/z 156.  Note: the second product ion column is used for 
 confirmation of detection of the analyte (if the ratio of the areas of the two 
 product ions listed in the 1st and 2nd column, respectively, is within a certain 
 range, it confirms the detection of the analyte – the ratio varies depending on 
 individual analyte) 
 
4. Adjust chromatograph 
 - Right click  select local chromatograph plot preferences  chromatogram  
plot  under filtrating  smooth data (points 5 or 7) AND remove spikes  
OK 
 
5, Zoom in to enlarge peak 
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 - Adjust x axis by dragging mouse along axis 
 - Adjust on y axis by just clicking 
 
6. Integrate peak 
 - Click on set click and drag action  integrate area 
 - Draw line along the base of the peak (BE consistent to where you draw the line) 
 - Enter data into Excel 
  - Apex = retention time 
  - Area = area of the peak (important parameter!) 
  
4.1.2. Automated integration  
Create a quantitation method 
1. Create a new method (create new method  next  finish) 
2. Select the file that you want to analyze (on left MS Data handling  compound table) 
3. Click “add” to add the number of ions you want to integrate(two ions for one analyte), so 
20 ions need to be integrated for 10 analytes 
4. Double click retention time column header to get total ion chromatogram 
5. Zoom out a specific peak to make it larger 
6. Name the ion (e.g., Sulfamethoxazle-156)  
7. On quantum ions tab select scan channels (under merged) and select the target ion 
8. Under integration tab, set integration window at 3.0 min, under “filter peaks” smooth the 
chromatogram with a factor of either 7 or 5 and set the “remove spikes” at a factor of 5 
9. If the integration peak looks weird, adjust the peak width and slope sensitivity to improve 
10. Under identification tab, select retention time with search time +/- 0.5 min 
11. Hit close 
12. For confirmation, get peak areas of both fragment ions for each analyte 
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13. Continue for each ion, adjusting peak width and slope sensitivity if necessary 
14. Save method in methods subfolder 
 
Data processing using the quantitation method  
Advantage: this method is more accurate than the manual integration method and the data 
files can be copied to Excel and saved 
1. Open the chromatograms folder 
2. Double click to open the chromatograms 
3. Select one file  quantitation  process active folder 
4. Under method folder, browse for the method to process the data with 
5. Click “process” to analyze data file with the method 
6. Click “view results” 
 - For EACH peak draw a line from beginning to the end of the peak and click  
“integrate” 
 - If the integration is not correct, need to edit method to adjust parameters.  Save 
  the method each time it is updated 
 - Click “done” after adjusting each 
7. Save method changes if you want (usually a good idea) 
8. Save the integrated data file: Print  sample report (ASCII)  folder data file, name as 
sample ID and save it so it can be opened and saved by Excel 
 
 
4.2. The method of standard addition  
1. Integrate the peaks of a specific analyte and the internal standard (either by manual or 
automatic integration) 
2. Set up an Excel Spreadsheet with rows or columns for spike amount (ng/L), simatone 
(I.S.) Area, and analyte Area 
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3. Calculate relative area = Area of analyte/area of I.S. 
 
4. Build two calibrations (one with 0-1 sample and the spiked samples, the other with the 
duplicate nonspiked sample (0-2) and the spiked samples) – Area (y) versus concentration (x) 
5. Extrapolate to get the absolute value of x when y = 0 
6. These two values are the concentrations in the original sample from duplicate 
measurements – average the two values and calculate the average deviation (A.D.) and the 
relative percent of difference (RPD).  Use two significant figures. 
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Appendix 3: 
 
North Carolina Land Use Maps 
 
Figure A.3.1 Land uses in the Cane Creek Watershed (Location of source Water for 
DWTP1).  The light pink color indicates the location of row crops.  Yellow color indicates 
hay pastures, and green indicates forests.  Map obtained from the NCSWAP for OWASA, 
2010. (NCSWAP, 2010c)  
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Figure A.3.2 Area and potential contaminant sites (PCS) for the Cane Creek Watershed 
(Location of source Water for DWTP1).  The Cane Creek watershed protection area is 
outlined in light blue and the critical area in dark blue.  The map shows the locations and 
types of PCS.  A limited number of PCS are present in the watershed including; animal 
operations, isolated pollution incidents, and non discharge permits. Map obtained from the 
NCSWAP for OWASA, 2010. 
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Figure A.3.3 Land uses in the Big Alamance Creek Watershed (Location of source Water for 
DWTP2).  The red color indicates commercial, industrial, transportation uses.  The orange 
indicates high intensity residential.  The light pink color indicates the location of row crops.  
Yellow color indicates hay pastures, and green indicates forest.  Map obtained from the 
NCSWAP for The City of Burlington, 2010. 
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Figure A.3.4 Area and potential contaminant sites (PCS) for the Big Alamance Creek 
Watershed (Location of source Water for DWTP2).  The Big Alamance Creek Watershed 
protection area is outlined in light blue and the critical area in dark blue. The map shows the 
locations and types of PCS.  A number of PCS are present in the watershed including; animal 
operations, NPDES permit sites, and isolated pollution incidents among others. Map obtained 
from the NCSWAP for The City of Burlington, 2010. 
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Figure A.3.5 Land uses in the Little River (Little River Reservoir) and Flat River (Lake 
Michie) Watershed (Locations of source water for DWTP3).  The red color indicates 
commercial, industrial, transportation uses.  The light pink color indicates the location of row 
crops.  Yellow color indicates hay pastures, and green indicates forest.  Map obtained from 
the NCSWAP for The City of Durham, 2010. 
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Figure A.3.6 Area and potential contaminant sites (PCS) for the Little River (Little River 
Reservoir) and Flat River (Lake Michie) Watershed (Locations of source water for DWTP3).  
The Little River (Little River Reservoir) and Flat River (Lake Michie) Watershed protection 
area is outlined in light blue and the critical area in dark blue. The map shows the locations 
and types of PCS.  A number of PCS are present in the watershed including; animal 
operations, non discharge permit sites, NPDES permit sites, and isolated pollution incidents 
among others. Map obtained from the NCSWAP for The City of Durham, 2010. 
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Appendix 4:  
 
Chlorine Isotope Ratios 
 
 
 
 
 
Figure A.4.1 Full Scan Mass Spectrum of Atrazine, a Mono-chlorinated BAC.  The 
Characteristic Chlorine Ratio of [M]:[M+2] for 216.1:218.1 corresponding to 35Cl:37Cl is 3:1. 
 
 
 
Figure A.4.2 Full Scan Mass Spectrum of Diclofenac, a Di-chlorinated BAC.  The 
Characteristic Chlorine Ratio of [M]:[M+2]:[M+4] for 293.8:296.3:298.3 corresponding to 
35Cl:37Cl:39Cl is 9:6:1. 
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Figure A.4.3 Full Scan Mass Spectrum of Sucralose, a Tri-chlorinated BAC.  The 
Characteristic Chlorine Ratio of [M]:[M+2]:[M+4] for 394.9:397.1:399:401 corresponding to 
35Cl:37Cl:39Cl: 41Cl is 27:27:9:1. 
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